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An agent that suppresses vomiting. Used to treat such 
conditions as motion sickness and vertigo and to 
counteract nausea and vomiting caused by other 
drugs.
Non symmetric.
An object which is not superimposable upon it’s 
mirror image.
An atom, and groups around it, which is not 
superimposable upon it’s mirror image.
The general property of “handedness”.
Two compounds which are stereoisomers but not 
enantiomers have a diastereomeric relationship.
% d.e. = ([A]-[B]/[A]+[B] ) x 100 (expressed as %
d.e.) where A and B are the amounts of individual 
diastereoisomers produced.
Any reaction in which only one diastereoisomer is 
formed exclusively or predominantly.
Replacement of an atom or group (one of a pair of 
identical groups) with a third group (unlike any 
existing group) gives rise to diastereoisomers.
Many compounds may be obtained in two different 
forms in which the m olecular structures are 
constitutionally identical but differ in the three- 
dimensional arrangement of atoms such that they are 
related as mirror images. In such a case the two 
possible forms are called enantiomers.
% e.e. = ([A]-[B]/[A]+[B] ) x 100 (expressed as %
e.e.) where A and B are the amounts of individual 
enantiomers produced.
Any reaction in which only one enantiomer is formed 
exclusively or predominantly.
Two atoms or groups that upon replacement with a 
third group (unlike any existing group) gives rise to an 
enantiomer.
Two diastereoisom ers that have a d ifferent 
configuration at only one chiral centre.
A compound which is diastereomerically and 
enantiomerically pure.







Consisting of a 1:1 mixture of enantiomers.
The face of a double bond in which the three groups, 
arranged by the priority rules, have the order A>B>C, 
in a clockwise fashion.
The face of a double bond in which the three groups, 
arranged by the priority rules, have the order A>B>C, 
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It has been demonstrated that phosphinamides such as (29) are efficient 
catalysts for the asymmetric reduction of prochiral ketones with borane. Reduction 
typically occurs in less than 1 hour at room temperature with modest asymmetric 
induction.
An investigation into the steric and electronic factors important for catalysis 
has revealed that the greatest reduction accelerations are achieved by derivatives in 
which the ‘R^-N-P=0’ structural unit can adopt a planar geometry, thus maximising 
electron donation from the nitrogen lone pair to the P=0 bond. Electron 
withdrawing substituents on the nitrogen atom of the N-P=0 unit decreases both the 
rate of catalysis and reduction selectivity. An electron rich substituent bonded to 
phosphorus dramatically increases the rate of catalysis with little effect on 
selectivity. Conversely, an electron withdrawing substituent bonded to phosphorus 
has a detrimental effect on both rate of catalysis and enantiomeric induction.
On the basis of experimental and theoretical data it is proposed that catalysis 
is achieved by activation of borane via a strong donation from the oxygen atom of 
the N-P=0 system coupled with a much weaker interaction of the carbonyl group 
lone pair electrons with the phosphorus atom.
We have also demonstrated that a combination of the phosphinamides with 
an electron accepting boronate ester, either as a bi-molecular co-operative system 
((98) together with (29)) or as a single molecular entity (108), significantly 
improves asymmetric induction, presumably as a consequence of more effective 
ketone binding.
Finally, we have shown that Diphenylphosphinyl group is an effective 
protecting group for primary a-amino ketones and that the ketophosphinamide 
products are excellent substrates for diastereoselective reduction with borane. The 
diphenylphosphinyl group both activates the borane reagent for hydride transfer and 
directs the intramolecular reduction.
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1 Introduction. 
Asymmetric Synthesis: whv it is important and how it can be 
achieved.
Section 1.1 The Phenomenon of Chirality.
Chirality is a fundamental symmetry property of three dimensional objects. 
In a chemical context, chirality refers to the three-dimensional structure of a 
molecule. Many molecules can occur in two different enantiomeric forms, differing 
in the spatial arrangement of the carbon atoms or groups, such that they are related 
as object to mirror image. In the absence of an external chiral influence both 
enantiomers have identical chemical properties and differ only in the direction in 
which they rotate the plane of plane-polarised light.
The demand for a flexible and easy route to homochiral compounds comes 
from the relationship between the absolute configuration of organic molecules and 
their biological properties. In much the same way that a right-handed glove will 
only fit the right hand, enzymes, cell receptors and all other molecular components 
of life are themselves constructed from molecules of a single “handedness” and are 
therefore sensitive to differences of configuration between molecules with which 
they interact Many biologically active compounds, such as drugs, contain one or 
more stereogenic centres. When a chiral drug interacts with its receptor site, which 
is also chiral, the two enantiomeric forms of the drug interact differently and may 
lead to different effects. Thalidomide (1) is perhaps the most dramatic example of a 
drug whose two enantiomers have profoundly different effects; the R-antipode 
provided the desired clinical response as an anti-emetic whereas the S-enantiomer 
was found to be responsible for the horrifying series of birth defects that occurred 
among children bom in the late 1960’s.^
DOPA (2) is used in the treatment of Parkinson’s disease. The active drug is
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the achiral compound dopamine, formed by the enzyme-mediated decarboxylation 
of (2), but this cannot cross the blood-brain barrier to reach the required site of 
action. The “prodrug” (2) can and is then decarboxylated by the enzyme dopamine 
decarboxylase. The enzyme is, however, specific for the (-) enantiomer of (2). It is 
therefore essential to administer only DOPA as the pure (-) stereoisomer to prevent 
a harmful build up of (+)-(2) which cannot be metabolised by the enzyme.^
(-)-DOPA (2 )
For many compounds two enantiomers can have quite different and distinct 
biological activities, for example the alkaloid (-) levorphanol (3) is a powerful 
narcotic analgesic. Its enantiomer (+) dextrorphan (4) has no analgesic activity, but 
is active as a cough suppressant.
HOHO
(3 )
There is increasing awareness in the pharmaceutical and medicinal chemical 
industries that neglect of stereochemistry results in a collection of worthless data. 
This leads to misleading conclusions and the waste of research time in the 
generation of “sophisticated nonsense” and hence inferior products.3b It is now 
appreciated that the pharmacologically less active or inactive isomers may well 
contribute to the toxicity or adverse effects of the drug. As a result legislation
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demands that on registration of a new compound the chirality of the drug substance 
is recognised, and the stereoisomer responsible for the activity of interest identified* 
Stereochemical considerations must be added to the specification of the drug 
substance, including assignment of absolute configuration, and detailed information 
on how the chiral centre is created. The most important addition to the normal 
requirements for drug approval is the need to “justify on chemical, pre clinical and 
clinical grounds the stereoisomeric form(s) chosen for marketing”.3
It is therefore of prime importance to be able to control the formation of 
asymmetric centres during the course of a synthesis. Especially delicate is the 
formation of the first stereocentre in a chiral molecule, and the past 15 years have 
seen an explosion of methods for achieving this g o a l .4
Section 1.2 The Preparation of Chiral Compounds.
There are various procedures used to prepare homochiral compounds:
1.2.1 Resolution of Racemic Mixtures.
Resolution may be thought of as the classical method of obtaining 
homochiral compounds. The procedure involves the derivatisation of the mixture 
with an enantiomerically pure resolving agent, then separation of the resulting 
diastereomeric compounds. The major disadvantage of this method is the “trial and 
error” element of finding a suitable resolving agent, and the fact that the required 
stereoisomer cannot be obtained in greater than 50% yield. This results in a serious 
waste of material on a large scale.
1.2.2 Modification of Naturally Occurring Compounds.
The ultimate source of chirality in all asymmetric synthesis is nature. The
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chiral compounds that occur in nature provide an enormous range and diversity of 
possible starting materials. Modification of naturally occurring molecules from 
nature’s “chiral pool” such as amino acids, sugars, alkaloids and terpenes has been 
used very effectively in asymmetric synthesis.^ An example is the synthesis of R- 
(+)-frontalin from naturally occurring R-(-)-linalool (5) by Magnus and Roy 
(Scheme 1).^












Two distinct methods are used to achieve this. The first is the use of a chiral 
auxiliary. The enantiomerically pure auxiliary is attached to an achiral substrate and 
used to direct the reaction and hence induce chirality into the molecule. It is then 
removed and can be recovered and recycled. Ideally both enantiomers of the chiral 
auxiliary must be available in enantiomerically pure form, and must be easily added 
and removed without racemisation of the induced chiral centre or the auxiliary 
itself. An example is the oxazolidinone methodology developed by Evans, 6 which 
has been used successfully for many asymmetric transformations including aldol
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reactions,^ Diels-Alder reactions 6b and alkylations.^c
The power of this methodology was demonstrated by Evans in his elegant 
synthesis of the Prelog-Djerassi lactone,^ the first stage of which involves the 
alkylation of the oxazolidinone derived from norephedrine (Scheme 2). Reaction of 
the internally chelated Z-enolate of the oxazolidinone with methallyl iodide occurs 
on the face opposite the methyl and phenyl groups of the auxiliary. The resultant 
97:3 mixture of diastereoisomers could then be purified to a ratio of >500:1. This 
illustrates a significant advantage of the auxiliary methodology in that the reaction 
products are diastereomeric, and hence can be separated and purified.




















The second method is asymmetric catalysis,^ which unlike stoichiometric 
methods, is capable of multiplying chirality. In this process, the reaction proceeds 
via a non-covalently bound complex between catalyst and substrate.
Section 1.3 The Principle of Asymmetric Catalysis.
Consider a prochiral molecule (A) with enantiotopic faces (Figure 1) which 
on addition of reagent (B) is transformed into a product (P); the reaction being 
catalysed by an organometallic complex (M).
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Addition of B gives Pr
Figure (1 )
Addition of B gives Ps
If the catalyst is achiral, P will be obtained as a racemic mixture Pr + Ps; 
one catalytic cycle will result in formation of one enantiomer of the product, the 
other enantiomer being obtained with the same probability in a catalytic cycle 
independent or connected to the first (Figure 2).
A






Reaction A+B  *- P, catalysed by [MLn]
If ligand, L, is racemic [Pr]=[Ps ]
If ligand, L, is non racemic [PrM P s ]
Figure (2)
The two cycles are mirror images of each other. If the catalyst is modified
by introduction of a chiral ligand, the two competitive cycles remain, but are no
longer mirror images of each other, and their relative efficiencies must differ. A 
good choice of ligand should increase the rate of formation of one enantiomer of 
product over the other resulting in increased enantioselectivity. An example is the
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addition of diethyl zinc to aldehydes catalysed by chiral amino alcohols (Scheme
Of the methods currently available for asymmetric synthesis, catalytic 
processes are the subject of intensive research at the present time. By definition the 
catalyst can be recovered unchanged at the end of the reaction and in many cases 
only a small quantity is required to direct a reaction, although in practice a larger 
quantity may be used to achieve a reasonable rate of conversion. The possibility of 
using sub-stoichiometric quantities of an enantiomerically pure compound to direct 
an asymmetric transformation obviously has great attractions for large scale 
industrial use where cost and environmental issues are critical. This thesis involves 
the study of an catalytic asymmetric transformation, namely the asymmetric 
reduction of prochiral ketones. The area of enantioselective carbonyl reduction has 
been studied extensively over the past 10 years though the majority of work has 
been centred on the use of stoichiometric methods. A detailed summary of the 
major advances in this area of asymmetric synthesis is given below.
T h e  A sym m etric  R educ tion  o f ketones.






The reduction of unsymmetrical ketones to homochiral alcohols is one of the
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most widely studied and synthetically important reactions in asymmetric organic 
synthesis. 10 The alcohols produced by such a process may be used as a chiral 
framework for a synthesis, or may be valuable products in their own right.
For ketone reduction, addition of hydride to one face of the carbonyl group 
gives an alcohol of one absolute configuration; addition to the opposite face gives 
the other enantiomer (Figure 3).
H vOH Add H' to ? \ Add H" to H° \  o HAPh Me front face Me back face Ph Me
(R) Figure (3 )  (S)
A variety of reagents has been developed over the last decade which control 
the selective addition of hydride to one of the two enantiotopic faces of the carbonyl 
group; many have been developed by chiral modification of common reducing 
agents such as lithium aluminium hydride, sodium borohydride, and borane. 10b
Section 1.4.1 Stoichiometric Reagents.
The most obvious method of controlling face selectivity for hydride delivery 
is the use of an enantiomerically pure hydride source. In principle these reagents 
will transfer hydride to each face of the ketone through two diastereomerically 
distinct transition states, one of which should be lower in energy than the other. 
Two examples of a successful application of this expedient are chiral aluminium 
hydride reagents 10c>e and organoboranes. 10g
1.4.1.1 Aluminium Hydride Reagents.
BINAL-H (6) was developed by Noyori 11 and is a modification of lithium 
aluminium hydride in which two hydrides are replaced by the chiral diol R-[ 1,1’-
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binapthyl]-2,2’diol and a third by a simple alcohol.
Page 9 s
OEt
(6 ) R- BINAL-H
H
The reducing agent exhibits extremely high face selectivity in the reduction 
of variety of aromatic, alkynylie and olefmic ketones. For example the reduction of 
tributylstannyl ketone (7) gives a single enantiomer of alcohol (8) which has been 
used in a concise synthesis of the cembranolides, a class of marine diterpenoid 
natural products (Scheme 4).
(7)
SnBu3







Cembranolide Scheme (4 )
The high selectivity is achieved through the intermediacy of a transition state 
in which a stabilising interaction occurs between the trialkyltin and ethoxy- groups, 
directing hydride from aluminium to one face of the ketone (Figure 4). 12





Figure (4 ) Transition state for 







The other outstanding source of “chiral hydrides” are enantiomerically pure 
alkylboranes.l0§’13 These are readily available from hydrocarbon precursors, and 
numerous structural variations have been reported. Of these the fL3-pinanyl-9- 
borabicyclo!3.3.1]nonane reagent (9) (commonly known as Alpine borane) 
developed by Midland is one of the most successful in terms of substrate scope and 
selectivity.
Like many trialkylboranes, Alpine borane is virtually inert to various 
functional groups, but is very effective for controlling asymmetric reductions 
particularly of acetylenic ketones. ^  The acetylene group can then be subsequently 
transformed to give a vast range of target molecules; in the example shown 
messoilactone, the defence allomone of the formicine ant, is the synthetic target 
(Scheme 5).
steps
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One of the drawbacks of the Alpine borane reagent is that it is not very 
reactive towards ketones. Its reactivity can be increased by increasing the Lewis 
acidity of the boron atom. Brown has utilised this effect in developing a variety of 
dialkylhaloboranes; chlorodiisopinocampherylborane (10) (IPC2 BCI) being by far 




Both reagents (9) and (10) are thought to work in a similar fashion and 
distinguish the two faces of a prochiral ketone on the basis of substituent size. In 
the case of (9) a six-membered boat-like transition state, in which the hydride (5- to 
the boron atom is transferred to the ketone, has been proposed. The larger of the 
ketone substituents (Rl) occupies a pseudo-equatorial position so as to minimise 
1,3-diaxial interactions (Figure 5). This results in a very high face selectivity.
Section 1.4.2 Catalytic Reagents.
All the above examples, despite their high efficiency and the high levels of 
asymmetric induction they impart, suffer one major drawback; namely they are all 
stoichiometric reagents. In other words one molar equivalent of chiral reducing 
agent is required for the transformation. On a large scale this may be prohibitively 
expensive and complications arising from the large quantities of reagent required 
may render them unusable. Far more attractive is a catalytic system in which a sub- 
stoichiometric quantity of chiral directing ligand can be used in conjunction with a
Ra
Figure (5 )  Transition state for
ketone reductions by (9 )  
RL=large group, RA=alkyne
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reducing agent. The catalyst can then, in theory, be recovered and recycled. 
Various reducing systems have been developed to this end.
1.4.2.1 Enzyme Mediated Reduction.
In recent years there has been a veritable renaissance in the field of 
enzymology due in part to the realisation that many enzymes will accept ‘unnatural 
substrates’. The asymmetric reduction of ketones, usually conducted with whole 
cells (normally yeasts) have proved very su ccessfu l.^  Baker’s yeast 
(Saccharomyces cerevisiae) has been used for the reduction of simple aryl ketones 







Enzymatic reduction is, however, limited with respect to substrate 
suitability. Also it is not always possible to access both enantiomers of product 
using enzymatic procedures.
1.4.2.2 Synthetic Reduction Catalysts.
In developing a synthetic reduction catalyst the aim is to mimic the action of 
an enzyme both in terms of selectivity and functional group specificity and to 
combine with this an ability to accept a wide range of ketone substrates. Synthetic 
chemists have developed a number of catalytic systems which satisfy these criteria.
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R-BINAP (1 1 )
One such reagent is the chiral phosphine BINAP 16a ( H )  developed by 
Noyori. BINAP is chiral by virtue of a biaryl linkage about which rotation is 
restricted, and is available in both enantiomeric forms. Complexes of BINAP and 
ruthenium have been used to direct the asymmetric hydrogenation of alkenes and 
ketones with extremely high selectivity (Scheme 7).16d
O o  0 .1  mol% [(R)-(BINAP)Ru(OAc)2], O
CH2 CI2 /MeOH, H2 (100 atm) f
OMe -----------------------------------------------  OMe
30 °C, 36 hrs 96% Yield 
99.4% e. e.
Scheme (7)
The major limitation with this methodology is that the substrate must contain 
a suitable co-ordinating group, such as an ester, in close proximity to the keto group 
in order to achieve good e n a n t i o s e l e c t i v i t y . l ^ d  Hydrogen is then transferred from 
metal to substrate in a well defined asymmetric environment centred on ruthenium 
(Figure 6). An example of an application of this methodology is the asymmetric 
synthesis of c a r n i t i n e *  6c (vitamin B t) , a compound responsible for human 
metabolism of long chain fatty acids (Scheme 8).
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Me
OMe
Figure (6 ) Substrate bound to ruthenium/ 
BINAP catalyst prior to asymmetric reduction.
0.05 mol% [(R)-(BINAP)Ru(OAc)2], 
CH2 CI2/MeOH, H2 (100 atm)
OEt












Another recent development in the field of metal based catalysts uses an 
alcohol as the primary reducing agent in a Meerwein-Ponndorf-Verley type 
r e d u c t io n .  17 The samarium based variation of this reaction has been developed by 
Evans using the complex (12) formed from the appropriate chiral amino diol and 
samarium triiodide.
This promotes the reduction of aryl/alkyl ketones using isopropyl alcohol as 
reductant with enantiomeric excesses up to 97%, presumably via a transition state 
similar to that shown (Figure 7). *8















Figure (7) Transition state 
for reduction of aryl/methyl 
ketone by isopropylalcohol 
catalysed by (1 2 )
By far the most widely used and powerful reduction catalyst is based on the 
oxazaborolidine structure first reported by Itsu n o ^ , and later by Corey who 
identified the structure and mechanism by which reduction takes p la c e d  The 
oxazaborolidines (13)-(15) contain adjacent donor (nitrogen) and acceptor (boron) 
sites, and are not in themselves reducing agents; they require borane as the 
stoichiometric reducing agent. The catalysts mimic an enzyme in that they bind 
ketone (in the acceptor site) and borane (in the donor site), bringing them together, 
allowing them to react in an asymmetric environment and releasing them.
The proline derived reagents shown were developed by Corey20 ? ancj 
catalyse the reduction of a wide range of ketones with enantiomeric excesses of
J-JntrpducM n EageJ.6
>9 5 %.20b Numerous modifications of the basic oxazaborolidine structure have 
been reported over the past few years, all with varying degrees of efficiency .21
The oxazaborolidine catalysed reduction has been used as the key step in 
coundess asymmetric syntheses, an early example being the synthesis of the |3- 
adrenoreceptor agonist Isoproterenol (16) (Scheme 9).22
(iPr)2Si
Four steps
^  10 mol% (13) /
I -------------------   (iPr)2Si
u  0.6 eq. BH3.THF q








More recendy the synthesis of highly complex molecules have been realised 
using oxazaborolidine catalysed reduction as a key step. The new chiral centre thus 
created subsequendy determines the absolute stereochemistry of the final product. 
Two such examples are the synthesis of Ginkolide B (17) ,23 a potent agonist of 
platelet activating factor, and Forskolin (18),24 an activator of ATP-AMP cyclase 
and therefore capable of controlling cellular levels of cyclic AMP (Schemes 10a and 
10b).





1 0  mol% (14) 





















Schem e (10b) Forskolin (18)
In all the above examples, ketone substituent size is important in 
determining the reduction selectivity. The ketone is assumed to co-ordinate with the 
electron poor boron atom through its lone pair trans to the large carbonyl appendage 
(phenyl in the case of acetophenone), with the borane co-ordinated to the adjacent
 1 Introduction.____________________________________________________________Page 18.
donor nitrogen atom (Figure 8).25 Both ketone and borane co-ordinate to the 
convex face of the catalyst which serves both to activate the reagents, and bring 
them within reactive distance of each other. Of the two possible transition states 
shown in Figure 8, the latter is disfavoured due to a strong steric interaction between 




state for reduction by (14).
Hydride is thus directed onto one face of the ketone selectively via a six 
membered transition state. Once reduction has taken place, the catalyst releases 
product and is then free to re-enter a catalytic cycle, reducing more ketone. The 
reducing system is a good example of the ‘ligand acceleration p h e n o m e n o n ’26 i.e. 
neither borane (stoichiometric reductant) nor the oxazaborolidine (catalyst) reduces 
ketone rapidly but a combination of these reagents form a complex which, in the 
case of acetophenone, results in quantitative reduction in a few minutes at room 
temperature.
Despite the effectiveness and apparent ubiquitous nature of the 
oxazaborolidine system there are a few disadvantages, mainly concerned with 
preparation. The traditional synthesis involved reaction of the appropriate amino
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alcohol with a boronic acid in boiling toluene, with azeotropic removal of water 







Schem e (1 1 )
This preparation has proved problematic for many groups; the catalyst 
prepared via this route affording erratic and non reproducible results, largely due to 
traces of unreacted boronic acid, and various alkoxy borane impurities.22 >2^ In a 
detailed study of the performance of oxazaborolidine (14), a group of Merck 
chemists found that traces of methylboronic acid or unreacted amino alcohol had a 
detrimental effect on catalyst efficiency, with a substantial erosion of 
enantioselectivity.2  ^ They also found that « 1  mol% of water was deleterious to 
enantioselection. In the reduction of (19), an intermediate in the synthesis of the 
carbonic anhydrase inhibitor MK-0417, it was found that under the conditions 
shown as little as 1 milligram of water per gram of ketone was sufficient to lower 
the enantiomeric excess from 95% to 50% (Scheme 12).2^
The oxazaborolidine catalysts thus require rigorous exclusion of water 
during use and careful preparation and purification. This presents a serious 
limitation for large scale and industrial application.
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H OH
(19)
1 0  mol% (14)







MK-0417 Schem e (12)
Developm ent of an A lternative Catalyst for the A sym m etric 
Reduction of Ketones with Borane.
Section 1.S Bationa)e.aad Catalyst Design.
Obviously no one reagent can be expected to provide all the desired traits 
one would like in a reducing agent. As synthetic targets become more complex so 
the demand for hew systems, complementary to those currently available, which can 
offer both high levels of selectivity and specificity and tolerate the presence of other 
sensitive functionality in complex substrates increases.
Our work in this area was promoted by the need for a catalytic reducing 
system based on borane as the stoichiometric reductant, which would be less 
susceptible to reaction conditions and easier to prepare and purify than the 
oxazaborolidines. With these goals in mind we envisaged replacing the -BR- 
component of these systems with a P(0)R unit, as typified by the phosphinamide 
structure shown (Figure 9).
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donor s ite
R1
X = OR, NR’ R2, alkyl, aryl
\ '— N'  R1, R2, R3 = alkyl, aryl
r3 R2 r3 = alkyl, aryl
Figure (9 )
Acceptor site
This structural fragment still has the essential requirements of the 
oxazaborolidine system, i. e. a suitable donor site in the oxygen atom of the P=0 
bond, and an adjacent acceptor site on phosphorus. These similarities, we believed, 
would result in a similar mechanism of action and reactivity profile (Scheme 13).
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R=R'= alkyl, aryl Scheme (1 3 )
There is a significant donation of electron density from the nitrogen lone 
pair to the P=0 bond in phosphinamides, though unlike the corresponding 
carboxylic amide nitrogen atom, phosphinic amide nitrogen is more basic since the 
lone pair is less involved in 7t-bonding to phosphorus.30 The geometry and 
protonation behaviour of carboxylic amides is interpreted in terms of resonance 
effects, resulting in the partial double bond character of the nitrogen acyl linkage. 
In amides derived from phosphoric acid R2P(0)NR2, conjugation effects are
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expected to be less important because of the different atomic orbitals (2p  and 3d) 
involved. The lesser involvement of the nitrogen lone pair in conjugation with the 
phosphinyl group is taken as a key factor responsible for the remarkably facile 
cleavage of the P-N bond under acidic conditions.^ * Such 7t-bonding is not entirely 
absent however since in some instances R2P(0)NR2 compounds show restricted 
rotation about the P-N bond, for example phosphinamide (20); the crystal and 
molecular structure of which has been d e t e r m i n e d .32 The large 7t-interaction of the 
nitrogen lone pair electrons with the phosphorus d-orbitals in this compound results 
in a shortening of the P-N bond length to 1.168 A and an elongation of the P=0 bond 
distance to 1.482A, which is longer than normal phosphoryl bonds.33,56
Though the nitrogen atom is fairly basic in these compounds, a number of 
X-ray crystal structures of related phosphinamide structures complexed to l i t h iu m ^ ^  
and l a n t h a n i d e 3 5  cations have been reported e.g. ( 2 1 )  and ( 2 2 ) .  In these systems 
complexation is invariably through the oxygen atom, with no evidence of nitrogen 
co-ordination. It therefore seemed likely that the oxygen atom in the N-P=0 system 
would be an effective donor for electrophilic reagents such as borane (Scheme 13).
, Li—Cl ^ L i
Me Me
1 Me(20) Me 
Third NMe2 omitted
[CILi.O=P(NMe2 ) 3 ] 4  (21 )
Me2N NMe2
\  ^  1 1 
Me2N ^  * 0 * s Jn. . . 0 ^ P- NMe2
O'" I '  0  [Sml2 (HMPA)4]
p *  I ^ p ^-NMe2
Me2N^" \ / (22)
NMe2 Me2N
Third NMe2 omitted
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Co-ordination of the oxygen atom to a molecule of borane should increase 
the level of positive charge at the phosphorus centre, making it more electrophilic 
and a better acceptor of electron density from the carbonyl group lone pair (the 
phosphorus atom in these systems is not usually regarded as a Lewis acid of any 
appreciable s t r e n g t h ) 7 6  Assuming the sequence of events in Scheme 1 3  above, the 
borane and ketone will be located within reactive distance of one another, and 
hydride transfer can then occur through a six membered transition state. 
Manipulation of groups attached to nitrogen and phosphorus should enable a 
suitable chiral environment to be generated, allowing selective delivery of hydride, 
in an absolute sense, to one face of the ketone.
The phosphinamide structures reported in the literature are all stable to air 
and moisture and are usually crystalline s o l i d s . 36 No phosphinamide-borane 
complexes have been reported,H6 though a single report of a borane protected 
oxazaphospholidene (23) being used as an asymmetric reduction catalyst was 
described by B u o n o , 3 7  however, no explanation of the mechanism of reaction was 
discussed.
7+ Ph
H3B - (2 4 ) Ph (2 5 )
Prior work In the Wills group had dem onstrated that the 
dihydobenzazaphosphole-borane complex ( 2 4 ) ,  prepared via <9rf/*o-lithiation of the 
silyl-protected amine,53 had a controlling influence on the reduction of 
acetophenone; the presence of 2 mol% of this compound in conjunction with borane 
dimethylsulfide complex in THF at room temperature gave a 2:1 mixture (ca. 30% 
e. e, R- major) of enantiomeric alcohols. In a very preliminary result it was also 
found that the corresponding phosphine oxide ( 2 5 )  had some catalytic activity. 55
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Since compounds structurally related to (25) are easier to prepare and handle 
than the P(III) complexes, we planned to execute a detailed study of the factors 
important for both catalysis and asymmetric induction in the corresponding P(V) 
system by structural modification of a series of simple analogues of the basic 
phosphinamide subunit. For example variation of the steric bulk of both the 
nitrogen and phosphorus substituents and the electronic properties of the R.2N-P= 0  
structural unit. Analysis of conformational effects by preparation of simple cyclic 
systems should also, we felt, give an insight into the mechanism of catalysis and aid 
the design of a more rigid chiral environment around the phosphorus centre.
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2 Results and Discussion.
Section 2.1: Initial Study.
Oxazaphospholidines (26) and (27) satisfied the structural requirements of 
our proposed catalyst. These compounds were prepared as a 1.25:1 mixture of 
diastereoisomers, via a literature procedure, from 1R, 2S-ephedrine and 
phenylphosphonic dichloride and were separated by column chromatography.38,62a 
However both compounds were found to be unstable to the reaction conditions 
employed (0.6 equivalents of BMS, THF, rt), presumably as a consequence of 
reduction by borane.
(26) (27)  (28)
Similar results were obtained with the prolinol derived oxazaphospholidine
(28) prepared from S-prolinol and phenylphosphonic dichloride;39 an equimolar 
mixture of diastereoisomers decomposed within 20 minutes at room temperature on 
addition of BMS (as assesed by TLC). We suspected that the oxygen-phosphorus 
bond in these compounds may be reactive to borane 120 and turned our attention 
toward the acyclic phosphinamide (29).
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This compound was prepared in 89% yield as a crystalline solid by the 
reaction of (R)-(+)-a methylbenzylamine with diphenylphosphinic chloride 
(triethylamine, DCM, rt,), and appeared to be stable to reaction conditions. Sub- 
stoichiometric quantities of this compound were found to catalyse the reduction of 
acetophenone by BMS (Scheme 14).^
Addition of 10 mol% of (29) together with 0.6 equivalents of BMS resulted 
in >98% reduction of acetophenone in less than 60 minutes at room temperature. 
The progress of the reaction was followed using HPLC with a UV detection system 
(Figure 12). Since the molar extinction coefficient of the ketone is some 50 times 
that of the alcohol, a 1:1 ratio of ketone to alcohol represents a conversion of >98%. 
This acts as a convenient marker for the qualitative comparison of catalyst 
performance and was used to compare the examples described throughout, although 
in all cases where the time was less than 1 hour, no acetophenone could be detected 
in the reaction mixture after this time. In contrast uncatalysed reduction required 
some 14 hours under the same conditions to proceed to the same extent. The 
resulting alcohol consisted of a 1.7:1 mixture of enantiomers (26% e.e., S- major, 
82% yield) as assessed by both comparison of the optical rotation with reported 
literature values and chiral HLPC.^
Encouraged by the dramatic acceleration of the reaction obtained on adding 
the phosphinamide, the utility of (29) was then further investigated by varying 
catalyst concentration and reaction conditions (Table 1).
0 H OH HO H
0.6 eq. BMS/ THF 
rt
10 mol% (2 9)
S (Major) R (Minor)
82%, 26% e. e.
Scheme ( 1 4 )
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0 rt THF > 12 hrs 75% -
10 rt THF < 1 hr 82% 26% (S)
2 rt THF 1.5 hrs 75% 23% (S)
100 rt THF <30 min 69% 13% (S)
2 rt Toluene 2  hrs 88% 30% (S)
2 rt DCM 2.5 hrs 77% 18% (S)
10 o°c** THF 3 hrs 75% 20% (S)
10 60 °C THF < 1 hr 79% 18% (S)
* 0.6 equivalents of BMS added to a 1M solution of ketone and catalyst.
** Catalyst partially precipitated at this temperature.
Table 1 Reduction of Acetophenone catalysed by (29).
Variation of reaction solvent appeared to have little effect on reduction rate 
and a marginal effect on selectivity, with DCM being the least favourable. 
Increasing the temperature appeared to have a detrimental effect on selectivity, 
whilst at 0°C partial precipitation of catalyst occurred resulting in both reduced rate 
of catalysis and enantioselectivity. In all cases the enantiomeric excesses were 
modest, but the relatively small difference in selectivity obtained when the catalyst 
concentration was reduced to 2  mol% suggested that virtually all the reduction was 
proceeding through the catalyst mediated pathway even at the lower concentration.
Since alkoxy-borane complexes such as (30) could reduce further ketone to 
give alcohol of opposite configuration to that produced by the catalyst, we replaced 
BMS with catecholborane (31), which has only one transferable hydride, and 
obtained a similar enantiomeric excess (24%, S-major, 83% yield) but at a 
considerably reduced rate (10 mol% (29), THF, rt, >98% reduction in 12 hrs). 
Some catalyst decomposition was also apparent using this reagent
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H O— BH2XPh Me 
(30)
The use of monochloro borane (a more reactive source of hydride) gave, as 
expected, considerably lower selectivity (3% e.e., S-major, 71% yield) presumably 
due to competitive background reduction (10 mol% (29), THF, rt).
Slow addition of ketone to a solution of phosphinamide and borane in THF, 
an expedient known to be essential for good selectivity in a oxazaborolidine 
systems,80,45 resulted in no change in selectivity. Both addition of borane to a 
solution of catalyst and ketone (the mode of addition used previously and 
throughout) and the reverse addition of ketone to a solution of catalyst and borane 
gave the same selectivity.
In all cases quantitative recovery of catalyst was possible via column 
chromatography and the recovered compound, which appeared spectroscopically 
identical to the original material, could be reused with no loss in catalytic activity, 
enantioselectivity or chemical yield of alcohol.
The reduction of ketones (32)-(39) was then examined using 10 mol% of 
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Rs = Small group (Me, Et,CH2CI, C 02Et)














10 < 1 hr 82% 26% (S)
(33) 10 <1 hr 88% 23% (S)
(34) 10 <1 hr 80% 30% (S)
(35) 10 <1 hr 97% 21% (S)
(36, X=CI) 10 <1 hr 83% 22% (R)
(36,X=Br) 10 <1 hr 80% 25% (R)
(37) 10** <1 hr 46% 46% (S)
(38) 10 <1 hr 80%*** 5% (S)
(39) 10 <1 hr 91% 24% (S)
* 0.6 equivalents of BMS, THF (ca. 1M), ketone, rt.
** The reaction was carried out at 0 °C.
*** The diol was formed, see ref. 41.
**** The enantiometic excesses were measured by comparison
of optical rotation with reported values, see ref. 42.
Table 2 Reduction of Ketones (32)-(39) Catalysed by (29).
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Reduction of ketones (33)-(39) gave the corresponding alcohols with 
enantiomeric excesses similar to those obtained for acetophenone. The a-bromo 
enone (37) gave a product of slightly higher e.e. but in disappointing yield, while a -  
ketoester (38) was reduced to the diol in very low e.e.41 In all cases the 
enantioselectivity appeared to be determined on the basis of size of ketone 
s u b s t i t u e n t ^  with hydride being delivered in the absolute sense illustrated in 
Scheme 15.
On this basis (38) would have been predicted to give the opposite 
enantiomer, however it is likely that in this case a competitive co-ordination with 
the ester group may have modified the borane reactivity.
The precise mechanism by which chiral information was transferred during 
the reduction is uncertain, though it seemed likely that the chiral centre in the side 
chain exerts a conformational effect on the two diastereotopic phenyl rings, which 
in turn exert a steric influence on the approach of the ketone to the phosphorus 
atom.
A single crystal X-ray structure of (29) was determined (Figure 10 and 
Appendix 1) which clearly showed the conformation of the phenyl rings with 
respect to the amide side chain, and a rehybridised sp2 nitrogen atom implying good 
overlap between the nitrogen lone pair and the phosphorus atom. The ^H-NMR 
spectrum of (29), however, showed no evidence of restricted rotation around the P- 
N bond even at low temperature.
Replacing phosphinamide (29) with triphenylphosphine oxide resulted in no 
acceleration of the reduction reaction. The nitrogen atom thus appeared essential 
for catalysis presumably due to its electron donating properties.
An encouraging observation was the apparent insensitivity of the catalyst to 
moisture, a problem in oxazaborolidine mediated reductions.28 in an experiment in 
which one equivalent of water (relative to catalyst (29)) was added to a mixture of 
acetophenone and (29) prior to borane addition, the rate of reduction appeared 
uneffected, and a product of identical e.e. (26%, S-major, 85% yield) was obtained.
Figure 10 
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Encouraged by these initial observations, and the apparent stability and 
robustness of the phosphinamide system to reaction conditions we began an 
investigation of the steric and electronic factors important for catalysis.
Section 2,2;. Modification of Basic Phosphinamide Structure,
In order to confirm that a hydrogen bonding interaction between two 
molecules of (29) giving a dimeric species^’ 30a? or between catalyst and substrate 
was not a prerequisite for catalysis (Figure 11), we prepared compound (40) in 58% 
yield by N-methylation of (29) (n-BuLi, THF, Mel, rt), or in slightly higher yield by 
reaction of N-methyl-a methylbenzylamine^^ with diphenylphosphinic chloride 
(triethylamine, DCM, rt, 82% yield).
Ph 











Ph Fk .B .
' O ^ h
Me
Ph
R = R-(+)-a methylbenzyl 
Figure 1 1
R1= Me (40) 
Bn (41)
The presence of the methyl group appeared to have very little effect on the 
rate of catalysis (>98% reduction in < 2 hours at rt), and gave a product of 12% e.e. 
in favour of the S- enantiomer (90% yield) at a concentration of 10 mol%. The 
corresponding N-benzyl compound (41), prepared in 40% yield by alkylation of
(29) under the above conditions, was a very poor catalyst for acetophenone 
reduction requiring some 3-4 hours for complete reaction and giving a racemic 
alcohol product, presumably due to a steric effect.
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We next examined the effect of increasing the number of a  
methylbenzylamine groups bonded to phosphorus. Phosphonamide (42) was 
prepared from R-(+)-a methylbenzylamine and ethylphosphonic dichloride 
(triethylamine, DCM, rt) in 65% yield and the corresponding triamide (43) was 
prepared from phosphorus oxychloride under the same conditions in 80% yield. 
Both were crystalline solids, easily purified by flash chromatography and 
crystallisation. The use of these compounds for acetophenone reduction catalysis is 
summarised in Table 3.










42 2 rt < 1 hr 76% 26% (S)
42 10 rt < 1 hr 88% 28% (S)
42 20 rt < 1 hr 82% 33% (S)
42 2 0 °C 3 hrs 78% 35% (S)
43 10 rt < 1 In- 70% 20% (S)
* 0.6 equivalents of BMS added to a 1M THF solution of ketone and 
catalyst.
Table 3 Reduction of Acetophenone catalysed by Phophonamides (42) and (43).
The results obtained were very similar to those obtained with (29) again 
suggesting a dominant catalyst mediated reduction pathway. Slightly better 
selectivity was obtained with the C2 symmetric phosphonamide (42).
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We next wished to examine the steric effect of the phosphorus substituent in 
phosphonamides structurally related to (42).
Phenyl- and f-butylphosphonic dichloride were prepared from the 
corresponding commercially available phosphonic acids using oxalyl chloride.44 
Reaction of phenylphosphonic dichloride with 2 equivalents of R-(+)-a 
methylbenzylamine (2 equivalents of triethylamine, DCM, rt) gave the phenyl 
substituted phosphonamide (44) in 45% yield. Reaction of r-butylphosphonic 
dichloride with the amine under the same conditions gave an inseparable 1.6:1 
mixture of monochloro diastereoisomers (48) in 39% yield. Addition of the purified 
diastereomeric mixture (48) to a solution of lithiated a-methylbenzylamine (1.2 
equivalents of amine, 1 equivalent of w-BuLi, THF, 0 °C) in THF gave the required 
r-butyl phosphonamide (46) in 81 % yield.
H y e f? Me,  H
I  V
P h ' ' ^  N Ph
H R H
R= Ph (44)
R = /-P r(45) (4 8 >
R= f-Bu (46)
R= Cyclopentyl (47)
Due to the lack of commercial availability of the requisite phosphonic acids, 
we required a more flexible synthetic route to these compounds. To this end we 
developed the synthetic sequence outlined in Scheme 16.
Addition of 2 equivalents of R-(+)-a methylbenzylamine to a dilute solution 
of phosphorus oxychloride in DCM gave the intermediate monochloride (49) as a 
viscous oil. Reaction of a diethyl ether solution of the unpurified chloride with 4 
equivalents of the appropriate Grignard reagent47 at 0 °C  gave the required 
phosphonamides in good yield (Scheme 16).
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H Me





Et (42) 42% 
Ph (44) 45% 
/-Pr (45) 65% 
Cyclopentyl (47) 33%
Schem e 16
A summary of the results obtained using the phosphonamide derivatives as 










Ethyl (42) 10 rt < 1 hr 88% 28% (S)
Phenyl (44) 10 rt 2 hrs 83% 30% (S)
Phenyl (44) 2 rt 2-3 hrs 87% 18% (S)
Phenyl (44) 2 -30 °C 6 hrs 40% 21% (S)
z-Propyl (45) 8 rt 1-2 hrs 94% 50% (S)
r-Butyl (46) 2 rt 2-3 hrs 83% 13% (S)
Cyclo­
pentyl
(47) 10 rt 1-2 hrs 88% 15% (S)
* 0.6 equivalents of BMS added to a 1M THF solution of ketone and catalyst. 
Table 4 Reduction of Acetophenone catalysed by C2 symmetric phosphonamides.
4 eq. RMgBr 











Me O Me, H
N ^  P\^  N Ph
H a  H
(4 9 )
All the compounds examined gave similar rates of catalysis (as assessed by 
TLC analysis). Phenylphosphonamide (44) gave slightly higher selectivity than the
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corresponding ethyl- substituted analogue (42). Increasing the size of the 
phosphorus substituent from ethyl to isopropyl (45) gave a significant increase in 
selectivity, though the more sterically encumbered f-butyl compound (46) required a 
longer reaction time for complete reduction and gave an alcohol product of only 
13% e.e. These results indicated that the isopropyl group was an optimal size for a 
substituent at this position.
At this stage all of the compounds we had examined were achiral at 
phosphorus. Since variation of the steric environment around the phosphorus centre 
appeared to have a significant effect on selectivity in the C2 symmetric 
phosphonamide systems, we reasoned that introduction of a chiral environment at 
phosphorus, proximal to the reaction centre, either by desymmiterising the C2 
symmetric phosphonamides (44)-(47) or by replacing one of the diastereotopic 
phenyl groups in (29) with another group would give greater control of reduction 
facial selectivity.
To this end, phosphonamide (44) was treated with one equivalent of H-BuLi 




Schem e 17 41% (50)
This gave a 41% yield of the required epimers (50) as a 1:1 mixture. 
Attempts to separate the mixture by chromatography or crystallisation were
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unsuccessful, though pure samples of each compound could be obtained by 
preparative TLC. The absolute configuration at phosphorus was not determined. 










44 2 rt 2.5 hrs 87 % 18 (S)
50U** 2 rt 2.5 hrs 89% 21 (S)
50L 2 rt < 1 hr 81% 17 (S)
* 0.6 equivalents of BMS added to a 1M THF solution of ketone 
and catalyst.
** For convenience, the suffix U and L refer to epimer polarity; U 
being the less polar and L the more polar compound.
Table 5 Reduction of Acetophenone catalysed by (50U) and (50L).
Both compounds appeared to give similar reduction enantioselectivity; the 
magnitude being similar to the C2  symmetric phosphonamide (44). The more polar 
epimer (SOL) did, however, appear to be a more active catalyst in terms of 
acceleration of the reaction with no ketone being present in the reaction mixture (by 
TLC) after 1 hour.
Since the presence of an N-benzyl substituent did not appear to have a 
significant effect on selectivity in the phenylphosphonamide system (derived from
(44)), we attempted the same N-alkylation protocol with isopropyl phosphonamide
(45). No alkylation was achieved under the previously used conditions («-BuLi, 
THF, Benzyl bromide) presumably due to steric hindrance around the nitrogen 
atom. Repeating the reaction using methyl iodide as the alkylating agent gave the 
same result.
We next turned our attention to the diastereomerically pure phosphinamides 
(51) and (52).
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(51) (R,SP) (52) (R,Rp)
The preparation of these compounds had been reported by J e n n in g s ,48 with
the absolute configuration at phosphorus determined by single crystal X-ray 
diffraction of (51). Interestingly, the unit cell was found to contain two molecules 
which differ with respect to the conformation of the R.2 N unit relative to the P=0
nitrogen atom whilst the molecule in which they are close to planarity contains an
It would seem that the orientation of the lone pair electrons on the nitrogen 
atom relative to the P-0 bond is not highly energy sensitive and that packing 
considerations may play an important role in determining the actual conformation 
about the P-N bond (Figure 13). Though caution should be exercised in the use of 
ground state structures to predict conformation in solution, we considered these 
observations significant since an electron rich P=0 bond, we believed, was a 
prerequisite for effective activation of borane.
Figure 1 3
Attempted preparation of these compounds via the route reported by 
Jennings proved problematic (Scheme 18). All attempts to prepare pure samples of
bond. The molecule in which these are perpendicular contains an sp3 hybridised




Molecule 2  
in unit cell
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chloride (53) were unsuccessful, and difficulty in handling the aminophosphine (54) 







(5 4) (5 3)
Me
Reagents and conditions: i) HNEt2, Et20 , 0 °C, 2 hrs, rt overnight,62%; 
ii) 2 ,4 ,6 -Me3C6 H2 MgBr, Et20; iii) H ^ ,  acetone, reflux , 4 hrs; iv) cone HCI, 6  
days, <30%; v) SOCI2, reflux, 2 hrs, <10%; vi) R-(+)-amethylbenzylamine, Et3 N 
Et20, rt overnight.
Scheme ( 1 8 )
We found that addition of R-(+)-a methylbenzylamine to a very dilute 
solution of phenylphosphonic dichloride in DCM (1 equivalent of triethylamine, rt) 
gave mono-chloride (55) as a viscous oil. Reaction of a crude solution of the 
chloride in diethyl ether with 2.5 equivalents of mesitylmagnesium bromide gave, 
after chromatography and crystallisation, a low yield (<10%) of the R, R- 
diastereoisomer (52) as a white crystalline solid (Scheme 19). Assignment of the 
configuration at phosphorus was made by comparison of data with that reported by
Jennings.48
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V  1 eq. Et3N





2.5 eq. 2 ,4 ,6 -Me3 C6 H2MgBr 
Et2 0 , 0  °C
Schem e 19
Use of 2 mol% of this compound under standard reduction conditions 
(Scheme 14) gave an alcohol product of 20% e.e. (S- major, 96% yield) with 
reduction being complete in 2-3 hours at rt. The selectivity obtained with (52) 
appeared similar to that obtained with phosphinamide (29); the increase in time 
required for complete reduction , we believed, reflecting the increase in steric 
crowding around the phosphorus atom. Unfortunately attempts to isolate the R, S- 
diastereoisomer (51) were unsuccessful.
It thus appeared that generation of a chiral environment around the 
phosphorus centre in the a  methylbenzylamine derived catalysts had little effect on 
reduction selectivity, but appeared to effect the rate of ketone reduction. Rather 
than pursue this in an exhaustive series of studies, we moved on to examine other 
factors important for catalysis.
Section 2.3; Electronic Variation.
Our proposed catalyst cycle (Scheme 13) requires an electron rich P=0 bond 
for initial donation and activation of the borane reagent. The nitrogen lone pair, 
though less involved in n- bonding to phosphorus than the corresponding carboxylic 
amides,3 0 is important in that it increases electron density in the P=0 bond
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sufficiently to allow co-ordination to electrophilic borane. The importance of 
nitrogen n -bonding to phosphorus was next examined by introduction of an electron 
withdrawing group on the nitrogen atom. To this end we prepared compounds (56)- 
(58). The nitrogen lone pair in these compounds should be less involved in n- 
bonding to phosphorus due to conjugation effects.
(56)
O O O O










The N-sulfonyl phosphinamide (56) was prepared from the corresponding 
N-sulfonyl a m i n e 4 ^  and diphenylphosphinic chloride (sodium hydride, THF) in 













Gratifyingly, this compound appeared to show no catalytic activity; 
reduction of acetophenone requiring 10 hours at rt to go to completion and thus 
barely being distinguishable from the background reduction rate. The resulting 
alcohol was racemic.
Compounds (57)-(58) were prepared from the corresponding amino alcohols
SQpPh
(89%)
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as shown in Scheme 21. The requisite oxazolidinones were prepared according to a 
literature procedure using diethyl c a r bona t e .Addi t i on  of diphenylphosphinic 
chloride to the deprotonated oxazolidinone (sodium hydride, THF, rt) gave the 
phosphinamides as white crystalline solids in good yield.
O O o
(EtO)20  NaH, THF
IpN OH T 7 T Z  HN O ------------------- Ph / n u
\  /  ^  3________V___ /  Ph2P(0)CI P*1 V ___ /
R ' h  r h r"' h
R= H, 68% R= H, (57) 73%
i-Pr,79% /-Pr, (58) 85%
Scheme 21
Phosphinamide (57) again appeared to show reduced catalytic activity; 10 
mol% of this compound promoted >98% reduction of acetophenone in 3 hours at rt. 
The corresponding S-valinol derived compound (58) catalysed the reaction at a 
similar rate and gave an alcohol of 7% e.e. (R major, 84% yield).
These results suggested that electron withdrawing substituents on the 
nitrogen atom of the N-P=0 system considerably reduced the rate of catalysis and 
hence enantioselectivity (presumably due to competitive background reduction). 
Donation of electron density from nitrogen to the phosphorus atom thus appeared 
important for catalysis. The possibility of a steric effect also being in operation 
could not, however, be neglected. Also co-ordination of borane to the sulfonyl 
oxygen in (56) and the carbamate carbonyl group in (57) and (58) could have a 
detrimental effect on borane reactivity, however both the carbamate and sulfonyl 
derivatives were found to be stable to the reagent.
We next examined the effect of an electron donating substituent on 
phosphorus, an expedient which should increase electron density in the P=0 bond. 
Phosphonamide (59) was prepared by reaction of phosphorus oxychloride with two
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equivalents of R-(+)-a methylbenzylamine (Triethylamine, DCM), followed by 
reaction of the resulting crude chloride (49) with p-methoxyphenylmagnesium 
bromide,47 in 41% yield as described in Section 2.2 (Scheme 16).
Remarkably, in the presence of 5 mol% of this compound, no acetophenone 
could be detected in the reaction mixture (by TLC) after 15 minutes at room 
temperature. Addition of BMS to a solution of phosphonamide and ketone 
produced a noticeable exothermic effect and gave the alcohol in 24% e.e. (S major, 
90% yield).
We reasoned that the methoxy group significantly increases electron density 
in the P=0 bond through conjugation effects resulting in increased donation and 
hence activation of borane (Scheme 13). It appeared that donation of electron 
density to borane was important for catalysis and this suggested that the donor 
properties of the phosphonamides were more significant than their acceptor 
properties. The extent of asymmetric induction did not, however, appear to be 
greatly effected; the result obtained being of the same magnitude as the 
unsubstituted phenyl phosphonamide (44).
To corroborate this idea we next investigated the effect of an electron 
withdrawing substituent on phosphorus, which should have a adverse effect on 
catalysis.
Phosphinamide (60) was prepared as a single diastereoisomer in 28% yield 
by reaction of phenylphosphonic dichloride with one equivalent of R-(+)-a
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methylbenzylamine (1 equivalent of triethylamine, DCM) followed by reaction of 
crude chloride (55) with 2.5 equivalents of pentafluorophenylmagnesium bromide^! 




( 6 0 )
This compound did not appear to catalyse the reduction reaction; 
acetophenone was still present in the reaction mixture after stirring overnight at 
room temperature. Again we reasoned that the P=0 bond in this compound should 
be less electron rich than the corresponding hydro- derivative (29) due to inductive 
withdrawal of electron density by fluorine. By the same argument as outlined above 
we would expect this compound to show little or no catalytic activity. Since the 
fluorine atom is isosteric with hydrogen we believed this to be a purely electronic 
effect.
In summary, electron withdrawing substituents on the nitrogen atom of the 
N-P=0 unit appeared to decrease both the rate of catalysis and reduction selectivity. 
An electron rich substituent bonded to phosphorus appeared to dramatically increase 
catalytic rate, but with little effect on selectivity, and conversely an electron 
withdrawing group on phosphorus had a detrimental effect on both rate of catalysis 
and enantiomeric induction.
 2 Results and Discussion.________________________
Section 2.4: Conformationallv Restricted Systems.
Pape 46.
Having established the electronic requirements for effective catalysis, we 
turned our attention to the control of reduction selectivity. The acyclic compounds 
so far examined had given modest asymmetric induction due in part, we believed, to 
the conformational flexibility of these molecules. In order to probe the importance 
of the conformation of the R2 N-P= 0  unit in the catalytic process and improve 
asymmetric induction we prepared a series of compounds in which the 
conformational freedom of this subunit was restricted by ‘locking’ the phosphorus 
atom in a ring.
We first examined the effect of ring size on catalysis. To this end, cyclic 
phosphonamides (61) and (62) were prepared from the corresponding diamines via 
the method shown in Schemes 22 and 23.^2
Reaction of R-(+)-a methylbenzylamine with oxalyl chloride (2 equivalents 
of triethylamine, DCM, rt) gave the bri-amide in 84% yield. Reduction of a 
refluxing THF solution of the amide using LiAlH4  gave the corresponding diamine
(63) in 95% yield.61 Cyclisation of the diamine using ethylphosphonic dichloride 
(2 equivalents of triethylamine, DCM, rt) gave the phosphonamide (61) in 50% 
yield (Scheme 22). Similarly, reaction of benzoyl chloride with 1, 3- 
diaminopropane gave the crude M's-amide. Reduction of this material under the 
same conditions as above gave the d i a m i n e j n 6 8 % yield which was cyclised 
with the dichloride giving phosphonamide (62) in 6 8 % yield (Scheme 23).
(6 1 ) ( 6 2 )
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Ph 6 8 %
(6 2 )
Schem e 23
Remarkably, both compound (61) and (62) proved to be poor catalysts for 
the reduction of acetophenone by borane; reaction times in excess of 5 hours being 
required for reduction. The results are summarised in Table 6 .










(42) 2 < 1  hr 8 8 % 28% (S)
(61) 2 > 5 hrs 92% 2% (S)
(62) 2 > 5 hrs 8 8 % -
(64) 10 3 hrs 90% 4% (S)
(25) 10 4 hrs 85% 35% (R)
* 0.6 equivalents of BMS added to a 1M THF solution of ketone 
and catalyst at rt.
Table 6  Reduction of Acetophenone Catalysed by Conformationally 
Restricted phosphonamides.
The selectivity achieved using (61) was poor, again presumably due to 
competing background reduction. Comparison of the rate of catalysis with the 
corresponding acyclic phosphonamide (42) demonstrated a significant loss of 
activity with increased conformational rigidity. Similarly, the 6 -membered ring 
analogue (62) proved incapable of accelerating the reaction.
We next examined the fused bicyclic phosphonamide (64),H7 prepared 
from the R, R-diamine and phenylphosphonic dichloride (2 equivalents of 




This compound again appeared to be a poor catalyst; a reaction time in 
excess of 3 hours being required for >98% reduction and the enantioselectivity was 
poor (Table 6 ).
Similar results were obtained using cyclic phosphonamide (25), prepared in
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the Wills group by orr/io-lithiation of the r-BDPS-protected am ine,^ in which the
phosphonamide R.2N-P=0 unit is locked in a five membered ring. This compound 
again appeared to be less effective at catalysis than the acyclic series of compounds 
(c.f. phosphinamide 29)) though surprisingly gave an improved level of asymmetric 
induction (Table 6 ).
These observations suggested that the optimum geometry for catalytic 
activity is that in which the ‘R2 N-P=0 ’ system can lie in a single plane, thus 
maximising electron donation from the nitrogen lone pair to the P=0 bond. This 
suggestion is supported by a number of X-ray structures in which nitrogen is shown 
to be sp^ hybridised when this condition is satisfied, which implies a high degree of 
overlap48-56 (Figure 14), allowing activation of borane followed by initiation of 
catalysis (Scheme 13). In contrast X-ray studies of compounds structurally related 
to (64), in which co-planarity cannot be attained, contain essentially sp3 hybridised 




Effective R2 N-P= 0  overlap
0
II
R=R1 = alkyl, aryl Poor catalyst
Cannot donate to P=0
Figure 1 4
This interaction is, however, much weaker than the corresponding effect in 
carboxylic amides, and the energetic benefit can be outweighed by crystal packing
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effects in some cases^S (see the discussion of structure (51), Section 2.2). We 
reasoned that in compounds such as (61)-(64), which are poor catalysts, the co- 
planar geometry cannot be achieved, whilst in contrast the corresponding acyclic 
series of compounds (Section 2.2), which generate the highest acceleration in 
reduction rate, may readily achieve this.
Section 2.5;, Combined Ponor Catalysts,
2^ 1Jn ara id es Periyed from C2 S y m m etric Amines,
At this stage we had established a clear stereoelectronic requirement for 
effective catalysis, but were still plagued by low reduction enantioselectivity. We 
believed that a conformationally restricted system was important for generation of a 
rigid chiral environment around the phosphorus atom, but needed to combine with 
this the characteristics of a ‘fast’ catalyst i.e good R2N-P=0 coplanarity. This, we 
believed, would go some way to improving enantioselectivity. These requirements 






These molecules contain a sterically demanding exocyclic amine bonded to 
phosphorus which should, we believed, increase electron density in the P=0 bond 
via 7t-bonding and prevent both borane complexation and ketone co-ordination in 
this region of the catalyst.
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The ketone should co-ordinate with the phosphorus atom through its lone 
pair tram to the carbonyl phenyl group such that the bulky methyl group is oriented 








0 - - B
Me
(side view)
Figure 1 5 
Proposed reduction transition state.
The conformationally locked C2  s y m m e t r i c ^  component thus creates a 
steric environment which can direct the orientation of ketone approach to 
phosphorus and hence facilitate enantiofacial differentiation (Figure 15). The 
method we proposed to employ in assembling these molecules is shown in Scheme 
24.
Using this method, Alexakis has prepared a number of cyclic and bicyclic 
phosphoramidic chlorides^ from C2  symmetric diamines which have been 
employed as derivatising agents for the determination of the enantiomeric purity of 
both alcohols and am ines.^
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In order to establish reaction conditions and the efficacy of this route we 
initially chose N, N’-dimethylethylenediamine (67, Rl=Me) as a ‘model diamine’ 
for the reaction. Reaction of phosphorus oxychloride with the diamine in refluxing 
toluene in the presence of triethylamine as reported by A l e x a k i s 5 9 , 6 2  gave the 
corresponding chloride (6 8 , Rl=Me) in 6 8 % yield. Precipitation of amine 
hydrochloride salts during the reaction proved problematic and slowed the reaction 
considerably. We found that the procedure could be carried out more conveniently 
at room temperature in DCM (2.5 equivalents triethylamine) since the reaction 
mixture is homogeneous in this solvent. This gave the chloride (6 8 , R^=Me) in a 
reproducible 95% yield. The chloride appeared surprisingly stable and could be 
purified by chromatography and crystallisation without decomposition.
Attempted phosphinylation of R-(+)-a methylbenzylamine with chloride 
(6 8 , Rl=Me) in DCM (2 equivalents of triethylamine, rt) was unsuccessful. 
Refluxing the mixture gave only decomposition products. Repeating the reaction in 
THF gave similar results, however, addition of a THF solution of the chloride to a 
solution of lithiated amine (1.2 equivalents n-BuLi, THF) in THF at 0 °C gave the 
required phosphoramide (69) in 6 8 % yield (Scheme 25).









( 6 8 ) (69) R1= Me, 6 8 %
(70) R1 = R-a methylbenzyl, 40%
Scheme 25
Phosphoramide (69) was found to be a very effective catalyst for 
acetophenone reduction; 10 mol% giving complete reduction in <15 minutes at 
room temperature, and a reduction product of 17% e.e. (S major, 83% yield).
Having established a general procedure for preparation of the triamide 
catalysts and with the encouraging result above we began to implement a series of 
structural modifications.
Reaction of diamine (63) (prepared as described in Section 2.2.4)61 
phosphorus oxychloride under our revised reaction conditions gave the 
corresponding chloride (6 8 ), R*= R-a methylbenzyl) in 60% yield as a white 
crystalline solid (Scheme 24). Displacement of chloride with lithiated R-(+)-a 
methylbenzylamine occurred slowly at room temperature; unreacted starting 
materials being present after 2 days. Heating the mixture again resulted in 
decomposition of the chloride, presumably as a consequence of ring opening side 
reactions. Such anomalous reactions have been reported by S h a p ir o 6 3  and 
J o h n so n .6 4  Steric crowding around the phosphorus atom may account for this lack 
of reactivity. As a result, phosphonamide (70) could only ever be obtained in 30- 
40% yield.
Reaction of a solution of chloride (6 8 , R l=  R-a methylbenzyl) with 2 
equivalents of pyrrolidine in DCM proceeded rapidly at room temperature giving 
triamide (71) in 48% yield. The more nucleophilic nature of the cyclic amine 
probably accounts for its increased reactivity.
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(69) (70) (71)
Both compounds (70) and (71) were screened for catalytic activity. The 
results are summarised in Table 7 together with the results previously obtained for 
structurally related phosphonamide (61) and phosphoramide (43) (see Section’s 2.4 










(43) 1 0 < 1 hr 70% 20% (S)
m .2 > 5 hrs 92% 2% (S)
(70) 10 2.5 hrs 89% racemic
(71) 5 2.5 hrs 91% 5% (R)
* 0.6 equivalents of BMS added to a 1M THF solution of ketone and 
catalyst at rt.
Table 7 Reduction of Acetophenone catalysed by (70) and (71).
Phosphoramide (70) appeared to accelerate the reduction but gave no chiral 
induction, presumably due to the steric effect of the large nitrogen substituent 
preventing ketone co-ordination (the corresponding N-methyl analogue (69) gave 
modest selectivity at a considerably increased rate). Replacement of the exocyclic a  
methylbenzyl unit with pyrrolidyl again resulted in low selectivity (the product 
alcohol being of R configuration) with reduction occurring at a similar rate.
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Despite disappointing selectivity, the presence of the exocyclic amide bond 
did appear to increase the rate of catalysis relative to cyclic phosphonamide (61), 
though not as effectively as the conformationally less rigid phosphoramide (43).




Since it appeared that the size of the nitrogen substituent in (70) had a 
detrimental effect on selectivity, we turned our attention to bicyclic phosphoramide 






The synthesis of this compound was achieved as outlined in Scheme 26. 
Initially the synthesis was carried out using racemic diamine since it was hoped that 
separation of the resulting diastereoisomers would be possible, but unfortunately all 
attempts were unsuccessful.
In order to determine if the bicyclic triamide structure exhibited the required 
catalytic activity, a sample of the diastereomeric mixture prepared from racemic 
phosphoramidic chloride (74) (i.e. a 1:1 mixture of R, R, R and S, S, R- 
diastereoisomers) was screened in the reduction reaction. Remarkably the mixture
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appeared to be extremely effective at mediating the reduction of acetophenone; all 
ketone being consumed in under 15 minutes at room temperature and giving an 
alcohol product of 30% e.e. (S major, 87% yield) (Table 8 ). Since each 
diastereoisomer could give opposite face selectivity in the reduction, pure R, R, R- 
diastereoisomer (72) was prepared from commercially available R, R- 
diaminocyclohexane as outlined in Scheme 26.
2  eq. EtOC(0)CI 
aq. NaOH, toluene
NHC02Et
NHC02Et 9 7 %



















Reaction of the diamine with ethyl chloroformate in toluene gave the bis- 
carbamate in 97% yield. Reduction of a refluxing THF solution of the carbamate 
using LiAlH4 ^  gave the N, N’-dimethyl diamine (73) in 83% yield. Cyclisation of 
the pure R, R-dimethyl diamine with phosphorus oxychloride (2.5 equivalents of 
triethylamine, DCM) gave the corresponding phosphoramidic chloride (74) in 90% 
yield. Reaction of a THF solution of chloride (74 ) with lithiated R-(+)-a 
methylbenzylamine (1.2 equivalents of amine, 1 equivalent of «-BuLi, THF) in THF
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gave the required R, R, R-diastereoisomer (72) in 44% yield. Problems were 
encountered in the displacement step due to competitive reaction of lithium n- 
butoxide (presumably present in the «-BuLi) with the electrophile; the product of 
which proved difficult to separate from the requisite triamide. This problem could 
be partially alleviated by using fresh butyllithium.
Triamide (72) appeared to give considerably lower selectivity and required a 
longer reaction time than the diastereomeric mixture (1 hour, 8 % e.e., R major, 82% 
yield). The resulting alcohol was also of opposite configuration (Table 8 ). 
Assuming no synergic effects were in operation, we reasoned that the pure S, S, R- 
diastereoisomer should give the S-enantiomer of alcohol in high selectivity. Since 
the S, S-diamine is less readily available than the R, R- form, we prepared the 
enantiomer of the more active component of the mixture (i.e. the R, R, S- 
diastereoisomer (75)) in 36% yield via reaction of chloride (74) with lithiated S-(-)- 






As predicted 10 mol% of this compound catalysed the reduction of 
acetophenone, with complete reduction occurring in less than 1 0  minutes at room 
temperature, and gave an alcohol of 46% e.e. (R major, 84% yield) (Table 8 ).








1:1  mixture RRR, SSR < 15 min 87% 30% (S)
(72) RRR 1 hr 82% 8 % (R)
(75) RRS < 1 0  min 84% 46% (R)
(76) RR 30 min 8 8 % 19% (R)
* 0.6 equivalents of BMS added to a 1M THF solution of ketone 
and 1 0  mol% catalyst at rt.
Table 8  Reduction of Acetophenone Catalysed by Triamides Derived 
From Phosphoramidic Chloride (74).
It thus appeared that the diamine component of the system was directing the 
reduction to give alcohol of R configuration and that the directing influence of the a  
methylbenzyl group was either matched (in the case of the S- amine) or mismatched 
(in the case of the R-amine) with this diamine directing effect. With the R, R, S- 
diastereoisomer (75) both these effects are matched resulting in higher selectivity 
and increased rate of reduction (46% e.e., < 10 min.). In contrast, with the R, R, R- 
diastereoisomer (72), these effects essentially oppose one another resulting in 




In order to confirm that the exocyclic amide side chain was having a 
controlling effect, phosphoramide (76) was prepared in 55% yield by reaction of 
chloride (74) with lithated benzylamine (1.2 equivalents of amine, 1 equivalent of n-
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BuLi, THF) in THF. Repeating the reaction using this material as catalyst resulted 
in complete reduction of ketone in 30 minutes at room temperature and gave an 
alcohol product of 19% e.e. (R major, 8 8 % yield) (Table 8 ). This result also 
demonstrated that the diamine component was giving the predicted R-selectivity in 
the reduction reaction.
Since in the acyclic phosphinamide series (Section 2.2) a large nitrogen 
substituent appeared to prevent ketone approach to phosphorus, we reasoned that 
this effect could be utilised to our advantage in ‘amplifying’ diamine control of 
reduction selectivity by directing ketone approach ‘over’ the rigid bicyclic ring 
system. To this end we prepared triamide (77) as a 1:1 mixture of R, R, R and S, S, 
R-diastereoisomers in 42% yield by N-benzylation of the primary amide mixture (n- 
BuLi, THF, benzyl bromide). Unfortunately the mixture did not show any catalytic 
activity and the resulting alcohol was racemic.
In the solid state structure of bicyclic phosphonamides such as (64)57,66 the 
nitrogen substituents (R^) are syn to the axial cyclohexyl protons and thus anti to 
each other and as a result the nitrogen substituents (R^) act to project the chirality of 
the cyclohexyl carbon closer to the reaction centre (Figure 1 6 ).65b,74 since the 
nitrogen substituents are proximal to the reaction centre, we reasoned that the size of 
this substituent should have an effect on the efficiency of ‘chirality transfer’. To 
examine this effect we wished to prepare the corresponding N-H phosphoramide 
series (78)-(79).
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Addition of R, R-diaminocyclohexane to a dilute solution of phosphorus 
oxychloride in DCM (4 equivalents of triethylamine) gave the corresponding 
chloride (80). Attempted isolation of this material resulted in decomposition and 
formation of baseline material by TLC, however, in situ generation and trapping 
with R-(+)-a methylbenzylamine gave the required triamide (78) in 41% yield 
(Scheme 27). For direct comparison with the N-Me analogues, the corresponding 
R, R, S-diastereoisomer (79) was prepared in 40% yield via the same protocol using 
S-(-)-a methylbenzylamine. The results obtained using these compounds as 
reduction catalysts are summarised in Table 9 together with the N-methyl series for 
direct comparison.
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NHz P(0)CI3















H (78) RRR < 30 min 89% 6 % (R)
H (79) RRS < 30 min 85% 11% (R)
H* 1:1 mixture RRR+SSR < 30 min 83% 8 % (S)
Me (72) RRR 1 hr 82%
■
8 % (R)
Me (75) RRS < 1 0  min 84% 46% (R)
Me 1 :1  mixture RRR+SSR <15 min 87% 30% (S)
* prepared in 25% yield using racemic chloride (80) (Scheme 27).
** 0.6 equivalents of BMS added to a 1M THF solution of ketone and 
1 0  mol% catalyst at rt.
Table 9 Reduction of Acetophenone Catalysed by Triamides Derived 
from In Situ Generated Chloride (80).
The results obtained showed the same trends as the methyl series. It 
appeared that replacing the methyl group with hydrogen had little effect on rate of 
catalysis though it had a detrimental effect on selectivity. This, we presumed, was 
due to hydrogen being less effective at projecting chirality from the cyclohexyl
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carbon than the more sterically demanding methyl group.
From our work on the simple triamide structures such as (70) we believed 
that increasing the size of the nitrogen substituent would not be worthwhile since it 
appeared to have a detrimental effect on catalyst turnover rate in these systems 
resulting in lower reduction enantioselectivity (c.f. phosphoramides (69) and (70)).
Since the majority of systems we had examined at this stage contained a 
primary exocyclic amide we turned our attention to the corresponding secondary 
amide series. Compounds (81)-(82) were prepared by reaction of the appropriate 
amine with N, N-dimethylphosphoramidodichloridate (2 equivalents of 
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Scheme 28
(81), R1=H, 40%





Phophoramide (82) could also be prepared in better yield (58%) by 
methylation of the 6 /s-anion of (81) (2.2 equivalents of /i-BuLi, THF, rt then 
Mel)73 or by reaction of chloride (74) with dimethylamine generated in situ by 
addition of triethylamine to a solution of the hydrochloride salt ( 2  equivalents of
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triethylamine, DCM, rt, 53% yield). The pyrrolidine derived triamide (83) was 
prepared from chloride (74) in 84% yield (2 equivalents of pyrrolidine, DCM, rt). 











H (81) 90 min 90% 10% (R)
Me (82) 2  hrs 88% 3% (R)
Pyrollidyl (83) 30 min 89% 2% (R)
* 0.6 equivalents of BMS added to a 1M THF solution of ketone 
and catalyst in at rt.
Table 10 Reduction of Acetophenone Catalysed by Triamides (81)-(83).
These results showed that a secondary exocyclic amide bond appeared to 
lower selectivity, though again the rate of catalysis appeared virtually unaffected by 
this expedient Unlike the previous examples, however, the N-H derivative (81) 
appeared to give marginally better selectivity than the corresponding N-Me 
compound (82). This, we believed, was due to the increased steric crowding in (82) 
hindering ketone approach to the phosphorus atom. The pyrrolidyl compound (83) 
gave a disappointingly low selectivity (2 % e.e., 89% yield).
We next wished to examine the effect of introducing a more hindered 
secondary exocyclic amide bond. Attempted reaction of chloride (74) with hindered 
secondary amines such as diisopropylamine and 2 , 2 , 6 , 6 -tetramethylpipiridine 
proved unsuccessful, as did reaction of the corresponding lithium amides (1.2 
equivalents of amine, 1 equivalent of /z-BuLi, T H F ),67 presumably due to steric 
effects and the inherent lack of nucleophilic character associated with hindered 
lithium amides (Scheme 29). The same lack of reactivity was observed with 
hindered primary amines such as r-butylamine and /-propylamine and their lithium
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amide derivatives (Scheme 29). Attempted reaction of in situ generated chloride 








!=  r2 = tetramethylpiperidyl
r !=  r2= /-propyl 
R1= H, R2= t-butyl 
Scheme 2 9 R ^  H, R2=/-propyi
Reaction of the appropriate N, N-dialkylphosphoramidodichloridate with the 
diamine gave a possible route to these derivatives (Scheme 28), however, 
preparation of the hindered dichloridates proved unreliable.^
Clearly another strategy for the assembly of these structures was required. 
The corresponding c h l o r o a m i n o p h o s p h i n e s ^  are considerably more reactive to 
nucleophiles than their phosphorus (V) counterparts and we next examined the route 
outlined in Scheme 30.
Reaction of N, N’-dimethylethylene diamine with phosphorus trichloride in 
diethyl ether at -78 °C (2 equivalents of triethylamine) gave the chloride in 80% 
yield.69,70 Addition of a diethyl ether solution of 2, 2, 6 , 6 -tetramethylpiperidine 
to a diethyl ether solution of the chloroaminophosphine at -78 °C followed by 
warming to room temperature gave only decomposition products. The same result 
was obtained using diisopropylamine.
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R1= R2= tetramethylpipiridyl 
R1= R2= /-propyl
It thus appeared that preparation of these very hindered systems was not 
easily achieved and we became concerned that the phosphorus atom in these 
triamides may be too hindered to allow ketone co-ordination to phosphorus. The 
results obtained with both the dimethyl (82) and the pyrrolidyl (83) derivatives and 
the benzylated triamide (77) suggested this may indeed be the case. We therefore 
abandoned further attempts to prepare examples of this structural series.
We next decided to modify the conformationally locked C2  symmetric 
‘backbone’ of the phosphonamide ring system by replacing the cyclohexyl group 
with a rra/is-diphenyl arrangement as in triamides (84) and (85). This, we hoped, 
would aid transfer of ‘chiral information’ (possibly via a nitrogen substituent relay 
effect as described previously); the sterically demanding phenyl rings directing 
ketone approach. In this case the large groups are remote from the reaction centre 
which should, we hoped, prevent unfavourable steric crowding around the 
phosphorus atom.



















Phosphoramide (84) was prepared using the previously outlined procedure 
(Scheme 31). Addition of S, S-diphenylethylene diamine^ to a dilute solution of 
phosphorus oxychloride in DCM (4 equivalents of triethylamine) gave chloride (8 6 ) 
in situ which was trapped with R-(+)-a methylbenzylamine to give the triamide (84) 
in 64% yield.
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(84), 64% Schem e 31
The corresponding N-methyl derivative (85) was again prepared via a 
previously described route (Scheme 32). Reaction of S, S-diphenylethylene 
diamine with ethyl chloroformate in toluene gave the &/s-carbamate in 91% yield. 
Reduction of a refluxing THF solution of the carbamate using L iA lF L ^ gave the 
N, N’-dimethyl diamine in 81% yield. Cyclisation of the diamine with phosphorus
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oxychloride (2.5 equivalents of triethylamine, DCM) gave the corresponding 
phosphoramidic chloride (87) in 56% yield. Reaction of a THF solution of chloride
(87) with lithiated R-(+)-a methylbenzylamine (1.2 equivalents of amine, 1 




















The results obtained using these compounds as catalysts for acetophenone 
reduction are summarised in Table 11 (together with those obtained for the 
cyclohexyl series for comparison).










H (84) SSR < 10 min 87% 39% (S)
Me (85) SSR 45 min 81% 23% (S)
H (79) RRS < 30 min 85% 11% (R)
Me (75) RRS < 10  min 84% 46% (R)
* 0.6 equivalents of BMS added to a 1M THF solution of ketone and 
10 mol% catalyst at rt.
Table 11 Reduction of Acetophenone catalysed by triamides (84) and (85).
The trans-diphenyl system appeared to give an opposite trend to the 
corresponding cyclohexyl derivatives, (79) and (75), in that reduction rate and 
selectivity appeared to be higher with a primary bicyclic amide (84) relative to 
methylated analogue (85). This, we believed, was due to the enhanced long range 
projection of chirality from the axially disposed phenyl groups; the smaller nitrogen 
substituent resulting in less steric crowding around the phosphorus atom. The S, S- 
configuration of the diamine, by analogy with the cyclohexyl system, would be 
expected to direct the reduction to give S-stereochemistry and hence be matched 
with the propensity of the R -a methylbenzyl exocylic amide to give S-alcohol 
product. We did not, therefore, consider it worthwhile to screen the S, S, S- 
diastereoisomer series.
At this stage we had obtained a detailed structure activity relationship for the 
triamide catalysts and a summary of all the results is shown in Table 12 (Figure 17).
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Table 12 Summary of the results 
Obtained for the Reduction ofAcetophenone 
Catalysed by Structurally Related Triamides.







(69) H Me H
R-a-
MeBn <15 min 83% 17% (S)
(70) H R-a-MeBn H
R-a-
MeBn 2.5 hrs 89% racemic
(71)** H R-a-MeBn —pyrrolidyl— 2.5 hrs 91% 5% (R)
(78) R,R-cyhex. H H
R-a-
MeBn <30 min 89% 6% (R)
(79) R,R-cyhex. H H
S-a-
MeBn <30 min 85% 11% (R)
(72) R,R-cyhex. Me H
R-a-
MeBn 1 hr 82% 8% (R)
(75) R,R-cyhex. Me H
S-a-
MeBn <10  min 84% 46% (R)
(76) R,R-cyhex. Me H benzyl 30 min 88% 19% (R)
(77) racemiccyhex. Me benzyl
R-a-
MeBn >5 hrs 80% racemic
(81) R,R-cyhex. H Me Me 90 min 90% 10% (R)
(82) R,R-cyhex. Me Me Me 2  hrs 88% 3% (R)
(83) R,R-cyhex. Me —pym)lidyl— 30 min 89% 2% (R)
(84) S,S-diphenyl H H
R-a-
MeBn <10  min 87% 39% (S)
(85) S,S-diphenyl Me H
R-a-
MeBn 45 min 81% 23% (S)
* 0.6 equivalents of BMS added to a 1M THF solution of ketone and 10 mol%
catalyst at rt.
** 5 mol% of catalyst was used.
*** See Figure 17.
2 Results and Discussion. Page 70.
The greatest reduction accelerations appear to be achieved with a primary 
exocyclic amide nitrogen (R^=H). In examples in which and R^ are alkyl both 
the reduction selectivity and rate of catalysis are significantly reduced, presumably 
due to steric effects. In the R, R-cyclohexyl series (R^= cyclohexyl) greater 
selectivity is achieved when R^ is methyl and R^ is S-a methylbenzyl in which case 
the directing effect of all chiral centres is matched. The same trend is observed 
when R^ is hydrogen. In the corresponding trans-diphenyl system (R^=phenyl) 
reducing the size of the R^ substituent from methyl to hydrogen improves 
selectivity, though the enantioselectivity is lower than that achieved with the 
cyclohexyl system. In both cases the absolute configuration of the product agrees 
with the proposed mode of ketone approach to phosphorus (Figure 18), though the 
actual transition states may be more complex than this simple model since the 
configuration of the R^ substituent has a significant effect. Increasing the size of 
R^ has a detrimental effect on both the rate of catalysis and selectivity, again 




Figure 1 8  
Possible transition state for 
triamide catalysed reduction
Section 2.5.2: Triamides Derived from Non- C2 Symmetric Diamines.
Though the C2  symmetric diamide component of the catalysts appeared to 
have a moderate directing effect, the selectivity obtained with these systems was
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modest We next turned our attention to non-C2 symmetric triamide structures such 








(8 8 ) (89)
These compounds contain a rigid bicyclic ring system, the structure of which 
is similar to the corresponding oxazaborolidine systems.20 This, we believed, 
would direct ketone approach to the convex face of the molecule; the phenyl group 
of the catalyst would then exert a steric influence on preferred orientation of ketone 
approach. Compounds of this type had been reported by Fiaud7^a and the 
stereochemistry at phosphorus assigned by *H and ^ lp  NMR studies.
We prepared (88) and (89) in 88% yield as a 1.4:1 mixture of 
diastereoisomers (S, Rp (89) major) by reaction of commercially available S-2- 
(anilinomethyl)pyrrolidine with N, N-dimethylphosphoramido dichloridate (2 
equivalents of triethylamine, DCM) as shown in Scheme 33.
Both diastereoisomers were easily separated by column chromatography and 
crystallisation. The results obtained using these compounds as catalysts for 
acetophenone reduction are shown in Table 13.
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(88) SSp > 5 hrs 84% racemic
(89) SRp 2.5 hrs 82% 5% (R)
* 0.6 equivalents of BMS added to a 1M THF solution of ketone
and 10 mol% catalyst in THF at rt.
** configuration assigned by comparison with literature d a t a .  75a
Table 13 Reduction of Acetophenone Catalysed by Triamides (88) and (89).
Both diastereoisomers appeared to give disappointingly low selectivity, 
again presumably due to steric crowding around the phosphorus atom. The S, Rp 
diastereoisomer (89), in which the P=0 bond has an exo configuration, appeared to 
be a more active catalyst than (88) due, we believed, to the greater accessibility of 
the P=0 bond in this molecule for borane complexation. The corresponding S, Sp 
diastereoisomer (88) contains an extremely hindered P=0 bond (Figure 19 ).





(8 8 ) Figure 19
At this stage we had achieved some success using the combined donor 
protocol and began to suspect that the problems with the catalytic system, namely 
poor transfer of ‘chiral information’, lay with ketone binding. We therefore began 
to examine ways in which this might be improved.
Section 2,6; The Problem of Ketone Binding,
A major problem with catalyst efficiency, we believed, was the poor Lewis 
acidity of the phosphorus atom once borane co-ordination had occurred (Figure 20).
3 T A R1 = alkyl 
Ir  —  m ' " o  Ph R2 = alkyl, H 
\ 5  +r 2  R3= alkyl, aryl
Figure 2 0
A semi-empirical molecular modelling study of the N-P=0 catalysed 
reduction using AMI with MOPAC9477 confirmed that co-ordination of ketone to 
phosphorus was very weak and occurred at the latter stages of hydride transfer. In 
contrast in the corresponding oxazaborolidine mediated process the interaction of 
the carbonyl group lone pairs with the boron atom is considerably stronger.^5,78 
These results are also reflected by the high reactivity rates observed using electron 
rich phosphinamides which demonstrates that donation is the dominant effect.
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This interaction could possibly be made more favourable by adding electron 
withdrawing substituents to phosphorus, however we have demonstrated that 
electron withdrawing groups have a detrimental effect on selectivity since they also 
remove electron density from the P=0 bond thus reducing the ability of the catalyst 
to ‘activate’ the borane reagent for hydride transfer. This results in loss of control in 
the transition state due to lack of rigidity.
An alternative strategy was to combine the excellent borane activating 
properties of the phosphinamide with a good electron density acceptor such as a 
boron derivative either as a single molecular entity, or as a bi-molecular co­
operative system.
2.6.1 Amino Alcohol Derived Phosphinamides.
The diphenylphosphinyl group has been used as an effective protecting 
group in amino acid and peptide chemistry.31 Similarly, Sweeney has prepared N- 
phosphinyl derivatives of a number of amino alcohols79 We believed that addition 
of borane to an N-phosphinylated amino alcohol would generate an alkoxy borane 
species such as (90), which could further react with the acidic N-H of the 
phosphinylated product in an intramolecular sense to give an oxazaborolidine such 
as (91) (Scheme 34)80 The oxazaborolidine boron atom could then act as a Lewis 
acidic site for ketone co-ordination whilst the P -0  bond could activate borane 
(Figure 21).
HN OH HN^ OBH2 O\
°  Ph O
R= alkyl 
Schem e (34) (9 0 ) (9 1 )
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Me R= alkyl 
Figure (21)
To explore this idea we prepared phosphinamides (92)-(94) from the 
corresponding amino alcohols (S-valinol, 1R, 2S-(-)-norephedrine and 1R, 2S- 
ephedrine respectively) by reaction with diphenylphosphinic chloride in DCM (1.5 
equivalents of triethylamine) as shown in Scheme 35.
1R R2 1R R2
H , . \ ____ / , » H H «,.\____/ . ,» H
/  \  Ph2P(0)CI /  \
HN OH    3R —  N OH
Xo 3 1.5 eq. Et3N x
OCM
(92) R1=/-pr, R2 =R3=H, 75%
(93) R1=Me, R2=Ph, R3=H, 91%
Scheme 35 (94) R1=R3= Me, R2 =Ph, 30%
In all cases the reaction proceeded with regioselective N-phosphinylation 
(presumably giving the thermodynamic product) with no O-phosphinoylation 
observed, though the lack of reactivity of the secondary nitrogen atom in the case of 
ephedrine resulted in a lower yield of (94), presumably due to competitive O- 
phosphinoylation and subsequent destructive side reactions tacking place. The 
corresponding S-proline derived compound (95) was prepared in 81% yield via the 
same route. The silyl protected analogue of this compound (96) was also prepared 
from (95) in 78% yield (r-BDPS-Cl, DMF, imidazole) for comparison of catalytic 
activity with its precursor. The results obtained using these derivatives as catalysts 
for acetophenone reduction are summarised in Table 14.














(92) 2 > 3 hrs 54% 10% (R)
(95) 2 2-3 hrs 72% 12% (R)
(93) 10 2 hrs 80% 10% (S)
(93) 2 ** 2-3 hrs 75% 8% (S)
(93) 100** 2 hrs 81% 11% (S)
(94) 2 2-3 hrs 71% 5% (S)
(96) 2 4 hrs 80% 7% (R)
* 0.6 equivalents of BMS added to a 1M solution of ketone and
catalyst in THF at rt.
** A THF solution of catalyst was precomplexed with 1.1
equivalents of BMS for 8 hours at rt, then ketone was added 
followed by a further 0.6 equivalents of BMS.
Table 14 Reduction of Acetophenone Catalysed by Phosphinylated 
Amino alcohol /  borane complexes.
These compounds appeared to give lower selectivity and require longer 
reaction times than the simple phosphinamide systems previously examined. There 
appeared to be very little difference between the secondary (compounds (95) and 
(94)) and primary (compounds (92) and (93)) amide derivatives suggesting that 
oxazaborolidine formation may not have occurred under the reaction conditions 
employed. Both the ephedrine (94) and norephedrine (93) systems gave virtually 
identical results suggesting that the active catalyst in both cases was an acyclic 
alkoxyborane complex. Increasing the length of borane/ phosphinamide pre-
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complexation time did not appear to increase selectivity or rate of reduction with the
this compound resulted in a negligible improvement in catalyst performance.
The silyl protected derivative (96) appeared to give slightly lower selectivity 
than the parent hydroxy compound and required a longer reaction time, though 
again the difference in catalyst performance appeared negligible. These results 
suggested that the presence of the hydroxy group was not beneficial to catalysis, 
though we still believed that an alkoxyborane species would improve ketone 
binding in the phosphinamide system. We therefore turned our attention to the use 
of boronate esters derived from simple chiral diols.
2.6.2: Chiral Diols / Phosphinamide Donors.
In view of the disappointing results obtained with the amino alcohol derived 
systems we turned our attention to the use of diols. Chiral diols such as (97) are 
known to form boronate complexes (98) upon reaction with borane. Although these 
complexes contain a third hydride they do not act as reducing agents since transfer 
of the third hydride is extremely slow. However, upon addition of further borane 
they have the potential to catalyse reduction by binding to ketone and borane as 
depicted in Figure 22:^





R= alkyl, aryl Figure 22
There a number of reports in the literature of borane-0 adducts.81*83 a  
initio molecular orbital calculations on the proposed oxazaborolidine catalysed
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reduction mechanism have demonstrated that the reaction pathway via a borane-O 
adduct (99) is much less plausible than the accepted N-adduct previously described. 
However, it is well known that borane forms complexes with ethers such as 
THF. 121,82
H
K R= alkyl, H 
(9 9)
Katsuki has recently reported that chiral N-sulfonyloxazaborolidines such as 
(100) are capable of catalysing the enantioselective reduction of ketones giving an 
enantiomeric excess of 47% in the case of acetophenone.^l An oxygen-borane 
adduct was postulated as the likely intermediate in the reaction (Figure 23).
Me
’R R2 MSV . ^  >p'1K




H M0 \ j ^ °  h ^ H2
Ph
(1 0 0 ) , R=R1=Me, R2=Ph Figure 2 3
Garcia^ has reported that boronate complexes such as (98, R= Ph, 
-CC>2Me), formed in situ from the corresponding diol, do not show catalytic 
activity, though it seemed likely to us that ketone binding should occur with these 
complexes and that it was their weak interaction with borane which limited their 
performance as efficient catalysts ; the weak donation to borane resulting in slow 
hydride transfer. We believed that the ketone binding properties of boronate
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complexes such as (98) coupled with the donor characteristics of the 
phosphinamides should enhance the effect of both.
Our initial investigations involved the use of the chiral diols (97, R=Me) and 
(97, R=Ph). The borane complexes of these compounds (98) were prepared in situ 
by complexation of the R, R-diol with 1.1 equivalents of BMS in THF at rt for 20 
minutes.^ 3 We first examined the use of these complexes as catalysts for 



















> 12 hrs 













* 0.6 equivalents of BMS added to a 1M THF solution of ketone
and boronate complex (98) (formed in situ by complexation of the 
R, R-diol with 1.1 equivalents of BMS in THF at rt for 20 
minutes) at rt.
** Mainly unreacted ketone after 12 hours.
*** Diol/ borane complexed for 16 hours at rt prior to ketone addition.
Table 15 Reduction of Acetophenone Catalysed by Boranate (98).
The use of 10 mol% of (98, R=Me) in the reaction gave modest selectivity, 
although a very low yield of alcohol; the reaction mixture consisting mainly of 
unreacted ketone after stirring overnight. Repeating the reaction using an equimolar 
quantity of the same complex gave a reduction product of 41% e.e. with complete 
consumption of starting material. This suggested that at lower concentrations the 
complex had little or no catalytic activity (in terms of catalyst turnover) whilst at the 
higher concentration, presumably at which all of the ketone was complexed, poor 
catalyst recycling would not limit selectivity.
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Increasing the size of the R- substituent in (97) from methyl to phenyl 
appeared to have no effect on selectivity, however complexation of the diol with 
borane for extended lengths of time in forming (98, R=Ph) appeared to have a 
detrimental effect on selectivity, presumably due to partial decomposition of the 
boronate complex.
The S- configuration of the resulting alcohol appeared to agree with that 
predicted by the model illustrated in Figure 22. Assuming borane is attached trans 
to the adjacent R- group in (98) and the carbonyl group attached via the lone pair 
trans to the phenyl with the methyl group orientated away from the bulky catalyst, 
the predicted selectivity matches that observed, m
Having demonstrated the ability of the ketone to co-ordinate to the boronate 
complex in these systems we next examined the effect of a combination of 
phosphinamide (29) with the boronate complex (98) in the reduction reaction. The 













none : 10 < 1 hr 82% 26% (S)
(98,R-Me) 10 none >12 hrs <20% 21% (S)
(98,R=Me) 10 10 2 hrs 89% 47% (S)
(98,R=Me) 100 10 90 min 88% 56% (S)
(98,R=Me) 100 100 < 1 hr 74% 35% (S)
(98,R=Ph) 10 10 4 hrs 87% 52% (S)
(98,R=Ph) 100 10 2-3 hrs 91% 41% (S)
* Formed in situ by complexation of the diol with 1.1 equivalents of BMS
in THF at rt for 20 minutes.
** 0.6 equivalents of BMS added to a 1M THF solution of ketone, boronate
complex (98) (formed as described above) and phosphinamide (29) at rt.
Table 16 Reduction of Acetophenone Catalysed by Phosphinamide (29) in 
Combination with Boronate (98).
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Gratifyingly, the combination of phosphinamide (29) together with (98) 
gave higher levels of asymmetric induction than when used individually. The use of 
1 equivalent of boronate complex together with a catalytic quantity of 
phosphinamide appeared to increase selectivity, though a stoichiometric quantity of 
both components gave a lower result, presumably due to the dominating effect of 
the phosphinamide. The use of a catalytic quantity of boronate (98, R=Ph) together 
with phosphinamide (29) appeared to give better selectivity than in the 
corresponding methyl system (98, R=Me) though, for reasons that are not clear, 
increasing the concentration of the complex appeared to have a detrimental effect on 
selectivity.
These results suggested that the two materials were working together in a 
process in which their enantioselectivities were matched, this presumably being 
achieved by donation of electron density from the P=0 bond in (29) to the borane 
molecule appended to the oxygen atom in Figure 22, which underlines the 
productive collaboration of a good donor (29) and acceptor (98).
In order to eliminate the possibility that the phosphinamide was facilitating 
reduction by transfer of the third hydride from boronate (98) rather than b o ra n e ,87 a  
THF solution of 10 mol% phosphinamide (29), 1 equivalent of boronate complex 
(98, R=Me) and ketone was stirred for 18 hrs at room temperature after which time 
no alcohol was observed. Addition of a further 0.6 equivalents of BMS resulted in 
>98% reduction of acetophenone in 90 minutes giving an alcohol of 54% e.e. (S 
major, 83% yield).
In order to assess the importance of the a-methylbenzyl chiral centre in 
directing the reduction and substantiate the combined donor/ acceptor effect we 
conducted an experiment using 10 mol% of achiral phosphinamide (101), prepared 
in 91% yield by reaction of benzyamine with diphenylphosphinic chloride (2 
equivalents of triethylamine, DCM) and 10 mol% (98, R=Me). This combination 
gave an alcohol product of 14% e.e. (S major, 86% yield) in 3 hours at room 
temperature, which suggested that the phosphinamide was intimately involved in
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controlling not only rate of catalysis but also reduction selectivity.
0 H
II Ph
( 1 0 1 )
H
(84)
Repeating the experiment using 10 mol% of triamide (84), which we knew 
gave good S- reduction selectivity (Section 2.5) resulted in a considerable erosion of 
selectivity in the presence of the boronate complex (23% e.e. compared with 40% 
without the boronate present), with a reaction time in excess of 5 hours being 
required for >98% reduction of the ketone. The reasons for this are again not 
immediately apparent.
We next wished to examine the effect of varying the boron substituent in
(98) on the performance of the boronate complex in the reduction reaction and 
therefore turned our attention to boronates (102) and (103).
We reasoned that increasing the Lewis acidity of the boron atom in (98) by 
introduction of a chlorine atom should allow the carbonyl group to complex more 
strongly. 14a t 0 this end we prepared boronate (102) in situ by reaction of diol (97, 
R=Me) with 1.1 equivalents of monochloroborane in THF at room temperature. 
The use of 10 mol% of this complex together with 10 mol% of phosphinamide (29) 
gave a reduction product of 14% e.e. (S, major, 61% yield) in 3 hours at room
B — Bu
( 1 0 2 ) (103)
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temperature, however partial decomposition of the phosphinamide under the 
reaction conditions was also observed using this material, presumably due to the 
increased Lewis acidity of the diol complex.85,79a
Boronate ester (103) was prepared in 95% isolated yield by reaction of the 
diol (97, R=Ph) with butyl boronic acid in pentane at room temperature. 83,86 iq 
mol% of this compound together with 10 mol% of phosphinamide (29) gave a 
reduction product of 25% e.e. (S major, 88% yield) in 4 hours at room temperature 
(c.f. boronate (98, R=Ph), 52% e.e., 4 hours). It thus appeared that increasing the 
size of the boron substituent had a detrimental effect on selectivity, again 
presumably due to steric effects.
To complete our examination of the scope of this process we investigated 
the tartrate- derived boronates (104) and (105) (prepared in situ from the 
corresponding diol and BMS as described above) and the diamine derivative (106) 
(prepared in situ by reaction of the diamine with BMS in THF at room temperature) 












(104) > 5 hrs 88% 35% (S)
(105) > 5 hrs 79% 10% (S)
(106) 2-3 hrs 81% 17% (S)
* 0.6 equivalents of BMS added to a 1M THF solution of ketone,
10 mol% of boronate (formed in situ by complexation of the 
diol with 1.1 equivalents of BMS in THF at rt for 20 minutes) 
and 10 mol% of phosphinamide (29) at rt.
Table 17 Reduction of Acetophenone Catalysed by Phosphinamide (29) 
in Combination with (104H106).
In all cases reduction appeared slow and the selectivities were lower than the 
corresponding alkyl boronates (98). Diethyl tartrate- derived boronate complex 
(104) together with phosphinamide (29) gave overall S- reduction selectivity though 
in this case the configuration of the boronate may not have been ‘matched’ with that 
of the phosphinamide. The corresponding S, S- diamide (105), however, gave the 
same major reduction product but in lower enantiomeric excess. Decomposition of 
boronate complex (104) occurred during the reaction possibly as a result of 
reduction of the ester functionality.121 Diamine complex (106) did not appear as 
effective as the corresponding alkyl boronate complex (98, R=Ph) in this process. 
This was surprising since it would be expected to behave more like an 
oxazaborolidine than (98). 122 The formation of an acyclic amine-borane complex 
on adding BMS to the diamine rather than (106) could account for this lack of 
reactivity.
2.6.3: Phosphinamide / Diol as a Single Molecular Entity.
Having established that the presence of a boronate complex considerably 
improved the selectivity of the phosphinamide catalysed reduction, we planned to
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capitalise on these observations by combining the N-P=0 structural unit and the diol 
motif into a single molecular entity.
Phosphinamide diol (107), we believed, upon reaction with borane should 
generate the active catalytic species, boronate (108), in situ. The ketone could then 
co-ordinate with the electron accepting boron atom via an interaction with one of 
the oxygen lone pairs as shown (Figure 24). This would result in removal of 
electron density from the carbonyl group and consequently increase its reactivity (in 
much the same way as the oxazaborolidine system). Complexation of the ketone 
could then occur on either face of the borocyclic ring to give X or Y respectively 
(Figure 24). Borane (stoichiometric reductant) is then free to co-ordinate to either 
one of the ring oxygen atoms lone pairs; complex X giving A or B whilst Y would 
give C or D . Since this interaction is known to be weak, the borane is not 
significantly activated in terms of reactivity. In complex A, however, the 
phosphinamide can adopt a suitable conformation to donate electron density and 
promote hydride transfer to the co-ordinated ketone. Since the borocyclic ring of 
the catalyst is also sterically demanding, co-ordination of the ketone via its lone 
pairs should occur with the methyl group orientated away from the bulky ring 
system; hydride should then be delivered to the re face giving the S- enantiomer of 
product.
H
( 1 0 7 ) (108)
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2.6.3.1 Preparation of Phosphinamide Diols bv Asymmetric Dihvdroxvlation.
In order to explore this idea we required a route to diastereomerically pure 
phosphinamide diol (107). One very effective synthetic route to chiral diols is the 
Sharpless asymmetric dihydroxylation of the appropriate olefin.^8 This 
methodology has been successfully applied to a number of di-BOC protected allylic 
amines, with good selectivity reported for di- and tri- substituted double bonds 
(Scheme 36). Though no examples of dihydroxylation of diphenylphosphinyl 
protected allylic amines had been reported, we believed this represented a very 











R1=R2= H, 93% yield, 34% e.e.
R 2 R1=H, R2= Ph, 78% yield, 97% e.e. 
R1=R2 =Me, 44% yield, 47% e.e.
Schem e 36
To this end we prepared alkene (109) in 79% yield by alkylation of (29) (1.2 
equivalents of n-BuLi, THF, allyl bromide) (Scheme 37).
Dihydroxylation of (109) under standard Sharpless conditions using AD- 
mix-p88,89 (ijuujoi alkene, 1.4g AD-mix, r-butanoL/water) gave a 91% yield of a 
1.7:1 mixture of diastereomeric diols (ca. 30% d.e., as assessed by and 31p 
NMR) (Scheme 37), with the R, R-diastereoisomer being in excess. The diol 
configuration was determined by comparison of NMR data with a pure sample of 
the corresponding R, S-diastereoisomer prepared later (see below). The poor
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dihydroxylation selectivity obtained with alkene (109) was consistent with that 
reported by Sharpless for di-BOC protected terminal alkenes (Scheme 36).
All attempts to separate the mixture by chromatography and crystallisation 
proved unsuccessful, however use of 10 mol% of the boronate complex (110) 
(formed in situ by reaction of a THF solution of the diol mixture with BMS at rt) in 
the reduction of acetophenone gave a reduction product of 16% e.e. (S major, 84% 
yield), >98% reduction occurring in 3 hours at room temperature. ‘Correction’ of 
this value for catalyst purity and assuming that no synergic effects were in 
operation, this result suggested that a diastereomerically pure sample should give an 





H 0 H O
MeS02NH2 
f-BUOH / H20
H CH HO H
1.7:1 (RR:RS), 91% yield
Scheme 37
H Me 9
0 — B 
H
(110) RR:RS 1.7:1
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Encouraged by this preliminary result, we next wished to examine the effect 
of changing the configuration of the hydroxy centre at C-2 in order to determine if 
the directing effect of the amide side chain was significant. Remarkably, attempted 
dihydroxylation of alkene (109) using AD-mix-a, which should again have given a 
diastereomeric mixture of diols though in this case enriched in the R, S- 
diastereoisomer as a result of preferential oxidation of the opposite face of the 
alkene, resulted in the formation of the same mixture of diastereoisomers in 72% 
yield and in an identical ratio.
Intrigued by this result and the apparent overriding effect of the a- 
methylbenzyl chiral centre in determining face selectivity, we repeated the 
dihydroxylation of alkene (109) in the absence of the phthalazine ligand (1 
equivalent of alkene, 3 equivalents of K3 Fe(CN)6 , 3 equivalents of K2 CO3 , 1 
mol% K20sC>2(0H)4, 1 equivalent of H2NS02Me, f-Butanol/ water). This again 
appeared to give the same product mixture in 74% yield.
We believed this apparent directing effect to be due to intramolecular co­
ordination of the P=0 bond to osmium during the dihydroxylation, prior to 
rearrangement of the osmaoxetane intermediate and generation of the glycolate 
ester, preventing co-ordination of the phthalazine ligand and hence transfer of 
stereochemical information (Figure 25). The uncatalysed reaction appeared to 
proceed at a comparable rate (ca. 6 hrs at room temperature) to those under AD-mix 
control suggesting that a neighbouring group interaction may be in operation.
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Figure 25
Despite all attempts to separate the diastereoisomers by physical methods 
and chemical derivatisation no pure samples could be obtained. We still felt, 
however, that the dihydroxylation reaction could be utilised for preparing 
structurally related phosphinamide diols and felt that this warranted further 
investigation. Substitution of the double bond in (109) could, we believed, improve 
oxidation selectivity. Also structural analogues of diol (107) might be easier to 
separate from a diastereomeric mixture. To this end we prepared alkenes (111) and 
(112) in 87 and 74% yields respectively from phosphinamide (29) under previously 
described conditions (1.2 equivalents of w-BuLi, THF, allylic halide).
H Me 9 H Me 9  Phn
Ph
(111) ( 1 1 2 )
Attempted dihydroxylation of (111) using AD-mix-p (1 equivalent alkene, 
420 mg AD-mix, f-butanol/water) gave a 76% yield of the corresponding a-hydroxy 
ketones (113) as an inseparable 1.3:1 mixture of diastereoisomers, presumably as a
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result of over- oxidation of the benzylic hydroxy group under the reaction 
conditions; a phenomenon usually only observed with strong oxidising agents such 
as alkaline permanganate. 109 Jh \s result seemed especially surprising in that 
dihydroxylation of conjugated alkenes such as stilbene under Sharpless AD-mix 
conditions results in a virtually quantitative formation of the diol with no over­
oxidation observed.^’ HO
Treatment of a THF solution of the mixture with BMS gave a complex 
mixture of diastereomeric diols which could not be separated.
Dihydroxylation of alkene (112) using AD-mix-p (lequivalent alkene, 360 
mg AD-mix, f-butanol/water) proceeded in 91% yield, again giving an inseparable 
mixture of diastereomeric diols (114) in a ratio of 1.6:1 (ca. 25% d.e.).
Use of 10 mol% of the boronate complex of this mixture (115) (prepared in 
situ by reaction of the diol mixture (114) with BMS at room temperature) gave a 
reduction product of 9% e.e. (S major, 84% yield), with >98% reduction occurring 
in 5 hours at room temperature. It seemed likley that the lower selectivity and 
longer reaction time required for reduction reflected the increase in steric crowding 
in boronate (115) relative to (110).
2.6.3.2 Preparation of Phosphinamide Diols from Chiral Glycidol.
At this stage the low selectivities and difficulty of diastcreoisomer
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separation suggested that the asymmetric dihydroxylation reaction would not 
provide a means of preparing the requisite diastereomerically pure phosphinamide 
diols. We therefore turned our attention back to (107) and began to examine other 
routes to this compound.
Alkylation of both R-(+)-a methylbenzylamine and phosphinamide (29) 
using bromide (116)90 (1.2 equivalents of «-BuLi, THF, bromide (116)) proved 
unsuccessful (Scheme 38), presumably due to the low reactivity of a- 
heterosubstituted halides to nucleophilic attack.91
Similarly, attempted ring opening of THP- protected glycidol (117)93 with 
deprotonated phosphinamide (29) proved unsuccessful (Scheme 39).






the preparation of amino a l c o h o l s . 9 2  Similarly, glycidol derivatives have been ring 
opened at C - 3  generating amino d i o l s . 9 2 b  Since homochiral g l y c i d o l 9 3  i s  readily
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available we were particularly interested in this process since regioselective ring 
opening at C-3 would generate the required 1, 2-dihydroxy-3-amino motif required 
for the phosphinamide diol catalysts (Scheme 40).
O RNH2
CP FN
I, Lewis acid - -
H H CH
P = protecting 
group
R = alkyl Scheme 40
Reaction of R-(+)-a methylbenzylamine with R-glycidol using lithium 
perchlorate as c a t a l y s t ^ 0 (l equivalent of amine and epoxide, 1 equivalent of 
lithium perchlorate, acetonitrile, rt) gave low yields of the required amino diol 
largely due to loss of material as a result of high water solubility. The polarity of 
the product also made purification difficult. Repeating the reaction with r-BDMS- 
protected g ly c id o l9 4  (prepared in 73% yield using 1.1 equivalents of f-BDMS-Cl,
1 .2  equivalents of triethylamine and 0.05 equivalents of DMAP in DCM at rt.) gave 
the corresponding mono protected amino diol (118) in 90% yield as a single 
regioisomer (as assessed by and NMR) (Scheme 4 1 ) .  The corresponding t- 
BDPS protected epoxide gave a very low yield (<15%) of ring-opened product 
presumably due to the steric effect of the larger protecting group.
f-BDMS-CI
OH
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Remarkably, attempted phosphinylation of (118) using diphenylphosphinic 
chloride in DCM (2 equivalents of triethylam ine) gave the O- 
diphenylphosphinoylated product (119) in 48% yield. This, we believed, may have 
been due to the greater thermodynamic stability of O-phosphinoylated secondary 
alcohols (in amino alcohols in which both the amine and alcohol are primary 
regioselective N-phosphinylation occurs in high y ie ld ^ , see Section 2.6.1). 
Another possibility is that phosphinoy! group migration from nitrogen to oxygen 
may have taken place during the reaction (Figure 26) though this usually requires 
acid catalysis.79b
In order to prevent O-phosphinoylation we attempted to protect the hydroxy 
group as its /-BDMS- ether. Reaction of mono protected amino diol (118) with 1- 
BDMS-C1 (1.2 equivalents of triethylamine, 0.05 equivalents of DMAP, DCM, rt) 
gave the corresponding N-silylated product (120) in 56% yield. Repeating the 
reaction using DMF/ imidazole (1 equivalent of r-BDMS-Cl, 2.2 equivalents of 
imidazole, DMF, rt) gave a 52% yield of the same product.
0 Sit-BuMe2 Ph OSit-BuMe2
0
(1 1 9) Figure 2 6
OSit-BuMe2
R = Sit-BuMe2 
(12  0 )
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This result seemed at first surprising, though similar observations have been 
reported in the literature. For example Dunlap has found that treatment of IS, 2R- 
norephedrine ( 121) with J-BDMS-C1 in the presence of triethylamine afforded what 
appeared to be a mixture of protected amine and alcohol in variable ratios, however 
it was found that refluxing this mixture in benzene gave the corresponding silyl 
ether (122) e x c l u s i v e l y . 95 Refluxing 6/s-silylamino alcohol (120) for 6 hours in 
toluene resulted in no silyl migration.
At this stage we had established an effective method for preparation of the 
diastereomerically pure 1, 2-dihydroxy-3-amino framework, but still required a 
reliable method for regioselective phosphinylation of the nitrogen atom.
magnesium halides or organolithium reagents proceeded with regioselective 
cleavage of the primary P-0 bond giving the corresponding protected amino alcohol 
(123) as a single diastereoisomer with overall retention of configuration at 
phosphorus (Scheme 42) 97
Me Ph Me Ph
H2N OH H2N OSit-BuMe2
(121) (12  2 )
Brown^ had reported that reaction of oxazaphospholidine (27) with alkyl
o-MeO(C6H4)mgBr
THF PhMe Me
(2 7) (1 2 3), 70% 
(retention)Scheme 4 2
To examine the use of this strategy for the N-phosphinylation of (118) we
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prepared epimeric oxazaphospholidines (124) and (125) in 45% yield and in a ratio 
of 1.4:1 by reaction of mono protected amino diol (118) with phenylphosphonic 
dichloride (2.2 equivalents of triethylamine, DCM, rt) (Scheme 43). The epimeric 
oxazaphospholidines (1 2 4 ) and (125) were readily separated by flash 
chromatography. The absolute configuration at phosphorus was inconsequential 
(since this chiral centre would be destroyed on ring opening) and was therefore not 
determined.
Treatment of a THF solution of either epimer with 1.5 equivalents of 
phenylmagnesium bromide^ at -30 °C followed by warming to room temperature 











(124) or (125)  
R = Sif-BuMe2
(126), 65-70% R=Sif-BuMe2 
(107), 85% R=H
Scheme 44
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Cleavage of the silyl- group using 2 equivalents of TB AF (THF, 0 °C) gave 
the R, S-phosphinamide diol (107) in 85% yield. This compound was 
spectroscopically identical to one diastereoisomer in the mixture obtained by
that phosphinamide diol (107) was the minor component of the diastereomeric 
mixture obtained via the oxidation route. The pure R, S-diastereoisomer was then 
screened for catalytic activity.
In situ complexation of (107) with BMS in THF at room temperature for ca 
2 hours (presumably generating boronate (108)) followed by addition of 
acetophenone and a further equivalent of BMS resulted in >98% reduction in 3 
hours at room temperature. The resulting alcohol was obtained in a disappointing 
9% e.e. (S major, 82% yield).
We were concerned that boronate (108) may be considerably more sensitive
the presence of impurities might have a more pernicious effect on catalyst 
performance. Phosphinamide diol (107) was further purified by double 
crystallisation from diethyl ether/ pentane and dried via azeotropic removal of water 
using chloroform. The ketone (initially dried by distillation from calcium hydride)
dihydroxylation of alkene (109). Comparison of ^H and 31p NMR data revealed
H OH
H Me ?,II
1 0  mol% 108 (Major)
+




(1 0 8 ) 8 8 % yield 
59% e.e.
Schem e 45
to reaction conditions than the phosphinamide catalysts alone,28 and believed that
was dissolved in THF and dried for 18 hours over activated 4A molecular sieves 
prior to use.28,118 xhe reduction was then repeated under rigorously anhydrous
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conditions and gratifyingly the alcohol was obtained in 59% e.e. (S major, 88% 
yield) after 2 hours at room temperature (Scheme 45).
Again we believed that the a  methylbenzyl chiral centre was contributing 
significantly to the selectivity observed since if the configuration of the chiral centre 
at C-2 were the only controlling element, the ADH reaction product (containing ca. 
30% d.e. of the R, R-diastereoisomer) would have been predicted to give the 
opposite enantiomer of alcohol in the reduction (Figures 24 and 27).
To examine these effects in more detail we prepared a pure sample of the S, 
S-phosphinamide diol (127), the enantiomer of the major component of the ADH 
mixture, using S-(-)-a methylbenzylamine and f-BDMS-protected R-glycidol as 
shown in Scheme 46.
Ring opening of S-f-BDMS protected glycidol using the S-amine (1 
equivalent of amine and epoxide, 1 equivalent of lithium perchlorate, acetonitrile, rt) 
gave mono protected amino diol (128) in 96% yield as a single regioisomer. 
Cyclisation with phenylphosphonic dichloride (2.2 equivalents of triethylamine, 
DCM, rt) gave a 1:1 mixture of epimeric oxazaphospholidines (129) in 50% yield. 
Again both were readily separable by flash chromatography. Treatment of either 
epimer with 1.5 equivalents of phenylmagnesium bromide in THF at -30 °C gave, 
on warming to room temperature, the phosphinylated amino alcohol (130) in 59% 
yield. Removal of the silyl group using 2 equivalents of TBAF (THF, 0 °C) gave
Ph
H Me
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phosphinamide diol (127) in 91% yield as a white foam which was crystallised from 
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Boronate (131) was again prepared in situ by reaction of a THF solution of
(127) with BMS at room temperature for 2 hours. Dried acetophenone (see above)
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was then added followed by a further equivalent of BMS. This resulted in >98% 
reduction of starting material in 3 hours at room temperature. The resulting alcohol 
was obtained in 22% e.e. (S major, 80% yield), which implied that the enantiomer 
of this compound (i. e. the R, R-diastereoisomer) should give R- selectivity in the 
reduction. This result seemed somewhat surprising since a 30% d.e. of the R, R- 
diastereoisomer in a mixture with the R, S- isomer gave overall S- selectivity in the 
reduction (16% e.e., S major, 84% yield, see above). We believed this may have 
been due to the superior catalytic activity of the R, S-diastereoisomer in the mixture 
or a synergic effect occurring between the components of the mixture ‘modifying’ 
the active catalytic species.
Increasing the concentration of boronate (108) appeared to have a 
detrimental effect on selectivity; use of 1 equivalent of (108) in the reaction gave a 
reduction product of 8% e.e. (S major, 78% yield) which again at first appeared 
counterintuitive.
It has been presumed that the active catalytic species formed on 
complexation of the diol with borane are monocyclic and monomeric, though partial 
association or oligomerisation processes are commonplace in organoborane 
chemistry. 1^2 At higher concentrations of diol, monomer-dimer equilibrium (to an 
unspecified structure) may occur resulting in the formation of a compound with 
reduced catalytic activity. Such effects have been observed in oxazaborolidine 
system s.25,29,98
Work is currently underway in the Wills group to optimise reaction 
conditions for the reduction of acetophenone with borane catalysed by (108) and to 
prepare structural analogues of its precursor (107). 124
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Section 2.7: The Use of Phosphinamide N-Protecting Groups for the
Intramolecular Directed Reduction of Ketones. 1 ^
Many important pharmaceutical products and drug candidates are derivatives 
of chiral amino alcohols. Aryl ethanolamine derivatives of general structure (132, 
Rl=Ar) represent a very important class of P-adrenoreceptor agonists, used in the 
treatment of asthma, glaucoma and cardiovascular diseases. Examples include 
Terbutaline (133)99 ancj Salbutamol (134), 100 as well as peptide mimetics such as 
the enzyme inhibitor Statine (135). Preliminary studies on this class of 








(13 3) (1 3 4)HO
OH
(13 5)
The current synthetic routes to these materials involve classical resolution or 
lengthy multi-step synthesis.100,103 \\re believed that the inherent
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reduction directing ability of the phosphinamides together with their ability to act as 
an amine protecting group3179 would give access to these compounds. The key to 
this strategy lay in the use of the N-P=0 group of an adjacent protected amine to 
direct the reduction of a neighbouring carbonyl group in an asymmetric 106 (in the 
case of (132)) or diastereoselective104,105 the case of (136)) sense.
The ease of introduction and removal of the phosphinyl group^ make it an 
ideal candidate as a chiral auxiliary material (see Section 1.2.3) for the control of the 
asymmetric reduction of proximal ketones and the preparation of aryl ethanolamine 
targets (Scheme 47).
O H  i) R 2P(0)CI, o
H b3Se II . ipin/rt\n* BMSN  ► NRP(0)R2 -------







^  \  . nrp(0)r'2 or . (132)
1R i)Ph2P(0)CI p(°)R 2
(1 3 7 )
N
ii) NaH (1 3 8 )
(were R=H)
'R
R= H, alkyl, aryl
R*= chiral amine or alkyl group
R1= alkyl, aryl Scheme 47
Since secondary amino ketones are prone to facile dimerisation, the 
proposed route involved protection of an amino alcohol followed by oxidation to 
give the reduction precursor. Stereoselective reduction would then generate the 
protected chiral amino alcohol (137), which on deprotection would give the 
homochiral ethanolamine (132). Alternatively, cyclisation of the amino alcohol via 
literature procedures would give the corresponding homochiral aziridine (138)7^ 
This protocol could also be applied to the synthesis of diastereomerically pure 
amino alcohols such as (136).
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2.7.1 Diastereoselective Reduction.
Our initial investigations centred on the preparation of ketophosphinamide 
(139) which we believed would be a suitable model system for examination of 
reduction diastereoselectivity.
Attempted preparation of this compound by alkylation of (29) (rt-BuLi, 
THF, phenacyl chloride) yielded only products arising from ketone deprotonation. 
The same result was obtained using the corresponding bromide and iodide. 
Addition of the phosphinyl group as the final step was also considered but attempted 
preparation of amino ketone (140) by reaction of the amine with phenacyl bromide 
resulted in formation of dimeric products.
Preparation of amino alcohol (141) by Lewis acid mediated ring opening of 
styrene oxide with R-(+)-a methylbenzylamine (1 equivalent of amine, 1 equivalent 
of lithium perchlorate, acetonitrile, rt) also proved unsuccessful, generating an 
inseparable mixture of regioisomeric products in low yield. Since the synthesis of 
(439) proved problematic, we turned our attention to norephedrine as a precursor for 
these studies.
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equivalents of triethylamine, DCM, rt) gave the N-phosphinylated amino alcohol
(93) in 91% yield (see Section 2.6.1). Oxidation of this compound using pyridinium 
dichromate in DMF 10^ (5 equivalents of PDC, rt) gave ketone (142) in 90% yield 
(Scheme 48).
Me Ph Me 0
h A  AoH h A  / /
HN OH 5 e q P D C  .  HN Ph  
^ P\ ~ P h  ° MF ph
0 ph 0 ph
(9 3) (1 4 2), 90%
Scheme 4 8
Similar results were obtained using TPAP/ N M O ^^ though problems were 
encountered with separation of ruthenium residues from the product using this 
method. Since we were primarily concerned with reduction diastereoselectivity at 
this stage we were not concerned about possible racemisation of the a- chiral centre.
Reduction of ketone (142) with BMS (0.6 equivalents of BMS, THF, rt) 
returned the 1R, 2S product (i.e. (93) ) in 92% yield as a single diastereoisomer (as 
assessed by *H and 31p NMR) in 45 minutes at room temperature.^^ Sodium 
borohydride reduction of (142) (0.25 equivalents of NaBH4 , 9:1 EtOH/H20) gave 
amino alcohol (93) as an inseperable 2:1 mixture of diastereoisomers (syn- major, 
90% yield) confirming that the phosphinyl group was not only acting as a nitrogen 
protecting group but also activating the borane reagent and directing ketone 
reduction.
Replacing the diphenylphosphinyl group in (93) with a /-butoxycarbonyl 
(Boc) group also suggested this was the case. Reaction of 1R, 2S-norephedrine with 
di-terr-butyl dicarbonate (1 equivalent of (Boc)20, 1.1 equivalents of triethylamine, 
DCM, rt) gave the r-BOC- protected amino alcohol (143) in 8 6 % yield. 
Oxidation of (143) with pyridinium dichromate (5 equivalents of PDC, DMF, rt)
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gave ketone (144) in 70% yield. Reduction of ketone (144) with BMS (0.6 
equivalents of BMS, THF, rt) afforded the amino alcohol as an inseperable 3.75:1 
mixture of diastereoisomers (syn-(143) major) in 70% yield.
Me Ph Me O
H/,.^_______________________ ^
HN OH HN Ph
I I
f-BOC f-BOC
( 143)  ( 144)
The structure of the transition state for the intramolecular directed reduction 






Co-ordination of the ketone carbonyl group and phosphinyl oxygen atom to 
borane results in activation of the reducing agent and transfer of hydride can then 
occur anti- to the a  methyl group giving the observed product configuration.
2.7.2 Asymmetric Reduction Directed bv Remote Chiral Centres.
Encouraged by these results, we next wished to examine asymmetric 
proximal ketone reduction directed by remote chiral substituents on phosphorus 
(Scheme 47).
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(7 4), R= Me 
( 8  0), R= H Scheme 4 9
All attempts to couple amino alcohol ( 145) with cyclic chloride (74) proved 
unsuccessful, presumably due to the inherent lack of reactivity associated with the 
cyclic electrophile (Scheme 49). Use of the more reactive cyclic phosphoramidic 
chloride (80), generated in situ from the corresponding diamine and phosphorus 
oxychloride (4 equivalents of triethylamine, DCM) resulted only in formation of 
polymeric baseline materials by TLC.
Reaction of amino alcohol (145) with acyclic chloride ( 146), prepared in situ 
by reaction of R-(+)-N-methyl-a m e t h y l b e n z y l a m i n e ^  with phosphorus 
oxychloride (4 equivalents of triethylamine, DCM), gave an inseparable epimeric 
mixture of O- and N-phosphinlyated products (as assessed by 31p NMR) (Scheme 
50).
This result appeared somewhat surprising since reaction of amino alcohol 
(145) with diphenylphosphinic chloride gave exclusively the N-phosphinylated 
product (147) in 89% yield (1.5 equivalents of triethylamine, DCM). Oxidation of 
this compound was readily achieved using TPAP/ NMO^O® (1.8 equivalents of 
NMO, 5 mol% TPAP, 4A molecular sieve, DCM) to give the corresponding ketone 
(148) in 81% yield.
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Ketone (148) could also be prepared directly in 90% yield by slow addition 
(over 2  hours) of a-aminoacetophenone hydrochloride to a very dilute solution of 
excess diphenylphosphinic chloride in DCM at low temperature (1.5 equivalents of 
diphenylphosphinic chloride (0.04 M), 2.1 equivalents of triethylamine, 0 °C). No 
evidence of amino ketone dimerisation was observed under these conditions.
Again cyclic chloride (74) appeared to unreactive for this protocol; substrate 
dimer formation being the dominant reaction. The same problem was also 
encountered with both chlorides (80) and (146). In view of these disappointing
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results no further studies were undertaken on the coupling reaction.
2,L3;_rtie .Use of Chiral jtoronatss with PiphenyJclmspiiinYl Protected Amino 
Ketones.
Since diphenylphosphinyl protected amino ketone (148) was in hand, we 
next considered the use of a catalytic quantity of a suitable chiral boronate (98) 
which in combination with the phosphinamide motif could direct reduction of the 









Ph R = alkyl
To this end boronate (98, R=Me) was prepared in situ by reaction of the diol 
(97, R=Me) with 1.2 equivalents of BMS at room temperature in THF. Addition of 
ketone (148) followed by a further 0.6 equivalents of BMS gave protected amino 
alcohol (147) in 85% yield with complete reduction occurring in 30 minutes at room 
temperature. The product was, however, obtained in a disappointing 3% e.e. (as 
assessed by 31p NMR analysis of the corresponding crude Moshers esters). 1 *4
Work is currently underway in the Wills group to couple the dianion of 
amino alcohol (145) with chloride (74) and to develop a more efficient route to the 
requisite phosphinylated ketones. * 12
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3 Conclusions.
We have identified a novel class of catalysts for the asymmetric reduction of 
ketones by borane. These are characterised by the presence of an ‘N -P=0’ 
(phosphinamide) structural unit which is critical to their activity. The preparation of 
such compounds is generally trivial involving the reaction of a solution of the 
appropriate phosphorus chloride with amine in DCM, for example phosphinamide 
(29) prepared in 89% yield from diphenylphosphinic chloride and R-(+)-a 
methy lbenzy lamine.
The use of <10 mol% of (29) accelerates the reduction of acetophenone with 
borane by several hundred fold and gives enantiomerically enriched 1 - 
phenylethanol in 26% e.e. Structurally related acyclic phosphonamides of type 
(44)-(4 7 ) and (43) also give similar reduction accelerations, though 
triphenylphosphine oxide fails to catalyse the reaction.
Examination of conformationally restricted phosphonamides such as (25) 
and (61) in the reduction process have demonstrated a clear stereoelectronic 
requirement for catalysis. Effective electron donation from the nitrogen atom 
(which is sp^ hybridised) to the P=0 bond requires co-planarity of the full ‘R^N- 
P=0’ unit of the molecule (Figure 14). In this conformation donation from the 
nitrogen atom to the phosphorus d-orbital is presumably permitted. Cyclic systems 
such as (25) and (61) are not able to achieve this conformation and are poor 
reduction catalysts.
(29)
R= Ph (44) 
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H Me
Ph Nv  PhNH
( 25)  (61)
( 59 )  ^
Electron withdrawing substituents on both the nitrogen and phosphorus 
atoms have a detrimental effect on both the rate of catalysis and asymmetric 
induction. The presence of an electron donating substituent on phosphorus (e.g. p- 
methoxyphenyl in (59)) significantly increases the rate of catalysis, complete 
reduction of acetophenone occurring in <15 minutes at room temperature in the 
presence of 5 mol% of (59).
On the basis of experimental and theoretical data it is proposed that catalysis 
is achieved by activation of borane via a strong donation from the oxygen atom of 
the N-P=0 system coupled with a much weaker interaction of the carbonyl group 
lone pair electrons with the phosphorus atom (Figures 13 and 20).
We have also demonstrated that a combination of the phosphinamides 
together with an electron accepting boronate ester, either as a bi-molecular co­
operative system ((98) together with (29)) or as a single molecular entity (108) 
(prepared in situ from phosphinamide diol (107) and BMS), significantly improves 
asymmetric induction, presumably as a consequence of more effective ketone 
binding.










H OH 0 — B 
H
(9 8 ) (10 7) (108)
It has also been demonstrated that the diphenylphosphinyl group is an 
effective protecting group for primary a-amino ketones and that the resulting 
ketophosphinamide products are excellent substrates for diastereoselective borane 
reduction. The diphenylphosphinyl group both activates the borane reagent for 
hydride transfer and directs the intramolecular reduction.
The development of a novel phosphorus based catalyst for the asymmetric 
reduction of ketones has been described. A detailed examination of the 
phosphinamide diol derived catalysts still remains to be carried out together with the 
synthesis of structural analogues of (107). The mechanism of the reduction 
catalysed by (108) is not fully understood and needs further investigation.
If the project is successful then the potential returns will be considerable: a 
novel, robust and versatile catalyst for a pivotal organic transformation.
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4 Experimental.
General Details.
Tetrahydrofuran and diethyl ether were freshly distilled from sodium under 
an atmosphere of dry nitrogen using benzophenone as an indicator. Toluene was 
freshly distilled from sodium under a nitrogen atmosphere. Dichloromethane was 
freshly distilled from phosphorus pentoxide. All solvents were distilled prior to use. 
Reagents were either used as received from commercial sources or purified by 
recognised methods. 118 Petroleum ether (petrol) refers to that fraction which boils 
in the range 60-80 °C.
All reactions, unless otherwise stated, were carried out in flame dried 
Schlenk tubes under an atmosphere of dry nitrogen or argon.
Flash chromatography* 19 was performed using Merck 9835 (70-230 mesh) 
silica gel. All reactions were monitored by thin layer chromatography (TLC) 
earned out on aluminium sheets precoated with 60F254 silica gel, unless otherwise 
stated, and were visualised by UV light at 254 nm, then potassium permanganate 
solution, phosphomolybdic acid solution or anisaldehyde solution.
Ifi-NMR were recorded on a Jeol GX270 FT instrument operating at 270.2 
MHz or a Jeol EX400 instrument operating at 399.7 MHz. The observed spectra 
were for solutions in deuteriochloroform unless otherwise stated. The chemical 
shifts (6) were recorded relative to tetramethylsilane as an internal standard; all 
coupling constants, J, are reported in Hz. l^C-NMR spectra were recorded on a 
Jeol GX270 FT instrument operating at 67.8 MHz or a Jeol EX400 instrument 
operating at 100.4 MHz. The spectra were recorded for solutions in 
deuteriochloroform unless otherwise stated. The chemical shift (6) were recorded 
relative to deuteriochloroform (or relative solvent peak) as internal standard in a 
broad band decoupled mode; the multiplicities were obtained by using 135° and 90° 
“Distortionless Enhancement by Polarisation Transfer” (DEPT) or Off Resonance 
Decoupling experiments to aid in assignments (q, methyl; t, methylene; d, methine;
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s, quaternary). ^Ip-NMR spectra were recorded on a Jeol EX400 FT instrument 
operating at 161.7 MHz using 85% H3 P O 4  as external reference in 
deuteriochloroform.
Infra red spectra were recorded on a Perkin-Elmer 1600 FT-IR, either as 
liquid films, evaporated films from chloroform solutions, or as nujol mulls, between 
sodium chloride plates. Mass spectra were recorded on a VG analytical 7070E 
instrument with VG2000 data system using either an ionising potential of 70 eV 
(El), or by chemical ionisation (isobutane) (Cl), or fast atom bombardment (FAB) 
in 3NBA matrix. High resolution mass measurements (FAB and Cl) were recorded 
by the EPSRC MS service at Swansea. Melting points were recorded on a 
Gallenkamp melting point apparatus and are uncorrected. Optical rotations were 
recorded on a Perkin-Elmer 141 Polarimeter at ambient temperature, [a] values are 
reported as 10'^deg cm^ g-1. Microanalysis was carried out on a Carlo Erba 1106 
Elemental Analyser.
HPLC analysis was carried out using a Waters 501 HPLC pump, Waters 486 
Tuneable Absorbance Detector and a Waters 746 Data Module (analysis conditions 
are given in Section 4.1).
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Section 4.1: Initial Study.
Preparation o f Oxazaphosnholidines (26) - (27).
The preparation of diastereomeric oxazaphospholidines (26) and (27) was 
based on a literature procedure.38,62a
To a stirred solution of 1R, 2S-ephedrine (5.0 g, 0.03 mol) and triethylamine 
(16.7 cm 3, 0.12 mol) in ethyl acetate (200 cm3) at 0 °C  was added 
phenylphosphonic dichloride^ (4.25 cm^, 0.030 mol) dropwise over 10 minutes. 
The mixture was allowed to warm to room temperature over 18 hours. It was then 
poured into an equal volume of saturated ammonium chloride solution and 
extracted with DCM (3 x 50 cm^). The combined organic extracts were then dried 
(magnesium sulfate) and concentrated in vacuo to give a colourless solid (7.66 g) 
consisting of a 1.25:1 mixture of diastereoisomers which were separated on silica 
eluting with 0—> 50% ethyl acetate- petrol.
Tra/ES-diastereoisomer (27V obtained as a white crystalline solid (4.26 g, 50%), Rf 
0.65 (ethyl acetate); [a ]$ =  +36.2 (c 1.01, methanol) ( lit ,38 [a]J>2= +31.2 (c 1, 
methanol) ); 5 r  (270 MHz, CDCI3) 0.92 (3 H, d, J 6.4, 4-Me), 2.64 (3 H, d, J 10.1, 
N-Me), 3.79 (1 H, m, 4-H), 5.62 (1 H, m, 5-H), 7.21-7.62 (8 H, m, aryl H), 7.81- 
7.92 (2 H, m, aryl H);
CLY-diastereoisomer (261: obtained as a white crystalline solid (3.40 g, 40%), Rf 
0.45 (ethyl acetate); [a]J?= -33 (c 1.14, methanol); 8h  (270 MHz, CDCI3) 0.82 (3 
H, d, J 6 .6 , 4-Me), 2.76 (3 H, d, J 9.3, N-Me), 3.86 (1 H, m, 4-H), 5.99 (1 H, d, J
6.2, 5-H), 7.27-7.60 (8 H, m, aryl H), 7.88-7.96 (2 H, m, aryl H).
Preparation o f Oxazanhosnholidines (28).
This compound was prepared as a mixture of diastereoisomers by a 
modified literature p ro c e d u re . 39
4 Experimental. Page 115.
To a stirred solution of S-prolinol (0.24 cm^, 2.47 mmol) and triethylamine 
(0.7 cm^, 4.95 mmol) in DCM (10 cm^) at 0 °C was added phenylphosphonic 
dichloride44 (0.58 g, 2.47 mmol) dropwise over 5 minutes. The resulting mixture 
was stirred at 0  °C for 30 minutes then allowed to warm to room temperature and 
stired for a further 5 hours. It was then poured into an equal volume of saturated 
aqueous ammonium chloride solution and extracted with DCM (3 x 10 cm^). The 
combined organic extracts were dried (magnesium sulfate) and concentrated in 
vacuo to give a pale yellow oil. The crude mixture was then purified by 
chromatography on silica eluting with 0->2% v/v methanol- DCM. The product 
was a colourless solid (334 mg, 61%) consisting of a 1.3:1 mixture of 
diastereoisomers. The following assignments were made by comparison with 
reported values. 39
Trans-diastereoisomer: 6h  (270 MHz, CDCI3 ) 1.52-2.2 (4 H, m, 5-H and 6 -H), 
2.89 (1 H, m, 4p-H), 3.02 (1 H, m, 4a-H), 4.08 (1 H, m, 8 p-H), 4.19 (1 H, br m, 7- 
H), 4.76 (1 H, dd, J 15 and 4.5, 8 a-H) 7.7-7.91 (5 H, m, aryl H); cis- 
diastereoisomer: 1.72-2.21 (4 H, m, 5-H and 6 -H), 2.97 ( lH ,m , 40-H), 3.77 (1 H, 
m, 4a-H), 3.92 (1 H, ddd, J 8.5, 8  and 3 .5 ,80-H), 4.15 (1 H, br m, 7-H), 4.35 (1 H, 
m, 8a-H) 7.41-7.62 (5 H, m, aryl H).
Preparation o f R-( + )-(N-phenethyl)-diphenylphosphinamide (29).
To a solution of (R)-(+)-a methylbenzylamine (0.54 cm^, 4.2 mmol) and 
triethylamine (1.2 cm^, 8.4 mmol) in DCM (20 cm^) was added 
diphenylphosphinic chloride (0.81 cm^, 4.2 mmol) dropwise at 0 °C. The resulting 
mixture was stirred at room temperature overnight. It was then poured into an 
equal volume of saturated aqueous ammonium chloride solution and extracted with 
DCM ( 3 x 10 cm^). The combined organic extracts were dried (sodium sulfate) 
and concentrated in vacuo to give phosphinamide (29) as a colourless solid which 
was purified by recrystallisation from DCM/ hexane (1.20g, 89%), m. p 158-162 °C
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(d) (found: C, 74.7; H, 6.2; N, 4.3. C20H20NPO requires C, 74.77; H, 6.23; N, 
4.36%); [cl]2d = +40.2 (c 1.0, Methanol); Umax (nujol)/ cm-* 1961, 1902, 1671, 
1307, 1204, 1172,1108, 1034,968,742 and 542; 6h  (400 MHz, CDCI3 ) 1.53 (3 H, 
d, J 6.7, CHC7/3), 3.23 (1 H, br m, NH), 4.35 (1 H, br q, J 6.7, CHCH3 ), 7.18-7.84 
(11 H, m, aryl H), 7.76-7.90 (4 H, m, aryl H); 6c (68  MHz, CDCI3 ), 25.9 (dq, Jpc 
33), 51.0(d), 125.9, 127.0, 128.2, 128.3, 128.4, 128.5, 131.8, 131.9, 132.3, 132.4,
145.0 (dd, Jpc 6 .6 ); 6p (162 MHz, CDCI3 ) 22.4 (1 P, s); m/z (El) 321 (M+, 4%), 
306 (30), 201 (70), 120 (100), 106 (60), 77 (50), 57 (50), 43 (50).
General Reduction Procedure.
The following procedure describes the initial activity screen for 
phosphinamide (29) and is typical (reaction times, yields and selectivities for related 
systems are described in the text). The same general procedure was adopted for all 
ketone substates.
To a stirred solution of phosphinamide (29) ( 10 mol%, 82 mg, 0.257 mmol) 
and acetophenone (0.3 cm^, 2.57 mmol) in anhydrous THF (2.5 cm^) was added 
BMS (10 M dimethyl sulfide complex, 0.15 cm^, 1.54 mmol) dropwise over 2 
minutes. Vigorous effervescence was observed. The mixture was then stirred at 
room temperature for 1 hour (or until all of the ketone was consumed by TLC. The 
mixture was then diluted with diethyl ether and saturated aqueous ammonium 
chloride solution (1 cm^) added dropwise. The organic phase was then separated 
and the aqueous layer extracted with diethyl ether ( 3 x 5  cm^). The combined 
extracts were then dried (sodium sulfate) and concentrated in vacuo. The catalyst 
was then removed by chromatography on silica, eluting with 2 0% v/v ethyl acetate- 
petrol. This gave 1-phenylethanol as a colourless oil which was further purified by 
distillation under reduced pressure (257 mg, 82%), b. p 44 °C / 0.5 mmHg (lit.,40 
98 °C / 20 mmHg); [cl]2d = -11.5 (c 1, methanol), 26% e. e. (S- enantiomer)40; 6jq
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(270 MHz, CDCI3 ) 1.47 (3 H, d, J 6 , CHC//3 X 2.15 (1 H, br s, OH), 4.85 (1 H, q, J 
6 , C//CH3 ), 7.22-7.37 (5H, m, aryl H).
The enantiomeric excess was confirmed by chiral HPLC analysis.
HPLC Conditions:








Techspere 5 ODS C18. 




UV at X= 254 nm. 
Acetophenone: 2.7 min. 
1-Phenylethanol: 2.05 min.













UV at X= 254 nm.
(R)-(+)-l-phenylethanol: 10.9 min. 
(S)-(-)-l-phenylethanol: 11.9 min.
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Section 4.2; Modification of the Basic Phosphinamide Structure.
Preparation ofR-( + )-(N-methyl)( N-l -phenethyD-diphemlphosphinamide (40).
To a stirred solution of R-(+)-(N-phenethyl)-di phenyl phosphinamide (29) 
(0.5 g, 1.56 mmol) in anhydrous THF (25 cm-*) at 0 °C was added w-butyllithium 
(1.6 M hexane solution, 1.08 cm^, 1.73 mmol) dropwise. The resulting pale yellow 
solution was stirred at 0 °C for a further 45 minutes. Methyl iodide (0.1 cm**, 1.56 
mmol) was then added and the mixture allowed to warm to room temperature 
overnight. It was then poured into an equal volume of saturated aqueous 
ammonium chloride solution and extracted with DCM (3 x 10 cm*). The combined 
organic extracts were dried (sodium sulfate) and concentrated in vacuo to afford 
phosphinamide (40) as a pale yellow oil. This was then purified on silica eluting 
with 0->30% v/v ethyl acetate- petrol (303 mg, 58%), m. p. 114-117 °C (from 
DCM/ hexane), (found C, 75.5; H, 6.3; N, 4.2. C2 1 H2 2 NOP requires C, 75.22; H, 
6.67; N, 4.18%); [ a ] ^  +49.9 (c 1.0, methanol); umax (nujol)/ cm"! 3014, 1539, 
1493, 1438, 1179, 1122, 982, 932, 698 and 6 6 6 ; 6 h  (400 MHz, CDCI3 ) 1.52 (3 H, 
d, J 7, CHCH3 ), 2.28 (3 H, d, J 10.7, N-Me), 4.65 (1 H, dq, J 8.9 and 7.8, CHCH3 ), 
7.27-7.42 (10 H, m, aryl H), 7.8-7.85 (5 H, m, aryl H); 6 c  ( 6 8  MHz, CDCI3 ) 16.9 
(q), 27.7 (dq, Jpc 4.4), 53.1 (dd, Jpc 3.3), 126.9, 127.6, 128.1, 128.3, 128.5, 131.6, 
132.16, 132.2, 132.3, 132.8,133.1, 141.0 (dd, Jpc 5.5); 6p (162 MHz, CDCI3 ) 30.7 
(1  P, s); mJz (Cl) 336 (M ++1 , 100%), 320 (4), 232 (5), 203 (15), 134 (35).
R-( + )-(N-benzvD(N-l-phenethyl)-diphenylphosphinamide (41).
This compound was prepared according to the above procedure using benzyl 
bromide (0.19 cm*, 1.56 mmol). Phosphinamide (41) was isolated as a white solid 
(256 mg, 40%), m. p. 114-117 °C (from DCM/ hexane), (found C, 78.7; H, 6.3; N,
3.2. C2 7 H2 6 NOP requires C, 78.83; H, 6.33; N, 3.41%); [a ]2D°= - 2  (c 1.0, 
methanol); u max (nujol)/ cm ' 1 2924, 1378, 1198, 1119, 1099, 1022, 880, 748 and
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695; 6 r  (270 MHz, CDCI3 ) 1.32 (3 H, d, J 7.1, CHC/%), 3.80 (1 H, dd, J 14 and
11.4, C # 2), 4.11 (1  H, dd, J 14 and 11.7, CH2 ), 4.67 (1 H, dq, J 9.75 and 7.2, 
C//CH3 ), 6.94-7.13 (4 H, m, aryl H), 7.14-7.39 (12 H, m, aryl H), 7.81-7.9 (4 H, m, 
aryl H); 6c ( 6 8  MHz, CDCI3 ) 19.9 (dq, Jpc 3.3), 47.5 (dt, Jpc 3.3), 55.3 (dd, Jpc,
4.3), 126.7, 127.3, 127.9, 128.1, 128.2, 128.25, 128.3, 128.4, 128.5, 128.6, 131.5,
131.6, 131.65, 132.5, 132.65, 132.7, 139.6, (dd, Jpc 3.3), 140.8 (dd, Jpc 4.4); 6p 
(162 MHz, CDCI3 ) 31.2 (1  P, s); m/z (Cl) 412 (M++1, 100%), 320 (32), 306 (17), 
201 (11), 91 (8 ).
Preparation of Acyclic C2 Symmetric Phosphonamides.
a) General Procedure from Phosphonic Dichlorides;
The following procedure is typical.
Preparation ofR, R-( +)-(N, N'-di-l-phenethyl) phenyl phosphonamide (44).
To a stirred solution of R-(+)-a methylbenzylamine (5.3 cm^, 41 mmol) and 
triethylamine (6.4 cm^, 46 mmol) in DCM (80 cm^) at 0 °C was added 
phenylphosphonic dichloride^ (2.91 cm^, 2 1  mmol) dropwise over 1 0  minutes. 
The cloudy solution was allowed to warm to room temperature and stirred 
overnight. The mixture was then poured into an equal volume of saturated aqueous 
ammonium chloride solution and extracted with DCM (3 x 15 cm^). The combined 
organic extracts were dried (magnesium sulfate) and concentrated in vacuo. The 
residue was then purified on silica eluting with 0-»50% v/v ethyl acetate- petrol. 
This afforded phosphonamide (44) as a white foam (6.71 g, 45%), m. p. 65-67 °C 
(from DCM/ hexane), (found C, 71.7; H, 7.0; N, 7.4. C2 2 H2 5 N2 OP requires C, 
72.52; H, 6.87; N, 7.68%); [a]|?=  +41.1 (c 1.0, methanol); Umax (nujol)/ cm~l 
1376, 1208, 1180 and 1126; 6 h  (400 MHz, CDCI3 ) 1.33 (3 H, d, J 6.7, CHC//3 ), 
1.41 (3 H, d, J 6.7, CHCH3), 2.69 (1 H, br t, J 8.5, NH), 2.83 (1 H, brt, J 9.5, NH),
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4.31 (1 H, m, C//CH3 ), 4.56 (1 H, m, C//CH3 ), 7.05-7.44 (13 H, m, aryl H), 7.71 (2 
H, m, aryl H); 6 c  (68 MHz, CDCI3 ) 25.5 (dq, Jpc 4.4), 25.9 (q), 50.2 (d), 50.8 (d),
125.8, 126.8, 127.0, 128.1, 128.3, 128.35, 128.6, 131.7, 131.8, 145.1, 145.2 (d,Jpc
5.6), 145.8 (d, Jpc 5.5); 6 p (162 MHz, CDCI3 ) 19.0 (1 P, s); m/z (Cl) 365 (M++1, 
100%), 349 (10), 120 (25), 105 (15), 89 (52).
R, R-( + )-(N, N'-di-l-phenethyl) ethyl phosphonamide (42).
This compound was prepared according to the above general procedure 
using R-(+)-a-methyl benzylamine (6.2 cm^, 46.8 mmol), triethylamine (7.31 cnP, 
52.5 mmol) and ethylphosphonic dichloride (2.56 cm^, 24 mmol) in DCM (70 
cm^). Phosphonamide (42) was isolated as a viscous oil which solidified on 
standing (9.6 lg, 65%), m. p. 65-66 °C (from DCM/ hexane), (found C, 68.1; H, 8.0; 
N, 8.8. C 18H25N2OP requires C, 68.33; H, 7.96; N, 8.85%); [a ]2D2= +72.6 (c 1.05, 
methanol); Umax (nujol)/ cm"* 3216, 1460, 1374, 1203, 1167, 1125 and 1087; &H 
(270 MHz, CDCI3 ) 0.95 (6  H, dt, J 18.6 and J 7.7, CH2C //3 ), 1.36 (3 H, d, J 7, 
CHC/£), 1.47 (3 H, d, J 6 .8 , CHC//3 ), 2.43 (1 H, br t, J 10.5, NH), 2.70 (1 H, br t, 
J 10.2, NH), 438  (1 H, m, CHCH3 ), 4.45 (1 H, m, CHCH3 ), 7.2-7.31 (10 H, m. aryl 
H); 6c (68  MHz, CDCI3 ) 6.7 (dq, Jpc 5.5), 21.9 (dt, Jpc 114), 25.6 (dq, Jpc 5.5),
26.1 (dq, Jpc 5.5), 50.0 (d), 50.2 (d), 125.6 (d), 125.7 (d), 126.8 (d), 126.9 (d),
128.4 (d), 128.5 (d), 145.6 (d, Jpc 3.25), 145.8 (d, Jpc 43); 6p (162 MHz, CDCI3 )
33.7 (1 P, s); m/z (Cl) 317 (M++1), 100%), 301 (10), 120 (22), 105 (13).
Phosphinamide Chloride (48).
Reaction of r-butlyphosphonic dichloride (1.52 g, 8 .68  mmol) with R-(+)-a 
methyl benzylamine (2.24 cnP, 17.4 mmol) and triethylamine (2.66 cm^, 19.1 
mmol) in DCM (25 cm^) according to the above general procedure gave, 
unexpectedly, the phosphinamide chloride (48) as an inseparable 1.6:1 mixture of
4 Experimental. Page 121.
diastereoisomers (883 mg, 39% ) , (found C, 55.3; H, 7.4; N, 5.3. C 1 2 H1 9 NOPCI 
requires C, 55.49; H, 7.37; N, 5.39%); Umax (nujol)/ cm-1 3215, 2971, 1476, 1450, 
1398, 1370, 1232, 1200, 1116, 1081, 1038, 972, 762 and 701; 6h  (400 MHz, 
CDCI3 ) major diastereoisomer: 1.28 (9 H, d, J 19.8, CMe3 ), 1.55 (3 H, d, J 6.8, 
CHC//3 ), 3.21 (1 H, br m, NH), 4.72 (1 H, m, CHCH3 ), 7.25-7.38 (5 H, m, aryl H); 
minor diastereoisomer: 1.24 (9 H, d, J 20, CMe3 ), 1.62 (3 H, d, J 7, CHC//3 ), 3.16 
(1 H, br m, NH), 4.84 (1 H, m, CHCH3 ), 7.25-7.38 (5 H, m, aryl H);6c (68 MHz, 
CDCI3 ) major diastereoisomer: 24.1 (q), 24.4 (q), 24.9 (d, Jpc 6.6), 51.3 (dd, J 3.3),
126.1 (d), 127.5 (d), 128.7 (d), 144.2 (s); major diastereoisomer: 24.0 (q), 24.44 (q), 
24.9 (d, Jpc 6.6), 50.4 (dd, Jpc 4.4), 1 2 6 .0  (d), 127.4 (d), 1 2 8 .6  (d), 143.9 (d, Jpc
4.3); 6p (162 MHz, CDCI3 ) major diastereoisomer: 58.5 (1 P, s); minor 
diastereoisomer: 58.2 (1 P, s); m/z (Cl) 262 (M ++1,30%), 260 (M++1, 100%), 224 
(5), 202 (10), 156 (6), 120 (21).
R, R, R-( + )-(Nt N \  N ”-tri-l-phenethyl) phosphoramide (43).
This compound was prepared according to the above general procedure 
using R-(+)-a methylbenzylamine (1.25 cm^, 9.72 mmol), triethylamine (1.35 cm^, 
9.72 mmol) and phosphorus oxychloride (0.3 cm^, 3.24 mmol) in DCM (15 cm^). 
Phosphoramide (43) was isolated as a colourless solid (1.05 g, 80%), m. p. 104-107 
°C (from DCM/ hexane); (found C, 70.4; H, 7.4; N, 10.3. C2 4 H3 0 N3 OP requires 
C, 70.76; H, 7.37; N, 10.32%); [a]b9= +23.1 (c 1.74, chloroform); Umax (nujol)/ 
cm' 1 3215,1601,1455, 1375, 1204, 1170, 1108, 1072, 980,878,744 and 699; 6h 
(400 MHz, CDCI3 ) 1.31 (9 H, d, J 6.8, CHCW3 ), 2.45 (3 H, br t, J 8, NH), 4.31 (3 
H, m, CACH3 ), 7.12-7.27 (15 H, m, aryl H); 8c (68 MHz, CDCI3 ) 25.6 (dq, Jpc
5.6), 51.0 (d), 125.8 (d), 126.9 (d), 128.5 (d), 145.7 (d, Jp c  3.3); 6p (162 MHz, 
CDCI3 ) 11.9 (1 P, s); m/z (El) 407 (M+, 40%), 392 (40), 302 (31), 287 (10), 120 
(40), 106(100).
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b) General Procedure bv Reaction of Chloride (49) with a G rignard Reagent:
The following procedure is typical.
Preparation ofR. R-(+)-(N. N ’-di-l-pheneth\l) isopropyl phosphonamide (45)
To a stirred solution of R-(+)-cx methylbenzylamine (1.7 cm^, 13 mmol) and 
triethylamine (1.81 cm^, 13 mmol) in DCM (20 cm^) at 0 °C  was added 
phosphorus oxychloride (0.61 cm^, 6.5 mmol) dropwise over 5 minutes. The 
resulting cloudy mixture was allowed to warm slowly to room temperature and 
stirred for a further 8 hours. The solvent was then removed in vacuo and the residue 
extracted with anhydrous ethyl acetate. The solution was filtered to remove 
hydrochloride salts and again concentrated in vacuo to give chloride (49) as a 
viscous pale yellow oil which decomposed slowly at room temperature:
8r  (270 MHz, CDCI3) 1.33 (3 H, d, J 6 .8 , CHCH3), 1.42 (3 H, d, J 6 .6 , CHCi/3), 
3.41-3.69 (2 H, br s, NH), 4.37 (2 H, m, C/7CH3), 7.08-7.29 (10 H, m, aryl H); m/z 
(Cl) 325 (M++1,0.3%), 323 (M++1, 1%), 147 (5), 105 (100).
The chloride was immediately redissolved in anhydrous diethyl ether (12 
cm^) and the solution cooled to 0°C. Isopropylmagnesium c h lo r id e ^ ^  (2 M diethyl 
ether solution, 4 equivalents, 13 cm^, 26 mmol) was then added dropwise over 10 
minutes. The cloudy mixture was stirred at 0 °C for 1 hour, then warmea slowly to 
room temperature and stirred for a further 3 hours (or until all chloride was 
consumed by TLC). The mixture was then poured into an equal volume of 
saturated aqueous ammonium chloride solution and extracted with DCM (3 x 10 
cm^). The combined organic extracts were dried (magnesium sulfate) and 
concentrated in vacuo. The residue was then purified on silica eluting with 0->5% 
v/v methanol- DCM to afforded phosphonamide (45) as a colourless solid (1.39 g, 
65%), m. p. 35-38 °C; [a] $= +24.0 (c 0.15, chloroform); Dmax (nujol)/ cm'* 3402, 
3200, 1392, 1276, 1124, 967, 867, 761 and 699; 8h  (270MHz, CDCI3 ) 0.86 (3 H,
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dd, J 17.2 and 7.1, (Cf/3)2CH), 0.99 (3 H, dd, J 17 and 7.3, (C//3)2CH), 1.22 (3 H, 
d, J 6.9, CHC//3), 1.41 (3 H, d, J 6 .8 , CHC//3), 1.62 (1 H, m, (CH3)2C//), 2.19 (1 
H, br t, J 10, NH), 2.60 (1 H, m, NH), 4.3-4.35 (1 H, m, C//CH3), 4.4-4.42 (1 H, 
m, C//CH3), 7.04-7.28 (10 H, m, aryl H); 6c (68 MHz, CDCI3) 16.4 (dq, Jpc 3.3),
16.7 (dq, Jpc 4.4), 26.0 (dq, Jpc 4.4), 26.4 (dq, Jpc 5.5), 27.9 (dd, Jpc 115 ), 49.5 
(d), 50.3 (d), 125.6 (d), 125.7 (d), 126.75 (d), 126.9 (d), 128.4 (d), 128.6 (d), 146.0 
(d, Jpc 4.4), 146.2 (d, Jpc 3.25; 6p (162 MHz, CDCI3) 33.7 (1 P, s); m/z (Cl) 331 
(M++1, 100%), 315 (11), 120 (20), 105 (19); (found [M+H]+, 331.1936. 
C 19H2 8N2OP requires m/z, 331.1939).
R. R-(+ )-(N. N ’-di-1-phenethvl) phenvlphosphonamide (44)
This compound was prepared according to the above general procedure 
using phenylmagnesium bromide 47 Phosphonamide (44) was isolated as a viscous 
oil which solidified on standing (1.06 g, 45%); data as above.
R. R-(+)-(N. N ’-di-l-phenethyl) etkvl phosphonamide (42)
This compound was prepared according to the above general procedure 
using ethylmagnesium chloride.47 Phosphonamide (42) was isolated as a viscous 
oil which solidified on standing (863 mg, 42%); data as above.
R. R-(+)-(N. N ’ -di-1-nhenethvl) cvclopentvl phosphonamide (47).
This compound was prepared according to the above general procedure 
using chloride (49) (200 mg, 0.62 mmol) and cyclopentylmagnesium chloride (2 M 
diethyl ether solution, 0.94 cm^, 1.88 mmol) in anhydrous diethyl ether (10 cm^). 
Phosphonamide (47) was isolated as a colourless oil (72 mg, 33%), [a] 0 = +41.1 (c 
0.18, chloroform); a)max (film)/ cnr* 3219, 2967, 1453, 1373, 1208,. 1146, 994,
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912, 761 and 700; 8h  (270 MHz, CDCI3) 1.13 (3 H, d, J 7, CHC//3), 1.15-1.61 (12 
H, m, alkyl H), 2.3 (1 H, m, NH), 2.46 (1 H, m, NH), 4.23-5.2 (2 H, m, C//CH 3), 
7.09-7.23 (10 H, m, aryl H); 8c (68 MHz, CDCI3) 22.9 (dt, Jpc 5.5), 25.4 (dq, Jpc 
5.5), 26.0 (dq, Jpc 4.4), 26.4 (t), 27.2 (t), 33.9 (dt, Jpc 4.4), 37.7 (dd, Jpc 118), 
49.8 (d), 51.1 (d), 125.6 (d), 125.7 (d), 125.75 (d), 126.7 (d), 126.8 (d), 128.3 (d),
128.4 (d), 128.5 (d), 145.9 (s), 146.1 (d, Jpc 3.3); 8p (162 MHz, CDCI3) 10.9 (1 P, 
s); m/z (Cl) 357 (M++1, 100%), 341 (12), 305 (14), 120 (22), 105 (21); (found 
[M+H]+, 357.2101. C21H30N2OP requires m/z, 357.2096).
R. R-(+)-(N. N ’-di-l-nhenethvl)(p-methoxvphenvl) phosphonamide (59).
This compound was prepared according to the above general procedure 
using chloride (49) (1.0 g, 3.1 mmol) and p-methoxyphenylmagnesium brom ide^ 
(0.25 M diethyl ether solution, 3 equivalents, 37.2 cm^, 9.3  mmol) in anhydrous 
diethyl ether (50 cm^). Phosphonamide (47) was isolated as a colourless oil (500 
mg, 41%), [a ]£ =  +29.5 (c 1.3, chloroform); \)max (film )/cm '1 3212, 3028, 2970, 
1598, 1494, 1454, 1382, 1294, 1205, 1120, 967, 831, 760 and 899; 8h  (270 MHz, 
CDCI3 ) 1.53 (3 H, d, J 7, CHC//3 ), 1.61 (3 H, d, J 6 .8 , CHCH3 ), 2.84 (1 H, m, 
NH), 2.94 (1 H, m, NH), 4.02 (3 H, s, MeO), 4.4-4.62 (2H, m, C//CH3), 7.05 (2 H, 
dd, J 9 and 3, aryl H), 7.25-7.53 (10 H, m, aryl H), 7.85 (2 H, dd, J 12.8 and 8 , aiyl 
H); 8 c  (68  MHz, CDCI3) 25.2 (q), 25.3 (q), 49.8 (d), 50.3 (d), 54.8 (q), 113.2 (dd, J 
PC 14.3), 125.5 (d), 125.54 (d), 126.4 (d), 126.5 (d), 127.9 (d), 128.0 (d), 128.1 (d),
133.3 (dd, Jpc 10.9), 145.5 (s), 145.6 (d, Jpc 3.3), 161.6 (d, Jpc 3.4); 8p (162 
MHz, CDCI3) 18.7 (1 P, s); m/z ((-) FAB) 393 (M+-1, 100%), 331 (54), 303 (50), 
182 (21); (found [M-H]+, 393.1725. C23H26N2O2P requires m/z, 393.1732).
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Preparation ofR. R-(+)-(N. N ’-di-l-phenethvl) t-butvlphosphonamide (46).
To a stirred solution of R-(+)-a methylbenzylamine (0.1 cm^, 0.74 mmol) in 
anhydrous THF (9 cm^) at 0 °C was added w-butyllithium (2.4 M hexane solution, 
0.31 ciri^, 0.74 mmol) dropwise over 2 minutes. The resulting pale yellow solution 
was stirred at 0 °C for 30 minutes. A THF solution of chloride (48) (97 mg, 0.37 
mmol) was then added, the mixture warmed slowly to room temperature and stirred 
for a further 6  hours. An equal volume of saturated aqueous ammonium chloride 
solution was then added and the product extracted with DCM ( 3 x 5  cm^). The 
combined organic extracts were dried (sodium sulfate) and concentrated in vacuo. 
The residue was purified on silica eluting with 0—>5% v/v methanol- DCM to afford 
phosphonamide (46) as colourless solid (103 mg, 81%), (found C, 68.9; H, 8 .6 ; N,
7.6. C20H29N2OP. y4 H2O requires C, 68.87; H, 8.46; N, 8.03%); [a ]]?= +22.5 (c 
0.19, chloroform); t)max (nujol)/ cm- * 3225, 2871, 1494, 1455, 1207 and 996; 8h  
(270 MHz, CDCI3) 1.04 (9 H, d, J 15.4, CMe3), 1.23 (3 H, d, J 6 .8 , CHGH3), 1.5 (3 
H, d, J 6.8  CH C#3 ), 2.04 (1 H, br t, J 9, NH), 2.52 (1 H, m, NH), 4.41 (1 H, m, 
C//CH3), 4.60 (1 H, dq, J 12 and 7.5, CHCH3), 7.07-7.39 (10 H, m, aryl H); 5c  (68 
MHz, CDCI3 ) 25.3 (q), 26.6 (q), 32.4 (d, Jpc 117.7), 26.7 (q), 49.4 (dd, Jpc  2.2),
50.7 (d), 125.6 (d), 125.65 (d), 126.6 (d), 126.9 (d), 128.4 (d), 128.7 (d), 146.1 (s), 
146.6 (d, Jp c  3.3); 5p (162 MHz, CDCI3 ) 36.2 (1 P, s); m/z (Cl) 345 (M++1, 
100%), 329 (15), 287 (7), 120 (15), 105 (20).
Preparation of Catalysts Chiral at Phosphorus.
Preparation o f Epimeric Phosphonamid.es (50).
To a stirred solution o f R, R-(+)-(N, N ’-di-l-phenethyl)phenyl 
phosphonamide (44) (2.0 g, 5.5 mmol) in anhydrous THF (100 cm^) at 0 °C was
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added /z-butyllithium (2.2 M hexane solution, 2.5 cm^, 5.5 mmol) dropwise over 10 
minutes. The resulting pale yellow solution was stirred for a further 1 hour. Benzyl 
bromide (0.95 cm^, 7.7 mmol) was added and the mixture warmed to room 
temperature and stirred for 24 hours. It was then poured into a saturated aqueous 
ammonium chloride solution (50 cm^) and extracted with ethyl acetate (3 x 50 
cm^). The combined organic extracts were washed with saturated aqueous brine 
(30 cm3), dried (magnesium sulfate) and concentrated in vacuo. The residue was 
purified on silica eluting with 0—>40% v/v ethyl acetate- petrol. This afforded 
phosphonamide (50) as a colourless solid consisting of a 1:1 mixture of epimers 
(1.02 g, 41%). Pure samples of both epimers were obtained by preparative TLC (60 
mg of mixture repeatedly eluted with 30% v/v ethyl acetate- petrol). The prefix 
‘upper’ and ‘lower’ refers to elution order (50U being the least polar and 50L the 
more polar compound).
Upper diastereoisomer (50U1: m. p. 92-95 °C (from DCM/ hexane); (found C, 76.2; 
H, 7.0; N, 6.0. C2 9H31N2 OP requires C, 76.65; H, 6.83; N, 6.17%); [a]$=  -25.6 
(c0.18, chloroform); Umax (nujol)/cm ' 1 3150, 1178, 1133, 1116, 1028, 966, 923, 
743 and 696; 8h  (400 MHz, CDCI3) 1.24 (3 H, d, J 7, CHC//3), 1.33 (3 H, d, J 6.7, 
CHC//3), 2.42 (1 H, brm , NH), 3.70 (1 H, dd, J 16 and 11.6, C #2Ph), 4.12-4.22 (2 
H, m, C //2Ph and CHCH3), 5.09 (1 H, dq, J 10 and 7, C//CH3), 6.73-6.79 (2 H, m, 
aryl H), 6.93-6.95 (2 H, m, aryl H), 7.04-7.47 (14 H, m, aryl H), 7.61-7.84 (2 H, m, 
aryl H); 8c (100 MHz, CDCI3) 18.4 (q), 25.2 (q), 46.2 (dt, Jp c  3.7), 50.5 (d), 53.6 
(dd, Jp c  5.5), 125.8, 126.7,127.0, 127.5, 127.9, 128.0, 128.2, 128.4, 131.2, 132.0,
132.1, 132.3, 132.8, 140.0, 141.8 (d, Jp c  3.6), 145.0 (d, Jp c  5.5); 8p (162 MHz, 
CDCI3) 24.8 (1 P, s); mlz (Cl) 455 (M++1,50%), 391 (92), 279 (42), 167 (34), 149 
(100), 113 (45).
Lower diastereoisomer (50L1: (found C, 76.4; H, 6.7; N, 5.9. C29H 31N2 OP 
requires C, 76.65; H, 6.83; N, 6.17%); [cx]1^  +12.8 (c0.21, chloroform); 'Umax 
(nujol)/cm - 1 3150,1178,1132,1110,1028, 960,928,743 and 689; 8h  (400 MHz, 
CDCI3) 1.18 (3 H, d, J 7, CHCH3), 1.39 (3 H, d, J 7, CHC//3), 2.55 (1 H, br t, J 8 ,
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NH), 3.9-4.11 (2 H, m, C //2Ph), 4.34 (1 H, m, CHCH3 ), 4.73 (1 H, dq, J 10 and
6.4, C//CH3 ), 6.79-6.85 (2 H, m, aryl H), 7.01-7.25 (12 H, m, aryl H), 7.36-7.48 (4 
H, m, aryl H), 7.76 (2 H, m, aryl H); 5 c  (68  MHz, CDCI3) 19.1 (q), 25.3 (q), 46.9 
(dt, Jp c  3.6), 50.1 (d), 54.4  (dd, J p c  3.6), 125.9,126.7,126.85, 127.1,127.6,127.9,
128.1, 128.2,128.4,131.4,131.45,132.1,132.3,141.7,144.7, 145.3; 5p (162 MHz, 
CDCI3) 23.5 (1 P, s); m/z (Cl) 455 (M++1, 100%), 391 (22), 363 (55), 349 (26), 
149(46), 113(27), 105 (56).
Diastereomericallv Pure Phosphinamides.
General Procedure from Chloride (55):
The following procedure is typical.
Preparation o f (1R)-N-(l-Phenethvl)-(Rp)-P-nhenvl-P-(2.4.6 - trimethvlohenvl) 
p hosphinamide (52),
To a stirred solution of phenylphosphonic dichloride (1.1 cm^, 7.76 mmol) 
in DCM (15 cm^) at -78 °C  was added a solution of R-(+)-a methylbenzylamine 
(1.0 cm3, 7.76 mmol) and triethylamine (1.08 cm^, 7.76 mmol) in DCM (6 cm^) 
dropwise over 10 minutes. The resulting solution was allowed to warm slowly to 
room temperature and stirred for 10 hours. The mixture was then concentrated in 
vacuo and the residue extracted with anhydrous diethyl ether. The combined 
extracts were filtered to remove hydrochloride salts and again concentrated in vacuo 
to give chloride (55) as a viscous pale yellow oil. This was then redissolved in 
anhydrous ether (20 cm^) and the solution cooled to 0 °C . 2, 4, 6 -
trimethylphenylmagnesium brom ide^ (2 M diethyl ether solution, 2.5 equivalents, 
9.7 cm^, 19.4 mmol) was added dropwise over 10 minutes and the cloudy mixture 
stirred at 0 °C for 1 hour. It was then warmed to room temperature and stirred for a 
further 3 hours (or until all chloride was consumed by TLC). The mixture was then
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poured into an equal volume of saturated aqueous ammonium chloride solution and 
extracted with DCM ( 3 x 7  cm^). The combined organic extracts were dried 
(magnesium sulfate) and concentrated in vacuo. The residue was purified on silica 
eluting with 0—>50% v/v ethyl acetate- petrol. This afforded phosphinamide (52) as 
a white solid which was further purified by recrystallisation from toluene (253 mg, 
9%). The configuration at phosphorus assigned by comparison with literature data; 
isolated as a single d i a s t e r e o i s o m e r ^ ,  [a] d= -10.8 (c 0 .0 1 , chloroform) (lit.,48 
-10.50 cO.Ol, chloroform); 8r  (270 MHz, CDCI3) 1.63 (3 H, d, J 6 .8 , CHC//3), 
2.27 (3 H, s, 4-Me), 2.35 (6 H, s, 2-Me and 4-Me), 3.16 (1 H, br t, J 9, NH), 4.51 (1 
H, m, C//CH3), 6.82 (2 H, d, J 3.7, aryl H), 7.23 (5 H, s, aryl H), 7.4-7.43 (3 H, m, 
aryl H), 7.64-7.69 (2 H, m, aryl H); 5 c  (68 MHz, CDCI3 ) 21.0 (q), 23.7 (q), 25.6 
(q), 51.1 (d), 126.1, 127.0, 128.3, 128.4, 128.5,130.4, 130.6, 130.8, 131.0, 141.3,
143.4 (d, J p c  10), 145.1 (d, J p c  5.5); m/z (Cl) 364 (M++1, 100%), 290 (68 ), 274 
(7), 245 (9), 120 (100), 105 (32), 91 (15), 79 (32).
(1R )-N-( 1 -phenethvl )-P-nhenvl-P-(pentafluoronhenvl) phosphinamide (60).
This compound was prepared according to the above procedure using 
chloride (55) (2 0 g, 7.16 mmol) and pentafluorophenylmagnesium brom ide^ (2 M 
diethyl ether solution, 9 cm^, 18 mmol) in anhydrous diethyl ether (100 cm^). 
Phosphonamide (60) was obtained as a colourless solid (824 mg, 28%). The 
compound was isolated as a single diastereoisomer (configuration at phosphorus 
was not determined), m. p. 208-210 °C (from DCM/ hexane); (found C, 58.0; H, 
3.6; N, 3.2. C20H 15F5NOP requires C, 58.39; H, 3.65; N, 3.41%); [a ]g =  -20.5 (c 
0.2, methanol); Umax (nujol)/cm -1 3262, 1523, 1468, 1377, 1293, 1215, 1120, 
1101, 1086, 1018,976 and 958; 5 h  (270 MHz, CDCI3) 1.61 (3 H, d, J 7, CHCH3), 
3.59 (1 H, br t, J 8 , NH), 4.68 (1 H, m, CHCH3), 7.15-7.28 (5 H, m, aryl H), 7.45- 
7.61 (3 H, m, aryl H), 7.83 (2 H, dd, J 13.7 and 7.1, aiyl H); 6c  (68 MHz, CDCI3)
24.8 (dq, Jp c  7.7), 51.0 (d), 126.1, 127.5,128.4,128.8, 128.9, 130.8, 131.0, 133.0,
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133.1,143.5; 5p (162 MHz, CDCI3) 13.8 (1 p, s); m/z (Cl) 412 (M ++1,100%), 392 
(29), 308 (8), 120 (40).
Section 4.3: Electron Withdrawing Substituents on Nitrogen.
Preparation o f R-( + )-N-phen\lsulfonvl-a methvlbenzvlamine.
To a stirred solution of R-(+)-a methylbenzylamine (6 cm^, 46.5 mmol) and 
triethylamine (16.2 cn A  116.3 mmol) in acetonitrile (30 cm^) at 0 °C  was added 
benzenesulfonyl chloride (6.5 cm^, 51.2 mmol) dropwise over 5 minutes. The 
resulting white slurry was warmed to room temperature and stirred for 2 hours. It 
was then poured into saturated aqueous ammonium chloride solution (30 cm^) and 
extracted with diethyl ether (3 x 10 cm^). The combined organic extracts were 
dried (sodium sulfate) and concentrated in vacuo to afford the sufonyl amine as a 
white solid which was purified by recrystallisation from DCM/ hexane to give white 
needles (10.8 g, 89%), m. p. 95-97 °C (from DCM/ hexane); (found C, 64.1; H, 5.7; 
N, 5.35. C 14H 15NO2 S requires C, 64.37; H, 5.75; N, 5.36%); [a]g=  +62.2 (c 
2.14, chloroform); v max (nujol)/cm ' 1 3241,1440,1322, 1161, 1087, 871 and719; 
8h  (270 MHz, CDCI3) 1.43 (3 H, d, J 7, CHC//3), 4.49 (1 H, p, J 7, CJ/CH3), 5.14 
(1 H, br d, J 7, NH), 7.06-7.1 (2 H, m, aryl H), 7.12-7.21 (3 H, m, aryl H), 7.36-7.51 
(3 H, m, aryl H), 7.71-7.75 (2 H, m, aryl H); 5 c  (68  MHz, CDCI3) 23.4 (q), 53.5 
(d), 125.9 (d), 126.8 (d), 127.1 (d), 128.2 (d), 128.6 (d), 132.1 (d), 140.5 (s), 141.9 
(s); m/z (Cl) 262 (M++1,100%), 246 (22), 184 (26), 158 (10), 120 (20), 105 (37).
Preparation o f R-(-)-(N-phenvlsulfonvl)(N-l-phenethvl)-diphenvlDhosohinamide
(56).
Sodium hydride (60% suspension in oil, 114 mg, 2.85 mmol) was washed 
with dry petrol ( 3 x 1  cm^) then slurried in anhydrous THF (10 cm^). R-(+)-N-
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phenylsulfonyl-a methylbenzylamine (prepared as described above) (0.5 g, 1.9 
mmol) was then added portionwise under a rapid stream of nitrogen. The resulting 
white slurry was stirred at room temperature for 1 hour. Diphenylphosphinic 
chloride (0.4 cm^, 2.09 mmol) was added and the mixture stirred at room 
temperature for 8 hours. The mixture was then poured into saturated aqueous 
ammonium chloride solution (5 cm^) and extracted with ethyl acetate (3 x 5 cm3). 
The combined organic extracts were dried (magnesium sulfate) and concentrated in 
vacuo. The residue was purified on silica eluting with 0—>40% v/v ethyl acetate- 
petrol. This afforded phosphinamide (56) as a white solid (328 mg, 38%), m. p. 63- 
65 °C  (from DCM/ hexane); (found C, 67.3; H, 5.42; N, 2.9. C2 6 H 24NO3S 
requires C, 67.68; H, 5.21; N, 3.04%); [a] f=  -2.2 (c0.74, chloroform); \)max 
(nujol)/cm-1 1377, 1214, 1164, 1121, 903, 249, 726 and 690; 8r  (270 MHz, 
CDCI3 ) 1.84 (3 H, d, J 7, CHC//3), 5.56 (1 H, dq, J 12.7 and 6 .8 , CHCH3), 6.89 (2 
H, m, aryl H), 7.1-7.27 (5 H, m, aryl H), 7.37-7.59 (9 H, m, aryl H), 7.61-7.89 (4 H, 
m, aryl H); 8 c  (68  MHz, CDCI3) 19.2 (q), 58.0 (d), 127.4, 127.6, 127.8, 127.9, 
128.0, 128.1, 128.2, 122.4, 128.9, 132.2, 132.5, 132.8, 133.0, 133.2, 138.6 (s),
140.2 (s); 8p (162 MHz, CDCI3) 32.6 (1 P, s); m/z (Cl) 462 (M++1, 5%), 398 (10), 
358 (100), 320 (45), 274 (60), 232 (38), 218 (22), 201 (12), 143 (15), 105 (29), 89
(57).
Preparation of Oxzazolidinones
The preparation of these compounds was based on a literature procedure.^ 
Preparation of2-Oxazolidinone.
A stirred mixture of ethanolamine (4.9 cm^, 82 mmol), diethyl carbonate 
(20 cm^, 169 mmol) and anhydrous potassium carbonate (1.13 g, 8.2 mmol) was 
heated to ca. 130 °C  and the evolved ethanol removed by distillation. Once
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distillation appeared to cease the mixture was cooled to room temperature and 
diluted with DCM (20 cm^). The solution was then washed with water ( 2 x 5  cm^) 
then saturated aqueous brine (5 cm^) and dried (magnesium sulfate). The solvent 
was then removed in vacuo to give 2 -oxazolidinone as a white solid which was 
further purified by recrystallisation from ethyl acetate/ hexane (4.85 g, 6 8 %), m. p. 
86-88  °C (lit.,50 87-89 °C); 5 h  (270 MHz, CDCI3) 3.65 (2 H, t, J 8 .8 , C //2 ), 4.45 
(2 H, dd, J 8.5 and 7, CH±), 6.59 (1 H, br s, NH).
S-4-isopropvl-2-oxazolidinone.
This compound wa prepared according to the above procedure using S- 
valinol (1.51 g, 15 mmol), diethyl carbonate (3.6 cm^, 30 mmol) and anhydrous 
potassium carbonate (200 mg, 1.5 mmol). S-4-isopropyl-2-oxazolidinone was 
isolated as a white solid which was further purified by recrystallisation from ethyl 
acetate/ hexane(1.53 g, 79%), m. p. 70-71 °C (lit,50 70-73 °C); [a] 2g=  -16.5 (c 6 , 
ethanol) Git,50  [a]g>= -17 (c 6 , ethanol) ); 5h  (270 MHz, CDCI3) 0.77 (3 H, d, J
6 .8 , (C //3)2CH), 0.83 (3 H, d, J 6.6  , (Ctf3)2CH), 1.61 (1 H, m, (CH3)2C//), 3.51 
(1 H, m, C//CH2 ), 3.97 (1 H, dd, J 9.8 and 6 .2 , C H C //2 ), 4.31 (1 H, t, J 8 .6 , 
CHC//2), 7.11 (1 H, br s, NH).
Preparation of N-diphenvlphosphinvl Oxazolidinones.
General Procedure from Oxazoiidinones:
The following procedure is typical.
Preparation ofN-dinhenvlnhosphinvl-2-oxazolidinone (57).
Sodium hydride (60% suspension in oil, 0.5 g, 12.6 mmol) was washed with 
dry petrol ( 3 x 5  cm3) then slurried in anhydrous THF (20 cm^). 2-Oxazolidinone
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(1.0 g, 11.5 mmol) was the added portionwise under a rapid stream of nitrogen. 
The resulting mixture was then stirred for 1 hour at room temperature. 
Diphenylphosphinic chloride (2.2 cm^, 11.5 mmol) was added dropwise and the 
mixture stirred at room temperature for 6 hours (or until all of the oxazolidinone 
was consumed by TLC). The mixture was then poured into saturated aqueous 
ammonium chloride solution (10 cm^) and extracted with ethyl acetate (3 x 10 
cm3). The combined organic extracts were dried (magnesium sulfate) and 
concentrated in vacuo to give phosphinamide (57) as a white solid which was 
further purified by recrystallisation from DCM/ hexane. Obtained as white needles 
(2.41 g, 73%), m. p. 118-121 °C (from DCM/ hexane); (found C, 62.8; H, 4.95; N,
4.9. C 15H 14N O 3 P requires C, 62.72; H, 4.88; N, 4.88%); t)max (nujol)/ cm ' 1 
1750, 1213, 1121, 1052, 768, 727 and 692; 5 h  (400 MHz, CDCI3) 3.93 (2 H, t, J
7.6, C //2), 4.38 (2 H, t, J 7.6, 0 /2 ) .  7.42-7.46 (4 H, m, aryl H), 7.49-7.56 (2 H, m, 
aryl H), 7.79-7.84 (4 H, m, aryl H); 8c  (100 MHz, CDCI3) 43.8 (t), 63.9 (dt, Jpc
7.3), 128.5 (dd, Jpc 12.8), 131.8 (dd, Jpc 11), 132.9 (dd, Jpc 3.6), 156.2 (d, Jpc
7.4); 8p (162 MHz, CDCI3) 26.5 (1 P, s); m/z (Cl) 288 (M++1, 100%), 243 (12), 
201 (7), 88(25).
N-diphenvlphosnhinvl-(S)-4-lsopropvl-2-oxazolidinone (58).
This compound was prepared according to the above general procedure using 
sodium hydride (60% suspension in oil, 340 mg, 8.53 mmol), S-4-isopropyl-2- 
oxazolidinone (1.0 g, 7.75 mmol) and diphenylphosphinic chloride (1.48 crrA 7.75 
mmol) in anhydrous THF (20 cm^). Phosphinamide (58) was obtained as a white 
solid which was further purified by recrystallisation from DCM/ hexane. Obtained 
as white needles (2.18 g, 85%), m. p. 147-149 °C (from DCM/ hexane); (found C, 
65.3; H, 6.1; N, 3.9. C 18H 20NO3P requires C, 65.65; H, 6.08; N, 4.26%); [a] 
+120.2 (c 1.58, chloroform); \)max (nujol)/cm ' 1 1747, 1439, 1393, 1327, 1205, 
1126, 1052, 971, 752, 726 and 698; 5 h  (270 MHz, CDCI3 ) 0.68 (3 H, d, J 7,
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(C //3)2 CH), 0.8 (3 H, d, J 7, (C //3>2CH), 2.21 (1 H, m, (<CH3J2CH), 4,19 (1 H, dd, 
J 7.3 and 3, C//CH2), 4.34 (1 H, t, J 8 .6 , CHOT2 ), 4.44-4.47 (1 H, m, CHC//2),
7.25-7.81 (8 H, m, aryl H), 8.04 (2 H, dd, J 13.2 and 7.4, aryl H); 6 c  (68 MHz, 
CDCI3 ) 14.2 (q), 17.8 (q), 30.8 (d), 60.6 (dd, Jp c  3.3), 65.0 (dt, J p c  7.7), 128.2 
(dd, Jpc 2 .2 ), 128.4, 131.2 (dd, Jpc 7.7), 131.4 (dd, Jpc 11), 132.0 (dd, Jpc 11),
132.6, 132.8 (dd, Jpc 2 .2), 156.6 (d, Jpc 7.7), 203.6 (s); 8p (162 MHz, CDCI3 )
27.0 (1 P, s); m/z (Cl) 330 (M ++1,100%), 286 (10), 201 (15), 158 (32), 130 (36).
Section 4.4; Conformationallv Restricted Systems.
Preparation ofN . N’-bis (1 -(R)-phenvleth\l)-l. 2-ethvlenediamide .
To a stirred solution of R-(+)-a methylbenzylamine (2 cm^, 15.5 mmol) and 
triethylamine (6.5 cm^, 46.5 mmol) in DCM (40 cm^) at 0 °C  was added oxalyl 
chloride (0.7 cm^, 7.8 mmol) dropwise over 5 minutes. The resulting thick white 
slurry was warmed to room temperature and stirred for 3 hours. Saturated aqueous 
ammonium chloride solution (20 cm^) was then added and the mixture extracted 
with DCM (3 x 10 cm^). The combined organic extracts were dried (sodium 
sulfate) and concentrated in vacuo to give the &z\s-amide as a pale yellow solid 
which was further purified by recrystallisation from DCM/ hexane to give white 
needles (1.95 g, 84%), m. p. 195-199 °C (from DCM/ hexane); [a ]$ =  +97.1 (c 
0.42, chloroform); 'Umax (nujol)/cnr 1 3301, 1650, 1511, 1224 and 1126; 5 h  (270 
MHz, CDCI3 ) 1.54 (6 H, d, J 7, CH C//3), 5.06 (2 H, dq, J 7.6 and 7.5, C//CH3), 
7.23-7.36 (10 H, m, aryl H), 7.71 (2 H, br d, J 7.5, NH); 5 c  (68  MHz, CDCI3) 21.7 
(q), 49.5 (d), 126.2 (d), 127.7 (d), 128.8 (d), 141.95 (s), 158.9 (s); m/z (Cl) 297 
(M++1, 13%), 193 (54), 145 (6 ), 105 (100); (found [M+H]+, 297.1603. 
C 18H21N2O2 requires m/z, 297.1602).
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Preparation ofN. N ’-bis (l-(R)-phenvlethvD-l. 2-ethvlenediamine (63).
To a refluxing solution of N, N '-b is  (l-(R )-pheny le thy l)-l, 2- 
ethylenediamide (1.51 g, 5.1 mmol) in anhydrous THF (50 cm^) was added lithium 
aluminium hydride (4 equivalents, 0.77 g, 20.4 mmol) portionwise [CARE!: 
vigorous effervescence]. The stirred mixture was heated at reflux for 48 hours. It 
was then cooled to room temperature and water (1 cm^) was then added dropwise 
followed by 15% w/v aqueous sodium hydroxide solution (5 cm^). The resulting 
mixture was stirred at room temperature for 1 hour. It was then filtered through 
celite and the residues washed with DCM (3 x 50 cm^). The filtrate was dried 
(magnesium sulfate) and concentrated in vacuo. The residue was a brown oil which 
was further purified by distillation under reduced pressure b. p. 145-148 °C, 0.5 
mmHg (lit.,61 110 °C, 0.02 mmHg). The product was a colourless oil (1.31 g, 
95%), [a]|>6= +69.9 (c 1, chloroform) (lit.,61 ent- [a]^°= -69.4 (c 1.1, chloroform); 
8h  (270 MHz, CDCI3 ) 1.35 (6  H, d, J 6 .6 , CHC//3), 2.53 (4 H, s, C # 2), 3.4 (2 H, 
br s, NH), 3.65 (2 H, q, J 6.8  CHCH3), 7.2-7.41 (10 H, m, aryl H).
Preparation ofN. N ’-dibenzvl-l. 3-propanediamine.
To a stirred solution of 1, 3-diaminopropane (5 cm^, 59.9 mmol) and 
triethylamine (20.8 cm^, 149.7 mmol) in DCM (160 cm^) at 0 °C was added 
benzoyl chloride (13.9 cm^, 119.8 mmol) dropwise over 10 minutes. This resulted 
in the formation of a heavy white precipitate. The mixture was then allowed to 
warm to room temperature. It was then quenched by addition of saturated aqueous 
ammonium chloride solution (60 cm^) and extracted with DCM (3 x 50 cm^). The 
combined organic extracts were then washed with saturated aqueous brine (30 
cm^), dried (sodium sulfate) and concentrated in vacuo to give a white solid. The 
crude ^/5-amide was redissolved in anhydrous THF (300 cm^) and heated to reflux.
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Lithium aluminium hydride (5.36 g, 141.8 mmol) was then added portionwise 
[CARE!: vigorous effervescence] and the mixture heated at reflux for 36 hours. It 
was then cooled to room temperature and water (10  cm3) was then added dropwise 
with external cooling. 15% w/v aqueous sodium hydroxide solution (6 cm3) was 
then added dropwise followed by a further 15 cm3 of water. The resulting mixture 
was stirred at room temperature for 2 hours. It was then filtered through celite and 
the residue washed with diethyl ether (3 x 75 cm3). The organic phase of the 
filtrate was separated, dried (magnesium sulfate) and concentrated in vacuo to give 
the diamine as a yellow oil which was further purified by distillation under reduced 
pressure b. p. 187-188 °C, 0.5 mmHg (lit.,* 15 139 o q  0.6 mmHg). The product 
was a colourless oil (10.35 g, 68%), 8r  (270 MHz, CDCI3) 1.43 (2 H, br s, NH), 
1.68 (2 H, p, J 6 .8 , 2-CHi), 2.69 ( 4 H, t, J 6 .8 , 1- and 3-C//2), 3.76 (4 H, s, 
C //2Ph), 7.29 (10 H, m, aiyl H).
Preparation of C2 Symmetric Cyclic Phosphonamides.
General Procedure:
The following procedure is typical.
Preparation of 1.3-bis (l-(R)-phenvlethvl)-2-ethvl-l. 3. 2-diazaphosnholidine 2- 
oxide (61).
To a stirred solution of N, N 9-bis (l-(R)-phenylethyl)-l, 2-ethylenediamine 
(0.52 g, 1.92 mmol) and triethylamine (0.53 cm3, 3.84 mmol) in DCM (20 cm3) at 
0 °C  was added ethylphosphonic dichloride (0.21 cm 3,1.92 mmol) dropwise. The 
resulting mixture was warmed to room temperature and stirred for 18 hours. It was 
then poured into an equal volume of saturated aqueous ammonium chloride solution 
and extracted with DCM (3 x 10 cm3). The combined organic extracts were dried 
(sodium sulfate) and concentrated in vacuo. The residue was purified on silica
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eluting with 0—>10% v/v methanol- DCM. This afforded phosphonamide (61) as a 
colourless oil in (328 mg, 50%), [a]}>9= +31.8 (c 0.11, chloroform); “Umax (film)/ 
cm ' 1 3059,2973,2875,1378,1278 and 1209; 8h  (270 MHz, CDCI3 ) 1.05 (3 H, dt, 
J 19.8 and 7.7, CH2C //3), 1.61 (3 H, d, J 6 .8 , CHC//3), 1.63 (3 H, d, J 7, CHC//3), 
1.94 (2 H, dq, J 16.1 and 7.7, C //2CH3 ), 2.76-2.93 (3 H, m, 0 /2 ) ,  3.01-3.1 (1 H, 
m, 0 /2 ) ,  4.42-4.62 (2 H, m, O /C H 3 ), 7.24-7.48 (10 H, m, aryl H); 8c  (68 MHz, 
CDCI3) 7.8 (dq, Jpc 5.5), 19.2 (q), 20.1 (q), 23.1 (dt, Jpc 119.9), 41.9 (t), 42.0 (t),
53.0 (dd, Jpc 6 .6 ), 53.8 (dd, Jpc 5.5), 128.6 (d), 127.1 (d), 127.15 (d), 127.3 (d), 
128.3 (d), 128.4 (d), 142.1 (d Jpc 4.3), 143.0 (d, Jpc 4.3); 8p (162 MHz, CDCI3)
40.8 (1 P, s); m/z (El) 342 (M+, 18%), 327 (90), 313 (21), 265 (10), 237 (13), 223 
(25), 105 (100); (found [M]+ 342.1853. C20H27N2OP requires m/z, 342.1861).
/ .  3-dihfinzv!-2-ethyl-1. l-diainnhnsphorinane 2-oxide (62\
This compound was prepared according to the above general procedure 
using N, N’-dibenzyl-l, 3-propanediamine (1.5 g, 5.9 mmol), triethylamine (1.64 
cm’ , 11.8 mmol) and ethylphosphonic dichloride (0.63 cm3, 5.9  mmol) in DCM 
(50 cm3). Phosphonamide (62) was isolated as a white solid (1.31 g, 68%), m. p. 
79-82 °C  (from DCM/ hexane); (found C, 69.4; H, 7.7; N, 8.5. C 19H25N2OP 
requires C, 69.51; H, 7.62; N, 8.54%); p max (nujol)/cm ' 1 1378,1285, 1202, 1049, 
920 and 721; 8n  (270 MHz, CDCI3) 1.19 (3 H, dt, J  18.5 and 7.7, CH2C //3), 1.53- 
1.61 (1 H, m, 5-C//2), 1.71-1.85 (1 H, m, 5-C//2), 1.93 (2 H, dq, J 14.6 and 7.5, 
C //2CH3), 2.93-3.02 (4 H, m, 4- and 6 -C //2), 4.09 (2 H, dd, J 14.9 and 7, C //2Ph),
4.35 (2 H, dd, J 14.9 and 6.4, C //2Ph), 7.23-7.41 (10 H, m, aryl H); 8c  (100 MHz, 
CDCI3) 7.3 (dq Jpc 5.5), 19.2 (dt, Jpc 115.2), 24.7 (t), 46.3 (t), 50.4 (t), 126.7 (d),
127.5 (d), 127.8 (d), 127.9 (d), 128.6 (d), 128.7 (d), 138.4 (d, J p c  5.5);8p (162 
MHz, CDCI3) 34.1 (1 P, s); m/z (El) 328 (M+, 100%), 299 (14), 148 (35), 91 (14).
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R. R-(+)-4. 5-tetramethvlene-2-phenyl-1. 3 .2-diazaphosphorine 2-oxide (64).
This compound was prepared according to the above general method using 
R, R-(-)-diaminocyclohexane (400 mg, 3.51 mmol), triethylamine (0.98 cm^, 7.02 
mmol) and phenylphosphonic dichloride (0.51 cm^, 3.51 mmol) in DCM (10 cm^). 
Phosphonamide (64) was isolated as a white solid (696 mg, 84%), m. p. 186-188 °C 
(d) (from DCM/ petrol); (found C, 60.6; H, 7.4; N, 11.6. C12H 17N2OP requires C, 
61.02; H, 7.20; N, 11.86%); [a ]$  = +4.3 (c0.51, methanol); Dmax (nujol)/ cnr* 
3215, 1312, 1201, 1183, 1108, 1075, 951, 897 and 744; 8h  (270 MHz, CDCI3 ) 
1.21-1.52 (4 H, m, C //2 ), 1.64-1.98 (4 H, m, C//2), 2.77-3.04 (3H, m, CH and 2 x 
NH), 3.22 (1 H, m, CH), 7.31-7.49 (3 H, m, aryl H), 7.83 (2 H, m, aiyl H); 6c  (68 
MHz, CD3 OD) 26.2 (t), 26.8 (dt, Jpc 4.4), 34.8 (t), 36.2 (t), 57.1 (dd, Jpc 5.5),
59.1 (dd, Jpc 18), 129.8, 129.9, 130.0, 130.1, 132.6, 132.8, 132.9, 133.6; 5p ( 1 6 2  
MHz, CDCI3 ) 25.8 (1 P, s); m/z (El) 236 (M+ 100%), 194 (7), 101 (77), 86 (47); 
(found [M]+, 236.1037. C 12H 17N2OP requires m/z, 236.1078).
Preparation ofSp. R-(- )-dihvdrobenzaphosphole oxide (25).
This compound was obtained by desilylation of a sample of the 
corresponding f-BDPS protected phosphinamide prepared in the Wills group. The 
synthesis and X-ray structure of this precursor has been reported.^ 3 The 
deprotection was affected as follows:
To a s tirred  so lu tion  of Sp , R-(-)-N-(f-butyldiphenylsilyl) 
dihydrobenzaphosphole oxide (1.0 g, 2.07 mmol) in THF (17 cm^) was added 
TBAF (1 M THF solution, 4.1 cm^, 4.15 mmol) dropwise. The resulting solution 
was stirred at room temperature for 3 hours. It was then poured into saturated 
aqueous ammonium chloride solution (10 cm^) and extracted with ethyl acetate (3 x 
5 cm3). The combined organic extracts were dried (sodium sulfate) and
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concentrated in vacuo. The residue was purified on silica eluting with 0—>70% v/v 
ethyl acetate- petrol. This afforded phosphinamide (25) as a white solid (457 mg, 
91%), m. p. 232-234 °C (d) (from DCM/ hexane); (found C, 69.0; H, 5.8; N, 5.6. 
C 14H 1 4 NOP requires C, 69.13; H,5.80; N, 5.76%); [ a ] f=  -131.2 (c 0 .87 , 
methanol); Umax (nujol)/ cm- l3195, 2971, 1446, 1209, 1182, 1115, 754, 730 and 
694; 8h  (400 MHz, CDCI3) 1.64 (3 H, d, J 6.4, CHC//3 ), 3.71 (1 H, br d, J 11.6 , 
NH), 4.82 (1 H, m, C//CH3), 7.37-7.41 (4 H, m, aryl H), 7.42-7.49 (1 H, m, aiyl H), 
7.52-7.64 (2 H, m, aryl H), 7.67-7.72 (2 H, m, aryl H); 5 c  (100 MHz, CDCI3) 25.7 
(q), 56.1 (dd, Jpc 7.3), 123.9, 124.0,128.6,128.8, 128.9, 130.4 (s), 132.2 (dd, Jpc 
23.8), 132.6 (dd, Jpc 11.4), 134.0 (s), 149.0 (d, Jpc 20.1); 5p (162 MHz, CDCI3)
34.0 (1 P, s); m/z (Cl) 244 (M+, 100%), 228 (20).
4 Experimental. Paee 139.
Section 4.5: Combined Donor Catalysts.
Preparation of Chiral N-methvI Diamines.
The N-methyl diamines required for the preparation of the triamide catalysts were 
prepared according to a literature procedure.59,65
Preparation ofR. R-(-)-N. N’ -Dimethvlcvclohexane-L 2-diamine (73).
To a solution of R, R-(-)-cyclohexane-l, 2-diamine (4.5 g, 39.5 mmol) in 
toluene (60 cm^) at 0 °C was added ethyl choroformate (8.95 cm^, 93.6 mmol) and 
a solution of sodium hydroxide (3.74 g, 93.6 mmol) in water (4 cm^) 
simultaneously with rapid stirring at such a rate as to maintain the reaction 
temperature between 0 and 10 °C. Once addition was complete the thick white 
slurry was warmed to room temperature and stirred for 3 hours. The heavy 
precipitate was then filtered off and washed with DCM (3 x 30 cm^). The 
combined organic extracts were then dried (magnesium sulfate) and concentrated in 
vacuo. The residue was then recrystallised from DCM/ pentane to afford the 
dicarbamate as white needles (9.83 g, 97%).
To a solution of lithium aluminium hydride (1.76 g, 46.4 mmol) in 
anhydrous THF (80 cm^) was slowly added the dicarbamate (3.0 g, 11.6 mmol) 
portionwise at room temperature with rapid stirring. Once addition was complete 
the mixture was heated at reflux for 24 hours [CARE!: reflux temperature must be 
approached gradually to prevent a vigorous exothermic reaction]. The mixture was 
then cooled and ethylenediamine (4.25 cm^) added slowly followed by a 15% w/v 
aqueous sodium hydroxide solution (2 cm^) and water (4 cm^). It was then stirred 
for 30 minutes at room temperature. The precipitate was removed by filtration 
through celite and the residues washed with diethyl ether (3 x 30 cm^). The filtrate 
was then concentrated in vacuo. The resulting oil was redissolved in diethyl ether
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(30 cm3) and the aqueous phase removed. The solution was dried (sodium sulfate) 
and again filtered through celite. The filtrate was then concentrated in vacuo to give 
diamine (73) as an oil which was purified by distillation under reduced pressure 
(1.36 g, 83%), b. p. 76-80 °C (15 mmHg) (lit.,59  78-80 °C  (18 mmHg) ); [a] 2?= 
-115.4 (c4.36, chloroform) (lit.,59  [a]o  = -145.7 (c4.47, chloroform) ); 8h  (270 
MHz, CDCI3 ) 0.93-1.14 (4 H, m, Cf/2), 1.18-2.09 (8 H, m, CH , CH2  and NH),
2.35 (6  H, s, NMe).
S. S-(-)-N. N’-Dimethyl-1 .2-diphenvlethvlene-L 2-diamine.
This compound was prepared according to the above method. The 
dicarbamate was prepared using S, S-(-)-l, 2 -diphenyl-l, 2-ethylenediamine (1.0 g, 
4.72 mmol), ethyl chloroformate (1.1 cm^, 11.3 mmol) and aqueous sodium 
hydroxide solution (0.45 g sodium hydroxide in 0.5 cm^ water) in toluene (15 cm^) 
and was obtained as a white solid (1.53 g, 91%). Reduction of this compound (0.75 
g, 2.11 mmol) using lithium aluminium hydride (0.32 g, 8.44 mmol) in THF (20 
cm^) afforded the N, N’-dimethyl amine as a white solid (442 mg, 81%), m. p. 43- 
45 °C (from toluene) (lit.,65 46-47 °C); [a]^°= -22.5 (c 0.26, chloroform) (lit,65 
[a ]g =  -18.02 (c 1, chloroform)); 5h (270 MHz, CDCI3) 1.95 (2 H, br s, NH), 2.34 
(6 H, s, NMe), 3.63 (2 H, s, C //2Ph), 7.1-7.47 (10 H, m, aryl H).
Preparation of Phosphoramidic Chlorides.
General Procedure:
These compounds were prepared via a modified literature p r o c e d u r e .59 The 
following procedure is typical.
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Preparation o f  2-chloro-l. 3-dimethyl-1. 3. 2-diazaphospholidine-2-oxide (6 8 . 
R-M e).
To a stirred solution of N, N’-dimethylethylenediamine (67, Rl=M e) (0.39 
cm3, 3.7 mmol) and triethylamine (1.3 cm3, 9.3 mmol) in DCM (30 cm3) at 0 °C 
was added phosphorus oxychloride (0.35 cm3, 3.7 mmol) dropwise over 5 minutes. 
The resulting solution was then warmed to room temperature and stirred for 12 
hours. It was then concentrated in vacuo and the residue purified on silica eluting 
with 0—>30% v/v ethyl acetate- petrol. This afforded chloride (6 8 , R^=Me) as a 
white solid which was further purified by recrystallisation from toluene (598 mg, 
95%), m. p. 169-171 °C  (from toluene); Dmax (nujol)/ cm~l 3024, 2982, 1454, 
1992, 1265, 1117 and 765; 5 r  (270 MHz, CDCI3) 2.61 (6 H, d, J 12.8, NMe), 2.91-
3.04 (2 H, m, C //2), 3.17-3.28 (2 H, m, C//2); 5c (100 MHz, CDCI3) 31.3 (q), 45.6 
(t), 45.7 (t); Sp (162 MHz, CDCI3) 28.9 (1 P, s); mlz (El) 170 (M+, 30%), 168 (M+, 
100%), 133 (60), 86  (50), 43 (100); (found [M]+, 168.0198. C4 H ioN 2POC135 
requires /w/z, 168.0219).
2-chloro-l. 3-((R)-l-phenvlethvl)-l. 3. 2-diazaphospholidine-2-oxide (6 8 . R=(R)-J- 
phenvlethvl).
This compound was prepared according to the above general procedure 
using N, N '-bis (l-(R)-phenylethyl)-l, 2-ethylenediamine.(63). The chloride (68 , 
R= (R)-l-phenylethyl) was obtained as white needles (780 mg, 60%), m. p. 96-98 
°C (from DCM, hexane); (found C, 61.7; H, 6.4; N, 8.0. C 18H22N2OPCI requires 
C, 61.98; H, 6.36; N, 8.03%); [a ]g =  +8.7 (c 0.54, chloroform); Umax (nujol)/cm'^ 
3027, 2981, 1492,1454, 1394,1266,1226,1180,1117,1082,973 and 765; 5 h  (270 
MHz, CDCI3 ) 1.61 (3 H, d, J 6.95, CHC//3), 1.66 (3 H, d, J 6 .8 , CHC//3 ), 2.65- 
2.93 (4 H, m, C//2), 4.17 (1 H, dq, J 7.5 and 6 .8 , C//CH3), 4.69 (1 H, dq, J 10.5 and 
7, CHCH3), 7.19-7.38 (10 H, m, aiyl H); 5c (100 MHz, CDCI3) 17.0 (dq, Jpc 7.3),
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21.2  (dq, Jpc 9.2), 38.2 (dt, Jpc 14.6), 42.4 (dt, Jpc 14.7), 52.2 (dd, Jpc 7.3), 56.6 
(dd, Jpc 7.3), 126.9 (d), 127.3 (d), 127.6 (d), 127.7 (d), 128.5 (d), 128.7 (d), 140.5 
(d, Jpc 5.5), 141.8 (d, Jpc 10.9); 8p (162 MHz, CDCI3) 24.2 (1 P, s); m/z (Cl) 351 
(M+, 30%), 349 (M+, 100%), 333 (25), 313 (19), 105 (20).
Phosphoramidic Chloride (74).
This compound was prepared according to the above general procedure 
using R, R-(-)-N, N’-dimethylcyclohexane-l, 2-diamine (73) (1.36 g, 9.58 mmol), 
triethylamine (3.3 cm^, 23.95 mmol) and phosphorus oxychloride (0.9 cm^, 9.58 
mmol) in DCM (50 cm^). Chloride (74) was obtained as white needles (1.92 g, 
90%), m. p. 68-69 °C (from DCM/ hexane) (lit.,59 70 OQ; [<x]g= -55.4 (c 5.5, 
DCM) (lit.,59 [a] 20= .57.5  (c 5 .7 , DCM )); 6h (270 MHz, CDCI3 ) 1.09-1.32 (4 H, 
m, C //2 ), 1.79-1.96 (4 H, m, CZ/2), 2.45-2.52 (4 H, m, CH and NMe), 2.59 (3 H, d, 
J 11.9, NMe), 2.78 (1 H, m, CH).
Phosphoramidic Chloride (87).
This compound was prepared according to the above general procedure 
using S, S-(-)-N, N’-Dimethyl-l, 2-diphenylethylene-l, 2-diamine (200 mg, 0.83 
mmol), triethylamine (0.29 cm^, 2.08 mmpl) and phosphorus oxychloride (0.08 
cm 3,0.83 mmol) in DCM (10 cm^). Chloride (87) was obtained as a colourless oil 
(149 mg, 56%), [a ]g =  -12.9 (c 0.88, chloroform); 5 r  (270 MHz, CDCI3) 2.42 (3 
H, d, J 14.5, NMe), 2.61 (3 H, d, J 10.4, NMe), 3.84 (1 H, d, J 8 .6 , C//Ph), 4.15 (1 
H, dd, J 8.7 and 4.2, C//Ph), 7.2-7.39 (10 H, m, aryl H).
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Preparation of Triamide Catalysts bv Reaction of a Lithiated Amine with a 
Phosphoramidic Chloride.
General Procedure:
The following procedure is typical.
Preparation o f phosphoramide (69).
To a stirred solution of the R-(+)-a methylbenzylamine (1.2 cm^, 8.9 mmol) 
in anhydrous THF (15 cm^) at 0 °C  was added n-butyllithium (2.5 M hexane 
solution, 3.6 cm^, 8.9 mmol) dropwise. The solution was then stirred for 20 
minutes at 0 °C, warmed to room temperature and stirred for a further 10 minutes. 
It was then again cooled to 0 °C and a solution of 2-chloro-l, 3-dimethyl-1, 3, 2- 
diazaphospholidine-2-oxide (6 8 , R*=Me) (1.5 g, 8.9 mmol) in anhydrous THF (15 
cm^) was added dropwise. The mixture was allowed to warm slowly to room 
temperature and stirred for 12 hours. It was then poured into saturated aqueous 
ammonium chloride solution (10 cm^) and extracted with ethyl acetate ( 3 x 7  cm^). 
The combined organic extracts were dried (magnesium sulfate) and concentrated in 
vacuo. The residue was purified on silica eluting with 0—>10% v/v methanol- 
DCM. This afforded phosphoramide (69) as a white solid (1.53 g, 68%), m. p. 106- 
108 °C (from DCM/ hexane); [a ]g =  +48.6 (c 0.92, chloroform); 'Umax (nujol)/ cm" 
1 3200,1951,1679,1454,1378,1274 and 1000; 5h  (270 MHz, CDCI3) 1.63 (3 H, 
d, J 6 .8 , CHC//3), 2.35 (3 H, d, J 9.5, NMe), 2.86 (3 H, d, J 9.7, NMe), 3.07-3.57 (5 
H, br m, C/ / 2  and NH), 4.23 (1 H, m, C//CH3), 7.41-7.53 (5 H, m, aryl H); 5 c  (68 
MHz, CDCI3) 25.8 (dq, Jpc 7.7), 30.7 (q), 31.2 (dq, Jpc 4.4), 46.4 (dt, Jpc 13.2),
47.1 (dt, Jpc 12.1), 51.2 (d), 125.7 (d), 126.7 (d), 128.3 (d), 146.1 (d, Jpc 3.3); 5p 
(162 MHz, CDCI3) 24.6 (1 P, s); mlz (El) 253 (M+, 82%), 120 (100), 42 (9); (found 
[M+H]+, 254.1421. C 12H2 1N3OP requires m/z, 254.1422).
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Phosphoramide (70).
This compound was prepared according to the above general procedure 
using R-(+)-a methylbenzylamine (0.04 cm^, 0.29 mmol), /i-butyllithium (2.5 M 
hexane solution, 0.12 cm^, 0.29 mmol) and chloride (6 8 , R*= (R)-l-phenylethyl) 
(100 mg, 0.29 mmol) in anhydrous THF 2 cnA  Phosphoramide (70) was obtained 
as a viscous pale yellow oil (49 mg, 39%), [a ]g =  +22.5 (c 0.18, chloroform); t>max 
(film)/ cm-1 3217, 1456, 1375, 1170, 978, 744 and 699; 8r  (270 MHz, CDCI3) 
1.49 (3 H, d, J 7, C H O /3), 1.52 (3 H, d, J 8.2, CHC//3), 1.58 (3 H, d, J 7, CHC//3), 
2.65-2.87 (4 H, m, C # 2 ), 3.17 (1 H, br t, J 9.6, NH), 3.59 (1 H, m, C //CH 3 ), 4.41- 
4.52 (2 H, m, C//CH3), 7.01-7.51 (15 H, m, aryl H); 8p (162 MHz, CDCI3) 20.1 (1 
P, s); m/z (Cl) 434 (M ++1,100%), 419 (31), 329 (45), 106 (100); (found [M+H]+, 
434.2360. C26H33N3OP requires m/z, 434.2361).
Phosphoramide (72).
(R, R, R-diastereoisomer). This compound was prepared according to the 
above general procedure using R-(+)-a methylbenzylamine (0.07 cm^, 0.54 mmol), 
/i-butyllithium (1.43 M hexane solution, 0.32 cm^, 0.45 mmol) and chloride (74) 
(100 mg, 0.45 mmol) in anhydrous THF (2 cm^). Phosphoramide (72) was 
obtained as a white solid (61 mg, 44%), m. p. 138-142 °C  (from DCM/ hexane); 
[<*]£?= -11.0 (c 0.72, chloroform); \>max (nujol)/ cm~l 3239, 2993, 2958, 1641, 
1451, 1296, 1193, 1132, 1092, 1040, 978, 950, 899, 761 and 702; 8h  (270 MHz, 
CDCI3 ) 1.19-1.31 (4 H, m, C //2), 1.42 (3 H, d, J 6 .8 , CHC//3), 1.81-1.95 (4 H, m, 
C //2 ), 2.13 (3 H, d, J 10.4, NMe), 2.39 (1 H, m, C H \ 2.53 (3 H, d, J 11.5, NMe), 
2.56-2.66 (1 H, m, CH), 3.01 (1 H, br m, NH), 4.16 (1 H, m, C//CH3), 7.28-7.34 (5 
H, m, aryl H); 8c  (100 MHz, CDCI3) 24.3 (t), 25.8 (q), 26.3 (q), 27.9 (q), 28.5 (dt, 
JpC 8), 51.3 (d), 63.1 (dd, Jpc  8 .8 ), 62.8 (dd, Jpc  8 .8), 125.8 (d), 126.9 (d), 128.5 
(d), 146.1 (s); 8p (162 MHz, CDCI3) 27.3 (1 P, s); m/z (Cl) 308 (M ++1,100%), 292
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(10), 233 (7), 120 (21); (found [M+H]+, 308.1883. C 16H27N 3OP requires m/z, 
308.1892).
Phosphoramide (75).
(R, R, S-diastereoisomer). This compound was prepared according to the 
above general procedure using S-(-)-a methylbenzylamine (0.07 cm^, 0.54 mmol), 
/i-butyllithium (1.43 M hexane solution, 0.32 cm^, 0.45 mmol) and chloride (74) 
(100 mg, 0.45 mmol) in anhydrous THF (2 cm^). Phosphoramide (75) was 
obtained as a white solid (50 mg, 36%), m. p. 144-145 °C (from DCM/ hexane); 
[a] J>6= -143.5 (c 0.37, chloroform); t>max (nujol)/ cm"l 3239, 2993, 2956, 1450, 
1297, 1192, 1132, 1072, 1040, 978 and 701;8h (270 MHz, CDCI3) 1.17-1.27 (4 H, 
m, 0 /2 ) ,  1.41 (3 H, d, J 6 .6 , CHC//3 ), 1.64-1.79 (3 H, m, 0 / 2 ), 1.97 (1 H, m, 
0 / 2 ) ,  2.06 (3 H, d, J 11.4, NMe), 2.54-2.56 (5 H, d overlapping m, J 10.6, NMe 
and O /) , 3.08 (1 H, br m, NH), 4.02-4.08 (1 H, m, C//CH3), 7.21-7.27 (5 H, m, aryl 
H); 8c (68  MHz, CDCI3) 24.2 (t), 26.2 (q), 27.8 (q), 28.2 (dt, Jpc 8 .8), 28.3 (q),
51.0 (d), 64.0 (dd, Jpc 8 .7), 65.1 (dd, Jpc 9.9), 126.0 (d), 128.2 (d), 128.4 (d),
146.1 (s); 5p (162 MHz, CDCI3 ) 28.1 (1 P, s); m/z (El) 307 (M+, 5%), 232 (50), 
204 (40), 189 (23), 120 (30), 42 (50); (found [M+H]+, 308.1883. C 16H2 7N3OP 
requires m/z, 308.1892).
Phosphoramide (76).
This compound was prepared according to the above general procedure 
using benzylamine (0.06 cm^, 0.54 mmol), /i-butyllithium (1.56 M hexane solution, 
0.29 cm^, 0.45 mmol) and chloride (74) (100 mg, 0.45 mmol) in anhydrous THF (2 
cm^). Phosphoramide (76) was obtained as a viscous oil (72 mg, 55%), [a]J?= 
-61.4 (c 0.96, chloroform); Umax (film)/ cm"1 3229, 2933,2858, 1602,1449,1372, 
1296, 1194, 1132, 1073, 977, 899, 759 and 702; 5 h  (270 MHz, CDCI3) 1.11-1.25
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(4 H, m, CH2 ), 1.75 (2 H, m, C //2), 1.95 (2 H, m, 0 /2 ) ,  2.45 (3 H, d, J 8.2, NMe),
2.48 (3 H, d, J 7.7, NMe), 2.55-2.72 (2 H, m, CH), 3.21 (1 H, br s, NH), 3.98 (2 H, 
br d, J 7, 0 /2 P h ), 7.22-7.31 (5 H, m, aryl H); 5 c  (100 MHz, CDCI3) 24.2 (t), 28.2 
(q), 28.3 (q), 28.4 (t), 44.9 (t), 63.0 (dd, JPc 9.1), 64.6 (dd, Jpc 9.1), 127.0 (d),
127.1 (d), 128.4 (d), 140.3 (dd, Jpc 5.5); 5p (162 MHz, CDCI3 ) 28.9 (1 P, s); m/z 
(El) 293 (M+, 100%), 188 (5), 106 (19); (found [M+H]+, 294.1725. C 15H25N3OP 
requires m/z, 294.1735).
Phosphoramide (85).
This compound was prepared according to the above general procedure 
using R-(+)-a methylbenzylamine (0.07 cm^, 0.53 mmol), n-butyllithium (2.48 M 
hexane solution, 0.18 cm^, 0.44 mmol) and chloride (87) (140 mg, 0.44 mmol). 
Phosphoramide (85) was obtained as a white solid (62 mg, 35%), m. p. 206-208 °C 
(from ethyl acetate); [a] 8 = +115.3 (c 0.8, chloroform); Dmax (nujol)/ c m 'l  3239, 
2917, 1453, 1180, 1042, 742 and 698; 5h  (270 MHz, CDCI3 ) 1.53 (3 H, d, J 7, 
CH C//3 ), 2.13 (3 H, d, J 10.4, NMe), 2.51 (3 H, d, J 9.2, NMe), 2.25 (1 H, br t, J
10.3, NH), 3.91 (2 H, s, C //2Ph), 4.27 (1 H, m, C//CH 3), 6.58 (2 H, d, J 6 .8 , aryl 
H), 7.08-7.48 (13 H, m, aryl H); 5c (68 MHz, CDCI3) 26.7 (dq, Jpc 8 .8), 29.2 (dq, 
JpC 5.5), 29.6 (dq, Jpc 3.3), 51.2 (d), 70.6 (dd, Jpc 11), 72.0 (dd, Jpc 12.1), 125.6 
(d), 126.9 (d), 127.5 (d), 127.8 (d), 128.0 (d), 128.1 (d), 128.2 (d), 128.4 (d), 137.9 
(s), 138.1 (d, Jpc 6 .6), 146.0 (d, Jpc 2.2); 5p (162 MHz, CDCI3) 26.0 (1 P, s); m/z 
(FAB) 406 (M++1, 100%), 331 (7), 285 (10), 210 (12), 166 (9), 118 (17), 105 (25); 
(found [M+H]+, 406.2041. C24H29N3OP requires m/z, 406.2048).
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Reaction of Phosphoramidic Chlorides with Pyrrolidine.
Preparation ofl.3-bis (1-(R)-phenvlethvl)-2-pvrrolidvl-L 3. 2-diazaphospholidine
2-oxide (71).
To a stirred solution of chloride (6 8 , R*= (R)-l-phenylethyl) (200 mg, 0.57 
mmol) in DCM (5 cm^) was added pyrrolidine (0.10 cm^, 1.14 mmol) dropwise. 
The resulting mixture was stirred at room temperature for 5 hours. It was then 
poured into saturated aqueous ammonium chloride solution (2 cm^) and extracted 
with DCM ( 3 x 5  cm^). The combined organic extracts were dried (magnesium 
sulfate) and concentrated in vacuo. The residue was purified on silica eluting with 
0—>10% v/v methanol- DCM to afford triamide (71) as a colourless oil (105 mg, 
48%) [a]^°= -3.4 (c 0.48, chloroform); Dmax (film)/ cm-* 3060, 2971, 2856, 1493, 
1452, 1392, 1345, 1279, 1214, 1132, 1083, 1037, 1015, 780 and 700; 8h  (270 MHz, 
CDCI3 ) 1.54 (3 H, d, J 6 .8 , CH C//3 ), 1.58 (3 H, d, J 7, CHC//3), 1-75 (4 H, m, 
pyrrolidyl CH2), 2.74-3.02 (6 H, m, CH2 and pyrrolidyl C»2), 3.11-3.25 (2 H, m, 
CH2), 4.31 (2 H, m, C//CH3), 7.21-7.41 (10 H, m, aiyl H); 8c  (100 MHz, CDCI3)
19.9 (q), 20.2  (q), 26.3 (dt, Jpc 9.2), 41.5 (dt, Jpc 12.8), 42.6 (dt, Jpc 10.9), 46.4 
(dt, Jpc 5.5), 54.1 (dd, Jpc 5 .4 ), 54 .4  (dd, Jpc 3 .7 ), 126.8 (d), 126.9 (d), 127.0 (d),
128.2 (d), 143.2 (d, Jpc 5.5), 143.6 (d, Jpc 3.7); 8p (162 MHz, CDCI3 ) 20.0 (1 P, 
s); m/z (Cl) 384 (M++1, 100%), 278 (14), 195 (8), i05 (57), 91 (19), 70 (43); 
(found [M]+, 383.2045. C22H30N3OP requires m/z, 383.2126).
7. 3-dimethvl-4. 5-tetramethvlene-2-pvrrolidvl-l. 3. 2-diazaphosphorine 2-oxide 
(83L
This compound was prepared according to the above procedure using 
chloride (74) (100 mg, 0.45 mmol) and pyrrolidine (0.08 cm^, 0.9 mmol) in DCM 
(5 cm^). Triamide (83) was obtained as a white solid (97 mg, 84%), [a] g =  -85 (c
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0.32 chloroform); Umax (film)/ c n r 1 2932, 2830, 1443, 1337, 1302, 1254, 1227, 
1208, 1177, 1157, 1065, 961, 889, 851, 806 and 758; 8h  (270 MHz, CDCI3 ) 1.05- 
1.23 (4 H, m, C //2 ), 1.73-1.78 (6  H, m, CH2  and pyrrolidyl CH2), 1.89 (2 H, br t, J 
12.7, pyrrolidyl CH2 ), 2.39 (3 H, d, J 11.3, NMe), 2.42-2.57 (4 H, m, CH and 
NMe), 2.63 (1 H, m, CH), 3.03-3.39 (4 H, m, pyrrolidyl CH2 ); 8c  (100 MHz, 
CDCI3) 24.9 (t), 27.0 (dt, Jpc 7.4), 28.9 (dt, Jpc 9.2), 29.1 (dq, Jpc 9.1), 29.4 (q),
47.2 (dt, Jpc 3.7), 63.7 (dd, Jpc 7.3), 65.4 (dd, Jpc 9.1); 8p (162 MHz, CDCI3)
27.5 (1 P, s); m/z (El) 257 (M+, 100%), 188 (12), 70 (28); (found [M+H]+, 
258.1743. C 12H2 5N3OP requires m/z, 258.1735).
Preparation of Triamide Catalysts hv Reaction of a-Methvlbenzvlamine with 
In  Situ  Generated Chlorides (80) and (86).
General Procedure:
The following procedure is typical.
Preparation o f  R. R-4. 5-tetramethvlene-2-(N-l-(R)~phenvlethvl)-l. 3. 2- 
diazaphosphorine-2-oxide (78) via in situ trapping ofchoride (80),
To a stirred solution of R, R-(-)-cyclohexane-l, 2-diamine (200 mg, 1.75 
mmol) and triethylamine (4 equivalents, 0.97 cm^, 7 mmol) in DCM (20 cm^) at 0 
°C  was added phosphorous oxychloride (0.16 cm^, 1.75 mmol) dropwise. The 
resulting solution was stirred at 0 °C for 2 hours then warmed to room temperature. 
R-(+)-a methylbenzylamine (0.24 cm^, 1.93 mmol) was then added and the 
mixture stirred for 2 hours at room temperature It was then poured into saturated 
aqueous ammonium chloride solution (10 cm^) and extracted with DCM ( 3 x 5  
cm3). The combined organic extracts were washed with saturated aqueous brine 
(10 cm3), dried (magnesium sulfate) and concentrated in vacuo. The residue was 
purified on silica eluting with 0—>10% v/v methanol- DCM. This afforded triamide
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(78) as a white solid which was further purified by recrystallisation from DCM/ 
hexane (200 mg, 41%), [<x]J?= +57.4 (c0.97, chloroform); \)max (nujol)/ cm 'l 
3227, 1297, 1193, 1176, 1132, 1073, 1036, 967, 870 and 761; 5 r  (400 MHz, 
CDCI3) 1.28-1.09 (4 H, m, 0 /2 ) ,  1.36 (3 H, d, J 6.7, CHC//3), 1.46 (1 H, m, C//2), 
1.55-1.67 (2 H, m, C //2 ), 1.82 (1 H, br d, J 7.3, O / 2 ), 1.99 (1 H, br d, J 7.9, CH), 
2.45 (1 H, m, CH), 2.69 (1 H, br s, NH), 2.99 (1 H, br t, J 7.3, NH), 3.25 (1 H, br t, J
7.5, NH), 4.25 (1 H, m, C//CH3), 7.15-7.31 (5 H, m, aryl H); 6c  (68 MHz, CDCI3)
24.0 (dt, J p c  4.4), 25.8 (dq, Jp c  8 .8), 30.8 (dt, J p c  11), 31.1 (dt, J p c  13.3), 51.3 
(d), 59.2 (dd, Jp c  6 .6), 60.7 (dd, Jp c  5.5), 125.4 (d), 126.9 (d), 128.4 (d), 146.3 (d, 
JPC 2.2); 6p (162 MHz, CDCI3 ) 25.6 (1 P, s); m/z (Cl) 280 (M++1, 38%), 264 (8), 
147 (7), 120 (27), 105 (100), 91 (9), 79 (22); (found [M+H]+, 280.1581. 
C14H23N3OP requires m/z, 280.1579).
R. R-4. 5-tetramethvlene-2-(N-l-(S)-nhenvleth\l)-l. 3. 2-diazaphosphorine-2-oxide
(79) Via In Situ Trapping of Chloride (80).
This compound was prepared according to the above general procedure 
using S-(-)-a methylbenzylamine. Triamide (79) was obtained as colourless needles 
(from DCM/ hexane) (195 mg, 40%), m. p. 209-210 °C (d) (from DCM/ hexane); 
(found C, 59.9; H, 8.0; N, 14.9. C 14H22N 3OP requires C, 60.22; H, 7.89; N, 
15.05%); [a] -67.8 (c 0.5, chloroform); Dmax (nujol)/ cm 'l 3226 , 1297, 1192,
1132, 1073, 1036, 966, 870 and 761; 6h  (270 MHz, CDCI3) 1.04-1.21 (4 H, m, 
C //2), 1.35 (3 H, d, J 6.9, CHC//3), 1.37-1.73 (4 H, m, CHi), 2.29 (1 H, br d, J 7.2, 
CH), 2.37 (1 H, br d, J 7, CH), 2.76-2.93 (3 H, br m, NH), 4.31 (1 H, m, C//CH 3), 
7.11-7.22 (5 H, m, aryl H); 5 c  (100 MHz, CDCI3) 24.3 (t), 24.4 (t), 25.3 (dq, Jp c
7.3), 30.7 (dt, Jpc 11), 31.0 (t), 51.3 (d), 60.3 (dd, Jpc 7.3), 61.9 (dt, Jpc 5.5),
125.9 (d), 126.9 (d), 128.5 (d), 146.2 d, Jpc 2.5); 6p (162 MHz, CDCI3) 26.2 (1 P, 
s); m/z (El) 279 (M+, 10%), 264 (55), 159 (21), 120 (100), 96 (10), 77 (16).
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S. S-4. 5-diphenvl-2-(N-l-(R)-phenvlethvl)-L 3. 2’diazaphosvhorine-2-oxide (84) 
Via In Situ Ttrapping of Chloride (86).
This compound was prepared according to the above general procedure 
using S, S -(-)-l, 2-diphenyl-1, 2-ethylenediamine (200 mg, 0.94 mmol), 
triethylamine (0.52 cm^, 3.76 mmol), phosphorus oxychloride (0.09 cm^, 0.94 
mmol) and R-(+)-a methylbenzylamine (0.13 cm^, 1.03 mmol) in DCM (20 cm^). 
Triamide (84) was obtained as a white solid (227 mg, 64%), m. p. 140-143 °C (from 
DCM/ hexane); [a]J,°= +48.2 (c 1.06, chloroform); Dmax (nujol)/ cm“l 3171, 1275, 
1208, 1184, 1129, 1084, 1040 and 970; 8r  (270 MHz, CDCI3) 1.46 (3 H, d, J 6 .8 , 
CHC//3 ), 2.51 (1 H, br d, J 7.7, NH), 2.85 (1 H, br d, J 11.9, NH), 3.31 (1 H, br t, J
9.8, NH), 4.21 (1 H, d, J 8 .8 , C//Ph), 4.35 (1 H, d, J 8 .8 , C//Ph), 4.52 (1 H, m, 
C //C H 3), 6.65 (2 H, d, J 7, aryl H), 7.06-7.19 (9 H, m, aryl H), 7.21-7.41 (4 H, m, 
aryl H); 8c (100 MHz, CDCI3) 26.0 (dq, Jpc 7.4), 51.5 (d), 65.3 (dd, Jpc 7.3), 67.3 
(dd, Jpc 7 .4 ), 125.8 (d), 126.7 (d), 126.9 (d), 127.3 (d), 127.8 (d), 128.1 (d), 128.3 
(d), 128.4 (d), 128.6 (d), 139.4 (d, Jpc 12.8), 139.6 (d, Jpc 7.3), 146.0 (s); 8p (162 
MHz, CDCI3) 22.3 (1 P, s); m/z (Cl) 378 (M++1, 100%), 289 (31), 120 (11), 106 
(50), 85 (2 2 ); (found [M+HJ+, 378.1742. C22H25N3OP requires m/z, 378.1735).
Preparation of Triamide Catalysts bv N-Alkvlation.
Preparation ofN-benzvl triamide (77).
To a stirred solution of a 1:1 mixture of R, R -l, 3-dimethyl-4, 5- 
tetramethylene-2-(N-l-(R)-phenylethyl)-l, 3, 2-diazaphosphorine 2-oxide and the 
corresponding S, S, R-diastereoisomer (prepared as described above using chloride 
(74) in racemic form) (100 mg, 0.33 mmol) in anhydrous THF (2 cm^) at 0 °C was 
added /i-butyllithium (1.6 M heaxane solution, 0.22 cm^, 0.36 mmol) dropwise. 
The resulting pale yellow solution was stirred at 0 °C for 90 minutes. Benzyl
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bromide (0.05 cm3, 0.36 mmol) was then added and the mixture warmed to room 
temperature and stirred for 24 hours. It was then poured into saturated aqueous 
ammonium chloride solution (1 cm3) and extracted with diethyl ether ( 3 x 2  cm3). 
The combined extracts were dried (magnesium sulfate) and concentrated in vacuo. 
The residue was purified on silica eluting with 0—>5% v/v methanol- DCM to afford 
a 1:1 mixture of diastereomeric triamides (77) as a viscous oil (54 mg, 42%) which 
appeared to decompose rapidly at room temperature, Umax (chloroform film)/ cm 'l 
2924, 1198, 1119, 1023, 881 and 694; 8h  (270 MHz, CDCI3) 1.17-1.23 (11 H, m, 
CHC/ / 3  and 0 /2 ) ,  1.51 (3 H, d, J 7.1, CHC//3), 1.61-1.98 (8  H, m, C //2), 2.25- 
2.51 (12 H, m, NMe), 2.61-2.64 (4 H, m, CH), 3.60 (1H, dd, J 15.5 and 10.5, C //2), 
3.90 (1 H, d, J 10.5, 0 /2 ) ,  3.94 (1 H, d, J 2.7, C //2), 4.03 (1 H, dd, J 15.5 and 12.4, 
CH2 ), 4.77 (1H, dq, J 12.8 and 6 .6 , C//CH3 ), 5.04 (1 H, dq, J 10.5 and 7.1, 
C//CH 3), 7.01-7.36 (20 H, m, aryl H); m/z (Cl) 398 (M++1, 100%), 292 (35), 187 
(22), 91 (61).
R. R- l .  3-dimethvl-4. 5-tetramethvlene-2-(N. N -dim ethvlam ido)-l. 3. 2- 
diazaphosphorine 2-oxide (82).
This compound was prepared according to the above procedure using R, R- 
(-)-4, 5-tetramethylene-2-(N, N-dimethylamido)-l, 3, 2-diazaphosphorine-2-oxide 
(81) (100 mg, 0.49 mmol), w-butyllithium (1.5 M hexane solution, 0.8 cm^, 1.23 
mmol) and methyl iodide (0.08 cm3, 1.23 mmol) in anhydrous THF (3 cm3). 
Triamide (82) was isolated as a viscous oil which solidified on standing (66  mg, 
58%), m. p. 55-58 °C; [a]J?= -58.4 (c 1.22, chloroform); Umax (nujol)/ c m 'l 2932, 
1445, 1291, 1252, 1215, 1181, 1119, 1061, 986, 891 and 806; 8h  (270 MHz, 
CDCI3) 1.05-1.25 (4 H, m, 0 /2 ) ,  1.71-1.74 (2 H, m, C //2 ), 1.84-1.92 (2 H, m, 
0 / 2 ) ,  2.33 (3 H, d, J 11.5, NMe), 2.39 (3 H, d, J 10.6, NMe), 2.46-2.55 (1 H, m, 
O f) , 2.57-2.59 (7 H, d overlapping m, J 9.3, N(Me)2  and CH); 8 c  (100 MHz, 
CDCI3) 24.4 (t), 24.5 (t), 28.3 (q), 28.5 (dt, Jpc 10.9), 28.8 (dt, Jpc 9.1), 29.1 (q),
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36.9 (dq, Jpc 3.7), 63.3 (dd, Jpc 9.1), 65.5 (dd, Jpc 9.1); 8p (162 MHz, CDCI3)
31.0 (1 P, s); m/z (El) 231 (M+, 90%), 188 (100), 141 (64), 110 (31), 75 (22), 42 
(49); (found [M+H]+, 232.1571. C 10H23N3OP requires m/z, 232.1579).
Preparation of Triamide Catalysts bv Reaction of a Diamine with N. N- 
Dimethylphosphoramido Dichloridate.
General procedure:
The following procedure is typical.
R. R-(-)-4. 5-tetramethvlene-2-(N. N-dimethvlamido)-l. 3. 2-diazanhosnhorine-2- 
oxide (81).
To a stirred solution of R, R-(-)-cyclohexane-l, 2-diamine (562 mg, 4.93 
mmol) and triethylamine (1.37 cm^, 9.86 mmol) in DCM (20 cm^) at 0 °C  was 
added N, N-dimethylphosphoramido dichloridate (0.58 cm^, 4.93 mmol) dropwise. 
The resulting mixture was allowed to warm to room temperature and stirred for 3 
hours. It was then poured into saturated aqueous ammonium chloride solution (10 
cm 3) and extracted with DCM ( 3 x 5  cm^). The combined extracts were dried 
(magnesium sulfate) and concentrated in vacuo. The residue was purified on silica 
eluting with 0.—>5% v/v methanol- DCM to afford triamide (31) as a white solid 
which was further purified by recrystallisation from ethyl acetate (400 mg, 40%), 
m.p. 188-190 °C; (found C, 47.3; H, 9.2; N, 20.6. C8H 18N3OP requires C, 47.29; 
H, 8.87; N, 20.69%); [a ]J |=  -30 (c 1.05, chloroform); 'Umax (nujol)/ cm-l 3228, 
1319,1309,1206,1168,1118,1074,998 and 891; 5h (270 MHz, CDCI3) 1.32-1.43 
(4 H, m, CH2 X 1.73 (2 H, br m, 0/2), 1.86 (2 H, br m, C //2), 2.4 (1 H, br s, NH),
2.48 (1 H, br s, NH), 2.69 (6 H, d, J 10.3, NMe), 2.91 (1 H, bt t, J 10, C//), 3.12 (1 
H, br t, J 10.4, CH); 5c (100 MHz, CDCI3) 24.5 (t), 24.6 (t), 31.3 (dt, Jpc 11), 31.4 
(dt, J 12.8), 37.1 (q), 60.3 (dd, Jpc 9.1), 62.1 (dd, Jpc 5.5); 5p (162 MHz, CDCI3)
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29.9 (1 P, s); mlz (El) 203 (M+, 100%), 160 (46), 44 (24).
Preparation ofR.  R -l. 3-dimethvl-4.5-tetramethvlene-2-(N. N-dimethvlamido)-L 3.
2 -diazaphosphorine 2 -oxide (82).
This compound was prepared according to the above general procedure 
using R, R-(-)-N, N ’-Dimethylcyclohexane-l, 2-diamine (73) (prepared as described 
above, 500 mg, 3.52 mmol), triethylamine (1.0 cm^, 7.04 mmol) and N, N- 
dimethylphosphoramido dichloridate (0.42 cm^, 3.52 mmol) in DCM (20 cm^). 
Triamide (82) was isolated as a viscous oil which solidified on standing (308 mg, 
38%). The data for this compound is given above.
3-(Dimeth\lamino)-l. 2. 5. 6 . 7. 7a-hexahvdro-2-phen\lpvrrolof 1. 2-cJf l .  2. 
31diazaphosphole-3-oxide (8 8 ) and (89).
These compounds were prepared according to the above general procedure 
using (S)-2-(anilinomethyl)pyrrolidine (200 mg, 1.14 mmol), triethylamine (0.32 
cm3, 2.28 mmol) and N, N-dimethylphosphoramido dichloridate (0.15 cm^, 1.2 
mmol) in DCM (15 cm^). This afforded a 1.4:1 mixture of diastereomeric 
triamides (8 8 ) and (89) (266 mg, 88%) which were readily separable by flash 
chromatography, eluting with ethyl acetate. The absolute configuration at 
phosphorus was assigned by comparison with literature data
3S. 7aS diastereoisomer(8 8 ) isolated as white needles (108 mg, 36%), m. p. 99-101 
°C (from cyclohexane) (lit.,7 5a 100 °C); Rf 0.42 (ethyl acetate); [a] ^  = -20.5 (c
1.08, acetone) (lit.,75a [a ]g>= -25.5 (c 1, acetone) ); 8r  (270 MHz, CDCI3 ) 1.67-
2.04 (4 H, m, CH2 ), 2.63 (6 H, d, J 10.4, NMe), 2.85-2.99 (1 H, m, 0 /2 ) ,  3.35-3.41 
(1 H, m, 0 /2 ) ,  3.62-3.84 (3 H, m, 7a-OZ and 0 /2 ) ,  6.93 (1 H, t, J 7.3, aryl H), 
7.03-7.07 (2 H, m, aryl H), 7.24-7.29 (2 H, m, aiyl H); 5 c  (68 MHz, CDCI3) 26.0
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(dt, Jpc 2 .2), 32.1 (t), 36.2 (dq, Jpc 4.4), 45.2 (dt, Jpc 2 .2), 49.0 (dt, Jpc 16.5),
57.9 (dd, Jpc 7.7), 115.7 (dd, Jpc 5.5), 120.6 (d), 128.9 (d), 142.0 (d, Jpc 5.5); m/z 
(El) 265 (M+, 100%), 221 (13), 160 (50), 117 (53), 105 (44), 70 (95), 43 (28).
3R. 7aS diastereoisomer (89) isolated as white needles (158 mg, 52%), m. p. 146- 
149 °C (from cyclohexane/ ethyl acetate) (lit.,75a 150 °C); Rf 0.15 (ethyl acetate); 
[ a ] J =  +85.3 (c 0.98, acetone) (lit.,25a [a]g*= +86  (c 1, acetone)); 8h  (270 MHz, 
CDCI3) 1.61-1.68 (1 H, m, C //2), 1.96-2.18 (3 H, m, 0 /2 ) ,  2.62 (6 H, d, J 10.1, 
NMe), 3.11-3.32 (3 H, m, C //2 ), 3.67-3.77 (1 H, m, 0 /2 ) ,  4.01-4.08 (1 H, m, 7a- 
C//), 6.92 ( l H , t , J  7.3, aryl H), 7.04-7.21 (2 H, m, aryl H), 7.24-7.28 (2 H, m, aryl 
H); 5 c  (68 MHz, CDCI3 ) 27.3 (dt, Jpc 5.5), 31.6 (dt, Jpc 4.4), 36.7 (q), 43.5 (dt, 
JPC 4.3), 52.3 (dt, Jpc 12 .1), 56.4 (dd, Jpc 8.7), 114.8 (dd, Jpc 4.4), 120.8 (d),
129.0 (d), 142.6 (d, Jpc 6 .6); m/z (El) 265 (M+, 100%), 221 (14), 160 (48), 149 
(20), 117 (55), 70 (100), 43 (68 ).
Preparation o f 2-chloro-l. 3-dimethyl-1. 3 .2-diazaphospholane.
This compound was prepared by a literature procedure.69,70 j 0 a stirred 
solution of N, N ’-dimethylethylenediamine (5.0 g, 56.8 mmol) and triethylamine 
(15.8 cm^, 113.6 mmol) in anhydrous diethyl ether (100 cm^) at -78 °C was added 
phosphorus trichloride (5.0 cm^, 56.8 mmol) dropwise over 10 minutes. The 
mixture was warmed to room temperature and stirred for 2 hours. The amine 
hydrochloride precipitate was filtered off and the solids washed with anhydrous 
diethyl ether (3 x 30 cm^). The combined washings were then concentrated in 
vacuo to afford the chloride as a pale yellow oil which was purified by distillation 
under reduced pressure (6.95 g, 80%), b. p. 78-82 °C (0.5 mmHg) (lit.,69 70 °C, 0.2 
mmHg); 5 r  (270 MHz, CDCI3) 2.72 (6 H, d, J 14.6, NMe), 3.31 (4 H, m, C//2).
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Attempted Preparation of Triaminophosphines bv Reaction of 2-chloro-l. 3- 
dimethvl-1. 3. 2-riiazanhosnholane with Hindered Secondary Amines (Scheme 
30).
The following sequence was attempted using both 2, 2, 6 , 6 - 
tetramethylpiperidine and diisopropylamine and is based on a literature
procedure. 69
To a stirred solution of 2-chloro-l, 3-dimethyl-1, 3 ,2-diazaphospholane (6.0 
g, 39.2 mmol) in diethyl ether (100 cm^) at -78 °C  was added the amine (2 
equivalents, 78.4 mmol) dropwise over 10 minutes. The resulting mixture was 
warmed slowly to room temperature and stirred for 2 hours. The amine 
hydrochloride precipitate was filtered off and the solids washed with diethyl ether ( 
3 x 30 cm^). The combined washings were then concentrated in vacuo. The 
residue was a dark brown oil. NMR analysis of the crude product indicated mainly 
decomposition products with none of the reqiured triaminophosphine being present.
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Section 4.6 Improved Ketone Binding.
4.6.1 Amino Alcohol Derived Phosnhinamides.
General Procedure:
The following procedure is typical.
Preparation o f N-diohenvlohosohinvl protected norephedrine (93).
To a stirred solution of 1R, 2S-(-)-norephedrine (1.62 g, 10.7 mmol) and 
triethylamine (2.23 cm^, 16.05 mmol) in DCM (20 cm^) at 0 °C  was added 
diphenylphosphinic chloride (2.04 cm^, 10.7 mmol) dropwise over 5 minutes. The 
mixture was stirred at 0 °C for 1 hour then warmed to room temperature and stirred 
for a further 6 hours. It was then poured into saturated aqueous ammonium chloride 
solution (10 cm^) and extracted with DCM (3 x 10 cm^). The combined extracts 
were washed with saturated aqueous brine (10 cm^), dried (magnesium sulfate) and 
concentrated in vacuo. The residue was recrystallised from DCM/ hexane to afford 
phosphinamide (93) as white needles (3.42 g, 91%), m. p. 138-140 °C; (found C, 
71.5; H, 6.3; N, 3.9. C21H2 2 NO2P requires C, 71.79; H, 6.27; N, 3.99%); [a ]g =  
-58.3 (c 1.07, chloroform); v m3x (nujol)/cm ' 1 3200,1167, 9714,751,724 and 697; 
8r  (270 MHz, CDCI3) 1.01 (3 H, d, J 6 .8 , CHCH3), 3.11-3.16 (1 H, m, NH), 3.37- 
3.39 (1 H, m, C//CH3), 4.75 (1 H, br s, C//Ph), 5.87 (1 H, br s, OH), 7.12-7.46 (11 
H, m, aryl H), 7.71-7.88 (4 H, m, aryl H); 5c (100 MHz, CDCI3) 17.7 (dq, Jpc
7 .3), 53.8 (d), 76.7 (dd, Jpc 5.5), 126.7, 126.9, 127.8, 128.4, 128.5, 128.6, 131.5,
131.6, 131.9, 132.4,132.5, 141.1 (s); 5p (162 MHz, CDCI3) 25.2 (1 P, s); m/z (Cl) 
352 (M++1, 100%), 334 (29), 245 (37), 201 (20), 134 (22), 107 (10); (found 
[M+H]+, 352.1473. C21H2 3NO2P requires m/z, 352.1466).
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N-diphenvlphosphinvl protected ephedrine (94).
This compound was prepared according to the above general procedure 
using 1R, 2S-ephedrine (1.77 g, 10.7 mmol). Chromatography on silica, eluting 
with 0—>5% v/v methanol- DCM afforded phosphinamide (94) as a white solid 
(1.17 g, 30%), m. p. 190-191 °C (from ethyl acetate); (found C, 72.1; H, 6.6; N, 3.8. 
C22H2 4 N O 2 P requires C, 72.33; H, 6.58; N, 3.84%); [a]g>= -2.7 (c 0.74, 
chloroform); \)max (nujol)/ c n r 1 3300,2850,1601,1502,1438„1121,995,753,727 
and 696; S h  (270 MHz, CDCI3 ) 1.31 (3 H, d, J 7, CHC//3 ), 2.43 (3 H, d, J 10.8, 
NMe), 3.67 (1 H, m, CHCH3), 4.71 (1 H, br s, OH), 4.84-4.86 (1 H, m, CtfPh), 
7.39-7.67 (15 H, m, aryl H); 8c  (100 MHz, CDCI3) 13.6 (q), 31.0 (q), 58.0 (d), 76.7 
(dd, Jpc 18.3), 126.5, 127.2, 128.0,128.4,128.5,128.6,130.7 (s), 131.1 (s), 131.8,
132.1,132.2, 132.3, 132.35, 132.4, 142.6 (s); 5p (162 MHz, CDCI3) 34.3 (1 P, s); 
m/z (Cl) 366 (M ++1,100%), 348 (61), 258 (82), 203 (67), 148 (38), 107 (67).
N-dmhemlphosphinvl protected valinol(92).
This compound was prepared according to the above general procedure 
using S-valinol (1.0 g, 9.71 mmol), triethylamine (2.03 cm^, 14.57 mmol) and 
diphenylphosphinic chloride (1.85 cm^, 9.71 mmol) in DCM (25 cm ^). 
Chromatography on silica, eluting with 0—>10% v/v methanol- DCM afforded 
phosphinamide (92) as a white solid (2.21 g, 75%), m. p. 135-137 °C (from diethyl 
ether); (found C, 67.2; H, 7.3; N, 4.3. C 17H22NO2P requires C, 67.31; H, 7.31; N, 
4.62%); [a] 2/ = -40.5 (c i ,  methanol); Umax (nujol)/ cm- 1 3260, 1380, 1172, 725 
and 691; 5 h  (400 MHz, CDCI3) 0.94 (3 H, d, J 6.7, (C//3)2 CH), 0.96 (3 H, d, J 7, 
(0 / 3)2 CH), 1.81 (1 H, sep, J 6.7, (CH3)2C//), 2.81-2.84 (1H, m, CH), 3.02 (1 H, br 
dd, J 11.3 and 3.4, NH), 3.52 (1 H, dd, J 11.9 and 8 , C //2 ), 3.69 (1 H, br d, J 11, 
CH2 \  5.16 (1 H, br s, OH), 7.27-7.52 (6 H, m, aryl H), 7.77-7.96 (4 H, m, aryl H); 
5c (100 MHz, CDCI3) 18.5 (q), 19.8 (q), 31.2 (dd, Jpc 10.9), 60.8 (d), 66.1 (t),
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128.3, 128.5, 128.6, 128.7, 129.9 (s), 131.2 (s), 131.7, 131.8, 131.9, 132.2, 132.8, 
132.9; 8p (162 MHz, CDCI3 ) 26.3 (1 P, s); m/z (CD 304 (M++1, 100%), 286 (5), 
272 (16), 201 (11) 85(9).
N-diphenvlphosphinvl protected vrolinol(95).
This compound was prepared according to the above general procedure 
using S-prolinol (0.42 cm^, 4.16 mmol), triethylamine (0.87 cm^, 6.24 mmol) and 
diphenylphosphinic chloride (0.81 cm ^, 4.16 mmol) in DCM (20 cm ^). 
Chromatography on silica, eluting with 0—>10% v/v methanol- DCM afforded 
phosphinamide (95) as a viscous oil which solidified on standing (1.01 g, 81%), m. 
p. 98-99 °C (from DCM/ hexane);(found C, 67.5; H, 6.7; N, 4.6. C17H20NO2P 
requires C, 67.77; H, 6.64; N, 4.65%); [a ]^ =  +48.2 (c 1.06, chloroform); t>max 
(nujol)/ cm-1 3325, 1723, 1592, 1521, 1439, 1212, 1123, 774 and 669; 5h  (270 
MHz, CDCI3) 1.60-2.05 (4 H, m, C //2), 2.99-3.07 (2 H, m, C //2 ), 3.34-3.46 (2 H, 
m, C//2), 3.63-3.65 (1 H, m, CH), 4.92 (1 H, br m, OH), 7.2-7.84 (10 H, m, aryl H); 
6c (100 MHz, CDCI3) 25.1 (dt, Jpc 12.8), 29.3 (dt, Jpc 7.3), 48.3 (dt, Jpc 3.7),
61.3 (d), 65.2 (t), 128.3, 128.4, 128.5, 128.6, 131.35, 131.4, 131.6, 131.8, 131.9,
132.2, 132.25, 132.3; 5p (162 MHz, CDCI3 ) 27.5 (1 P, s); m/z (FAB) 302 (M++1, 
63%), 270 (15), 201 (34), 167 (15), 149 (100), 113 (19); (found [M+H]+, 302.1316. 
C17H21NO2P requires m/z, 302.1310).
N-diphenvlphosphinvl protected 2-amino-1 -phenvlethanol (147).
This compound was prepared according to the above general method using 
2-amino-1-phenylethanol (1.0 g, 7.3 mmol), triethylamine (1.52 cm^, 10.95 mmol) 
and diphenylphosphinic chloride (1.39 cm^, 7.3 mmol) in DCM (20 cm^). 
Phosphinamide (147) was obtained as a white solid (2.18 g, 89%), m. p. 159-161 °C 
(from DCM/ hexane); (found C, 70.7; H, 6.0; N, 4.1. C20H2 0NO2P requires C
4 Experimental. Page 159.
71.21; H, 5.98; N, 4.15%); Umax (nujol)/cm"1 3266,3168,1169,1119,1068,921, 
871,725 and 694; 5 h  (270 MHz, CDCI3) 3.09-3.81 (2  H, m, C //2), 3.82 (1 H, br d, 
J 6 .8 , NH), 4.88 (1 H, dd, J 7.5 and 3, CHPh), 7.22-7.46 (12 H, m, aryl and OH), 
7.75-7.83 (4 H, m, aiyl H); 5c (100 MHz, DMSO-d6) 55.0 (t), 73.2 (dd, Jpc 7.3),
126.2, 127.1, 128.0, 128.5, 128.6, 131.6, 131.65, 131.8, 131.85, 131.9, 132.6 (d, 
JpC 20), 134.0 (d, Jpc 20), 143.4 (s); 8p (162 MHz, CDCI3) 23.4 (1 P, s); mlz (Cl) 
338 (M ++1,22%), 320 (22), 231 (93), 202 (100), 155 (21), 107 (25), 77 (49).
Preparation o f t-BDPS-nrotected phosphinamide (96).
To a stirred solution of alcohol (95) (200 mg, 0.66 mmol) and imidazole (68 
mg, 1 mmol) in DMF (1.5 cm3) was added r-butyldiphenylsilyl chloride (0.16 cm^, 
0.62 mmol). The pale yellow solution was stirred at room temperature for 18 hours. 
It was then poured into saturated aqueous ammonium chloride solution (1 cm^) and 
extracted with ethyl acetate ( 3 x 2  cm^). The combined extracts were washed with 
water ( 2 x 2  cm3) then dried (magnesium sulfate) and concentrated in vacuo. The 
residue was purified on silica eluting with 0—>70% v/v ethyl acetate- petrol to afford 
silyl protected phosphinamide (96) as a colourless oil which solidified on standing 
(260 mg, 78%), m. p. 101-102 °C (from diethyl ether); [ a ] ]J=  -5.8 (c 1.04, 
chloroform); Umax (nujol)/ cm‘1 2964, 1520, 1472, 1438, 1112, 754, 714 and 671; 
5 h  (400 MHz, CDCI3 ) 0.72 (9 H, s, CMe3), 1.58 (2 H, m, C//2), 1.71-1.85 (2 H, m, 
C //2 ), 2.78-2.91 (1 H, m, C //2 ), 2.92-3.01 (1 H, m, C //2), 3.07 (1 H, dd, J 6.6  and 
5, CH2), 3.15 (1 H, dd, J 6.5 and 3, 0 /2 )  3.51 (1 H, m, O /) , 7.01-7.24 (14 H, m, 
aryl H), 7.33 (2 H, dd, J 7.9 and 1.5, aryl H), 7.41-7.51 (2 H, m, aryl H), 7.56-7.62 
(2 H, m, aryl H); 5 c  (68 MHz, CDCI3) 19.1 (s), 25.2 (dt, Jpc 5.5), 26.7 (q), 29.0 
(dt, Jpc 4 .4 ), 47.8  (t), 59.1 (d), 65.7 (dt, Jpc 4 .4 ), 127.5, 128.0 , 128.3, 128.45,
128.5, 129.5, 131.4, 131.5, 132.0, 132.1, 132.3, 132.4, 133.3 (s), 133.4 (s), 133.5 
(s), 135.3,135.5; 5p (162 MHz, CDCI3) 27.0 (1 P, s); m/z (FAB) 540 (M++1, 50%), 
482 (31), 462 (100), 270 (42), 201 (95), 135 (30); (found [M+H]+, 540.2496.
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C33H39N0 2 SiP requires m/z, 540.2488).
Reduction Procedure Using Amino Alcohol Derived Phosphinamides.
The general procedure described in Section 4.1 was employed for 
examination of these catalyst systems. The precomplexation studies were carried 
out using the norephedrine derived phosphinamide (93) as described below.
To a stirred solution of phosphinamide (93) (2 mol%, 0.05 mmol, 17.6 mg) 
in THF (2.5 cm^) was added BMS (10 M dimethyl sulfide complex, 5.5 pi, 0.055 
mmol) dropwise. Vigorous effervescence was observed. The mixture was stirred at 
room temperature for 8 hours. Acetophenone (0.3 cm^, 2.57 mmol) was then 
added, followed by BMS (10 M, dimethyl sulfide complex, 0.15 cm^, 1.54 mmol). 
The solution was then stirred at room temperature for 2.5 hours. The reaction 
mixture was then worked up and the alcohol isolated and purified as described in 
Section 4.1. 1-Phenylethanol was obtained as a colourless oil (235 mg, 75%), 
[ a ] ^  -4.7 (c 1, methanol), 11% e.e. (S).40; 8h  (270 MHz, CDCI3 ) 1.47 (3 H, d, J 
6 , CHCH3), 2.15 (1 H, br s, OH), 4.85 (1 H, q, J 6.4, C//CH3), 7.22-7.37 (5H, m, 
aryl H).
4.6*2 . Chiral Piols/ Phosphinamide Donors.
In Situ Generation of Boronate Esters.
General Procedure:
The following procedure is typical.
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Generation ofBoronate (98. R=Me).
To a stirred solution of R, R-(-)-butanediol (97, R=Me) (0.02 cm^, 0.22 
mmol) in THF (0.25 cm^) was added BMS (10 M dimethyl sulfide complex, 0.024 
cm3, 0.24 mmol) dropwise. Vigorous effervescence was observed. The mixture 
was then stirred at room temperature for 20 minutes. This solution was used 
immediately as described below.
Boronate (98. R=Ph).
This was generated according to the above procedure using R, R-(+)- 
dihydrobenzoin (97, R=Ph) (48 mg, 0.22 mmol). The solution was used 
immediately as described below.
Boronate (104).
This was generated according to the above procedure using L-(+)- 
diethyltartrate (46 mg, 0.22 mmol). The solution was used immediately as 
described below.
Boronate (105).
This was generated according to the above procedure using S, S-(-)- 
tetramethyl-D-tartaramide (45 mg, 0.22 mmol). The solution was used immediately 
as described below.
Boronate (102).
This was prepared according to the above procedure using R, R-(-)- 
butanediol (0 .0 2  cm^, 0 .2 2  mmol) and monochloroborane (dimethyl sulfide
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complex, 0.026 cm^, 0.26 mmol) in THF (0.25 cm^). The solution was used 
immediately as described below.
Diamine/ Borane Complex (106).
This was prepared according to the above procedure using S, S-(-)-N, N’- 
dimethyl-1, 2-diphenylethylene-l, 2-diamine (prepared as described in Section 4.5) 
(50 mg, 0.22 mmol). The solution was used immediately as described below.
Preparation ofBoronate (103).
This preparation was based on a literature procedure.83’ 116 t 0 a stirred 
solution of R, R-(+)-hydrobenzoin (97, R=Ph) (40 mg, 0.19 mmol) in pentane (1.5 
cm^) was added butylboronic acid (18 mg, 0.19 mmol). The solution was stirred at 
room temperature for 5 minutes. Solid sodium sulfate was then added (ca. 0.5 g) 
and the mixture filtered. The filtrate was concentrated in vacuo to give boronate 
(103) as a colourless oil which solidified on standing (51 mg, 95%), 6h  (270 MHz, 
CDCI3 ) 0.95 (3 H, t, J 7.1, C //3 ), 136-1.61 (6  H, m, C#2), 5.15 (2 H, s, C//Ph),
7.26-7.42 (10 H, m, aryl H). The crude product was used immediately without 
further purification.
Reduction Catalysed by Boronate Complexes in Combination with 
Phosphinamide (29).
The following is a typical procedure. Reaction times, yields and selectivities 
obtained with the above boronate complexes are described in the text (Section 
2.6.2).
To a solution of boronate ester (98, R=Me), prepared as described above 
(0.22 mmol in THF), was added phosphinamide (29) (70 mg, 0.22 mmol)
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portionwise under a rapid stream of nitrogen. Acetophenone (0.26 cm^, 2.2 mmol) 
was then added followed by BMS (10 M dimethyl sulfide complex, 0.13 cm^, 1.32 
mmol) dropwise. The resulting solution was stirred at room temperature for 90 
minutes. The reaction mixture was then worked up and the alcohol isolated and 
purified as described in Section 4.1. 1-Phenylethanol was obtained as a colourless 
oil (239 mg, 89%), [ a ]g =  -20.2 (c 1, methanol), 47% e.e. (S).40; 8h  (270 MHz, 
CDCI3 ) 1.47 (3 H, d, J 6 , C H C //3 ), 2.15 (1 H, br s, OH), 4.85 (1 H, q, J 6.4, 
C//CH3), 7.22-7.37 (5H, m, aryl H).
Reduction Catalysed bv Boronates (98. R=Ph) and (98. R=Me).
The following is a typical procedure. Reaction times, yields and selectivities 
are described in the text (Section 2.6.2).
To a solution of boronate ester (98, R=Ph), prepared as described above 
(0.22 mmol in THF), was added acetophenone (0.026 cm^, 0.22 mmol) followed by 
BMS (10 M, dimethyl sulfide complex, 0.013 cm^, 0.13 mmol) dropwise. The 
resulting solution was stirred at room temperature for 3 hours. The reaction mixture 
was then worked up and the alcohol isolated and purified as described in Section
4.1. 1-Phenylethanol was obtained as a colourless oil (24 mg, 90%), [a]g)= -18.1 (c 
1, methanol); 8h  (270 MHz, CDCI3) 1.47 (3 H, d, J 6 , CHC//3 ), 2.15 (1 H, br s, 
OH), 4.85 (1 H, q, J 6.4, C//CH3), 7.22-7.37 (5H, m, aryl H).
Preparation ofN-benzvldiphenvlphosphinamide (101).
To a stirred solution of benzylamine (0.46 cm^, 4.2 mmol) and triethylamine 
(1.17 cm^, 8.4 mmol) in DCM (20 cm^) at 0°C was added diphenylphosphinic 
chloride (0.81 cm^, 4.2 mmol) dropwise. The resulting mixture was warmed to 
room temperature and stirred overnight. It was then poured into an equal volume of 
saturated aqueous ammonium chloride solution and extracted with DCM (3 x 10
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cm^). The combined extracts were then dried (magnesium sulfate) and concentrated 
in vacuo. The residue was purified on silica eluting with 0—>10% v/v methanol- 
DCM to afford phosphinamide (101) as a white solid (1.18 g, 91%), m. p. 102-104 
°C  (from DCM/ petrol); (found C, 74.1; H, 5.9; N, 4.6. C19H 18NOP requires C, 
74.27; H, 5.86; N, 4.56%); x>max (nu jo iycn r1 3200,1589,1178,1125,1063,1026, 
997,909,859,726 and 699; 8h  (270 MHz, CDCI3 ) 3.31 (1 H, br d, J 5.6, NH), 4.11 
(2 H, t, J 7.5, 0 /2 ) ,  7.24-7.52 (11 H, m, aryl H), 7.89-7.97 (4 H, m, aryl H); 5 c  
(100 MHz, CDCI3) 44.3 (t), 127.0, 128.1, 128.2, 128.3, 131.5, 131.8, 131.9, 132,7 
(s), 139.5 (d, J p c  7.3); 8 p (162 MHZ, CDCI3) 23.6 (1 P, s); 1nil (Cl) 308 (M++1, 
92%), 233 (38), 203 (63), 148 (45), 106 (100), 91 (77), 77 (35).
4.6.3 Phosphinamide/ Dio! as a Single Molecular Entity.
4.6.3.1 Preparation of Phosphinamide Diols bv Asymmetric Dihvdroxvlation.
Preparation of Alkenes.
General Procedure:
The following procedure is typical.
Preparation o f Phosphinamide alkene (109).
To a stirred solution of phosphinamide (29) (1.0 g, 3.11 mmol) in anhydrous 
THF (45 cm^) at 0 °C  was added n-butyllithium (2.38 M hexane solution, 1.57 
cm^, 3.73 mmol) dropwise over 5 minutes. The resulting pale yellow solution was 
warmed to room temperature and stirred for 1 hour. Allyl bromide (0.29 cm^, 3.42 
mmol) was added and the mixture stirred for 18 hours. It was then poured into 
saturated aqueous ammonium chloride solution (20 cm^) and extracted with DCM 
(3 x 10 cm^). The combined extracts were then dried (magnesium sulfate) and
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concentrated in vacuo. The residue was purified on silica eluting with 0—>50% v/v 
ethyl acetate- petrol to afford alkene (109) as a white solid (882 mg, 79%), m. p. 88 - 
90 °C  (from DCM/ hexane); (found C, 76.2; H, 6.75; N, 3.9. C23H24NOP requires 
C, 76.45; H, 6.65; N, 3.88%); [a]k8= +41.0 (c 1.53, chloroform); a)max (nujol)/ cm* 
1 1590,1120, 1027, 916, 732 and 698; 8h  (270 MHz, CDCI3 ) 1.62 (3 H, d, J 7.1, 
CHC//3), 3.26-3.41 (1 H, m, C//2 ), 3.49-3.53 (1 H, m, 0 /2 ) ,  4.59 (1 H, dd, J 17.2 
and 2.7, alkene CH), 4.73-4.77 (2 H, m, alkene CH), 5.61 (1 H, m, O /C H 3), 7.22- 
7.47 (11 H, m, aryl H), 7.88-7.97 (4 H, m, aryl H); 8c  (68 MHz, CDCI3) 19.4 (dq, 
JPC 3.3), 46.4 (dt, Jpc  3.3), 54 .4  (dd, J p c  4 .4), 115.8 (t), 121 .1, 128.1, 128 .2 ,
128.4, 131.6,132.4,132.45, 132.6, 133.2 (s), 133.3 (s), 137.6, 137.7, 141.2 (d, Jpc 
4.4); 8p (162 MHz, CDCI3 ) 31.3 (1 P, s); ml2 (Cl) 362 (M++1, 100%), 346 (16), 
320 (88), 256 (40), 201 (66 ), 160 (25), 105 (33), 77 (22).
Phosphinamide Alkene (111).
This compound was prepared according to the above general procedure 
using phosphinamide (29) (275 mg, 0-86 mmol), fi-butyllithium (2.38 M, 0.43 cm^,
1.03 mmol) and cinnamyl bromide (0.14 cm^, 0.94 mmol) in anhydrous THF (15 
cm3). Alkene (111) was isolated as a white solid (326 mg, 87%), m. p. 98-100 °C 
(from DCM/ hexane); (found C, 79.3; H, 6.5; N, 3.2. C2 9 H 2 8NOP requires C, 
79.63; H, 6.41; N, 3.20%); [a]J,8= -»6.3 (c 0.51, chloroform); Dmax (nujol)/ cm ' 1 
1588,1206,1137,1117,1101,1067, 969, 898,727 and 699; 8h  (270 MHz, CDCI3)
1.64 (3 H, d, J 7, CHC//3), 3.52 (1 H, ddd, J 16.3,11 and 6 .6 , C //2), 3.69 (1 H, ddd, 
J 16, 10.8 and 5, C //2 ), 4.79 (1 H, dq, J 10 and 7.5, C//CH 3), 5.73-5.83 (2 H, m, 
alkene CH), 7.08-7.51 (16 H, m, aryl H), 7.91-8.01 (4 H, m, aryl H); 5 c  (68 MHz, 
CDCI3) 19.3 (q), 45.9 (dt, Jpc  4.3), 54.2 (dd, Jpc  4.4), 126.2,127.25, 127.3,128.3, 
128.4,128.5, 128.6, 128.9,131.0, 131.7, 131.75, 132.5,132.7, 133.5 (s), 136.8 (s),
141.4 (d, Jpc  4.3); 5p (162 MHz, CDCI3 ) 31.3 (1 P, s); m/z (El) 437 (M+, 42%), 
422 (31), 332 (100), 201 (79), 117 (32), 77 (31).
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Phosphinamide Alkene (112).
This compound was prepared according to the above general procedure 
using phosphinamide (29) (300 mg, 0.93 mmol), /i-butyllithium (2.38 M hexane 
solution, 0.47 cm^, 1.12 mmol) and prenyl bromide (0.12 cm^, 1.03 mmol) in 
anhydrous THF (15 cm^). Alkene (112) was obtained as a white solid (268 mg, 
74%), m. p. 50-52 °C  (from DCM/ hexane); (found C, 76.9; H, 7.2; N, 3.6. 
C2 5H2 8 NOP requires C, 77.12; H, 7.20; N, 3.60%); [a]g=  +24.1 (c 1.05, 
chloroform); t)max (nujol)/cnr* 1312, 1170, 1119, 1071, 996, 973, 895, 751, 725 
and 698; 5 h  (270 MHz, CDCI3) 1.04 (3 H, s, C //3), 1.47 (3 H, s, C //3), 1.62 (3 H, 
d, J 7.2, CHC//3), 3.31-3.53 (2 H, m, C//2), 4.71 (1 H, dq, J 10.2 and 7.2, C//CH3), 
4.97 (1 H, br m, alkene CH)t 7.21-7.54 (11 H, m, aryl H), 7.93-8.0 (4 H, m, aryl H); 
5 c  (68  MHz, CDCI3) 17.1 (q), 19.2 (dq, Jp c  3.25), 25.5 (q), 41.4 (dt, Jp c  3.3),
54.2 (dd, Jpc  3.3), 60.3 (s), 124.0, 124.1, 126.95, 128.05, 128.1, 128.2, 128.3,
131.4, 132.4,132.5,132.6, 132.65, 133.5 (s), 133.6 (s), 141.5 (d, Jpc  4.4); 5p (162 
MHz, CDCI3) 31.1 (1 P, s); m/z (El) 389 (M+, 37%), 320 (10), 284 (45), 201 (50), 
151 (32), 133 (42), 42 (100).
Oxidation of Alkenes.
General Procedure;
The following procedure is typical.
Preparation o f Piaster eomerically Enriched Phosphinamide Diol ent. (127).
To a rapidly stirred solution of AD-mix-p88,89 ^ g g  mg^ potassium 
osmate(VI) dihydrate (ca. 2 mg) and methanesulfonamide (26 mg, 0.28 mmol) in 
1:1 r-butanol/ water (1.4 cm^ of each) at 0 °C  was added alkene (109) (100 mg,
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0.28 mmol). The mixture was stirred for 5 hours at 0 °C, by which time all of the 
alkene had been consumed (by TLC). Sodium metabisulfite (450 mg) was then 
added with vigorous stirring and the mixture warmed slowly to room temperature. 
The mixture was then diluted with ethyl acetate (5 cm^) and the aqueous phase 
extracted with ethyl acetate (4 x 2  cm^). The combined extracts were washed with 
1 M aqueous sodium hydroxide solution (5 cm^), dried (magnesium sulfate) and 
concentrated in vacuo. The residue was purified on silica eluting with 0—>10% v/v 
methanol- DCM to afford the phosphinamide diol as a white foam (99 mg, 91%). 
This consisted of an inseparable 1.7:1 mixture of R, R- and R, S-diastereoisomers 
(as assessed by *H and 31p NMR) with the R, R-diastereoisomer being in excess. 
The diol configuration was assigned by comparison of NMR data with a pure 
sample of the corresponding R, S-diastereoisomer prepared by a different route (see 
below).
R. R-diastereoisomer: 5 h  (270 MHz, CDCI3) 1.65 (3 H, d, J 7, CHC//3), 2.81 (1 H, 
br s, OH), 2.82-3.17 (3 H, m, C //2), 3.19-3.31 (2 H, m, C/ / 2  and C//OH), 4.56-4.62 
(1 H, m, CHCH3), 5.47 (1 H, br s, OH), 7.01-7.64 (11 H, m, aryl H), 7.92-8.02 (4 
H, m, aryl H); 8p (162 MHz, CDCI3) 34.6 (1 P, s); R. S-diastereoisomer: 8h  (270 
MHz, CDCI3) 1.57 (3 H, d, J 7, CHC//3), 2.64 (1 H, br m, OH), 2.98-3.09 (2 H, m, 
C //2 ), 3.25-3.42 (2 H, m, Cf/2). 3.63-3.71 (1 H, m, C//OH), 4.45 (1 H, m, 
C//CH3), 5.41 (1 H, br m, OH), 7.25-7.55 (11 H, m, aryl H), 7.78-7.91 (4 H, m, aryl 
H); 8p (162 MHz, CDCI3) 35.7 (1 P, s).
Full data for pure samples of the R, S-diastereoisomer (107) and the 
enantiomer of the R, R-diastereoisomer (i.e. S, S-phosphinamide diol (1 2 7 )) 
prepared by a different route is given below.
Oxidation of alkene (109) with AD-mix-a.
Repeating the above reaction using AD-mix-a88,89 (308 mg), potassium 
osmate(VI) dihydrate (ca. 2 mg), methanesulfonamide (21 mg, 0.22 mmol) and
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alkene (109) (80 mg, 0.22 mmol) in 1:1 /-butanol/ water (1 cm^ of each) gave a 
mixture of phosphinamide diols (62 mg, 72%) in an identical ratio to that obtained 
with AD-mix-p (1.7:1), with the R, R-diastereoisomer again being in excess
Oxidation of alkene (109) without phthalazine ligand.
Repeating the above reaction using potassium ferricyanide (980 mg, 2.98 
mmol), potassium carbonate (411 mg, 2.98 mmol), potassium osmate(VI) dihydrate 
(ca. 4 mg), methanesulfonamide (95 mg, 1 mmol) and alkene (109) (360 mg, 1 
mmol) in 1:1 /-butanol/ water (5 cm^ of each) gave a mixture of phosphinamide 
diols (292 mg, 74%) in an identical ratio to that obtained with AD-mix- a  or P 
(1.7:1), with the R, R-diastereoisomer again being in excess.
Preparation o f a-Hvdroxv Ketones (113).
Oxidation of alkene (111) (300 mg, 0.69 mmol) according to the above 
general method using AD-mix-p88,89 (420 mg), potassium osmate(VI) dihydrate 
(ca. 2 mg) and methanesulfonamide (29 mg, 0.69 mmol) in 1:1 /-butanol/ water (1.5 
cm^ of each) gave an inseparable 1.3:1 mixture of diastereomeric a-hydroxy 
ketones (113) as a white foam (246 mg, 76%), Umax (chloroform film)/ cm"! 3319, 
3060, 2932, 1494, 1439, 1173, 1121, 909, 728 and 699; 5 r  (CDCI3 ) maior 
diastereoisomer: 1.39 (3 H, d, J 7, CHC//3), 2.96-3.11 (2 H, m, C //2), 4.05-4.09 (1 
H, m, C//OH), 4.38 (1 H, dq, J 10.4 and 7.1, C//CH3 ), 5.81 (1 H, br d, J 2.4, OH), 
7.23-7.56 (15 H, m, aryl H), 7.84-7.93 (5 H, m, aryl H); minor diastereoisomer: 1.63 
(3 H, d, J 7, CHC//3), 2.98-3.14 (1 H, m, C //2), 3.52 (1 H, ddd, J 15, 13.5 and 3, 
C //2 ), 4.30 (1 H, br d, J 10, C//OH), 4.59 (1 H, dq, J 10.2 and 7, C//CH3), 5.56 (1 
H, br d, J 2.4, OH), 7.22-7.54 (15 H, m, aryl H), 7.88-8.04 (5 H, m, aryl H); 5 c  (100 
MHz, CDCI3) major diastereoisomer: 17.6 (q), 47.0 (t), 54.8 (dd, Jpc  5.5), 75.2 (d), 
126.2-141.3 (aryl C) (ipso C=0 not observed); minor diastereoisomer: 19.3 (q), 45.8
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(dt, Jpc 3.6), 54.2 (dd, Jpc 3.6), 73.2 (d), 126.2-141.3 (aryl C) (ipso C= 0  not 
observed); 8p (162 MHz, CDCI3 ) maior diastereoisomer: 34.0 (1 P, s); minor 
diastereoisomer: 30.5 (1 P, s); mlz 470 (M++1, 90%), 408 (19), 364 (30), 334 (28), 
230 (90), 201 (84), 105 (100); (found [M+H]+, 470.1890. C29H29NO3P requires 
w/z, 470.1885).
Preparation o f Diastereomericallv Enriched Phosphinamide Diol (114).
Oxidation of alkene (112) (100 mg, 0.26 mmol) according to the above 
general procedure using AD-mix-p88,89 (350 mg)? potassium osmate(VI) dihydrate
(ca. 2 mg) and methanesulfonamide (24 mg, 0.26 mmol) in 1:1 r-butanol/ water (1.3 
cm^ of each) gave an inseparable 1.6:1 mixture of diastereomeric diols (114) as a 
viscous oil (99 mg, 91%), Dmax (film)/ cm 'l 3216, 1718, 1590, 1453, 1438, 1179, 
1122, 1027, 997, 851, 727 and 698; 8h  (270 MHz, CDCI3) maior diastereoisomer: 
0.81 (3 H, s, C //3), 0.82 (3 H, s, 0 / 3), 1.57 (3 H, d, J 6.9, CHC//3), 2.38 (1 H, br s, 
OH), 2.58 (1 H, br d, J 9.7, CH), 3.03-3.15 (1 H, m, 0 /2 ) ,  3.27 (1 H, m, 0 /2 ) ,  4.51 
(1 H, m, O /C H 3), 5.77 (1 H, br s, OH), 7.25-7.52 (11 H, m, aryl H), 7.74-7.85 (4 
H, m, aryl H); minor diastereoisomer: 0.91 (3 H, s, O / 3), 1.06 (3 H, s, O / 3 ), 1.61 
(3 H, d, J 7.1, C H O /3), 2.62 (1 H, br s, OH), 3.04-3.11 (1 H, m, O / 2 ), 3.11 (1 H, 
m, 0 /2 ) ,  3.68 (1 H, br d, J 9.5, CH), 4.47 (1 H, m, C//CH 3), 5.93 (1 H, m, OH),
7.25-7.72 (11 H, m, aryl H), 7.83-7.97 (4 H, m, aryl H); 5 c  (100 MHz, CDCI3) 
maior diastereoisomer: 17.5 (q), 24.1 (q), 25.8 (q), 46.0 (t), 55.0 (dd, Jpc 5.5), 71.3 
(s), 74.9 (d), 127.6-141.3 (aryl C); minor diastereoisomer: 20.7 (q), 23.8 (q), 26.2 
(q), 46.3 (t), 55.9 (dd, Jpc 5.5), 71.7 (s), 76.5 (d), 127.6-141.3 (aryl C); 8p  (162 
MHz, CDCI3) maior diastereoisomer: 34.6 (1 P, s); minor diastereoisomer: 36.0 (1 
P, s); mlz (Cl) 424 (M++1, 64%), 406 (14), 390 (30), 364 (38), 230 (100), 201 (75), 
105 (50); (found [M+H]+, 424.2042. C25H31NO3P requires mlz, 424.2041).
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4.6.3.2 Synthesis of Diastereomericallv Pure Phosphinamide Diols (107) and 
(130) via Ring Opening of *-BDMS Protected Glvcidol.
Preparation o f  t-BDMS protected glvcidol.
To a stirred solution of R-(+)-glycidol (1.79 cm^, 27 mmol) and 
triethylam ine (4.5 cm ^, 32.4 mmol) in DCM (40 cm^) was added t- 
butyldimethylsilyl chloride (4.48 g, 29.7 mmol) and DMAP (160 mg, 1.35 mmol). 
The cloudy solution was stirred at room temperature for 18 hours. Saturated 
aqueous ammonium chloride solution (15 cm^) was then added and the mixture 
extracted with DCM (3 x 10 cm^). The combined extracts were dried (magnesium 
sulfate) and concentrated in vacuo. The residue was purified on silica eluting with 
0—>7% v/v ethyl acetate- petrol to afford the f-BDMS protected alcohol as a 
colourless oil (3.76 g, 73%), [a]i?= +10.1 (c 1.92, benzene) (Lit.,94  [a] i?= +4.95 (c
1.94, benzene) ); 8 h  (270 MHz, CDCI3) 0.08 (6  H, s, CH3), 0.91 (9 H, s, CMe3),
2.62 (1 H, dd, J 5.2 and 2.6, 0 /2 ) ,  2.78 (1 H, dd, J 4.8 and 4.2, CH2 ), 3.03 (1 H, m, 
CH), 3.66 (1 H, dd, J 12 and 4.6, C « 2 ), 3.84 (1 H, dd, J 12 and 3, 0 / 2 ) ;  6c  (68 
MHz, CDCI3) -5.4 (q), 18.3 (s), 25.85 (q), 44.4 (t), 52.4 (d), 63.7 (t).
Preparation o f  Mono Protected Amino Diol (118).
To a solution of S-3-[(rm-Butyldimethylsilyl)oxy]-l, 2-epoxypropane 
(prepared as described above) (3.7 g, 19.7 mmol) in dry acetonitrile (10 cm^) was 
added lithium perchlorate (2.1 g, 19.7 mmol). The mixture was stirred until the 
lithium salt had dissolved then R-(+)-a methylbenzylamine (2.53 cm^, 19.7 mmol) 
was added dropwise and the mixture stirred at room temperature for 12 hours. 
Water (5 cm^) was then added and the mixture extracted with ethyl acetate (3 x 5  
cm3). The combined extracts were dried (magnesium sulfate) and concentrated in 
vacuo. The residue was purified on silica eluting with 0—>10% v/v methanol- DCM
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to afford the R, S-mono protected amino diol (118) (5.48 g, 90%) as a single 
regioisomer which was further purified by distillation under reduced pressure b. p. 
149-153 °C  (0.3 mmHg), [a]#=  +16.3 (c0.8, chloroform); Umax (film)/ cm- l 
3463, 3291, 3064, 2955, 1603, 1471, 1462, 1361, 1112, 838 and 778, 624; 8r  (270 
MHz, CDCI3 ) 0.01 (6 H, s, C i/3 ), 0.85 (9 H, s, CMe3 ), 1.53 (3 H, d, J 6 .6 , 
CHC//3), 2.64 (1 H, dd, J 12.1 and 3.7, C//2 ), 2.76 (1 H, dd, J 12 and 8.4, C //2), 
3.45-3.61 (2 H, m, C //2 ), 3.55 (2 H, br s, OH and NH), 3.71 (1 H, m, C//OH), 4.01 
(1 H, q, J 7.1, CHCH3 ) 7.26-7.38 (5 H, m, aryl H); 8c  (68 MHz, CDCI3) -5.5 (q), 
-5.4 (q), 18.2 (s), 22.4 (q), 25.8 (q), 49.8 (t), 59.3 (d), 65.3 (t), 69.65 (d), 126.9 (d),
128.1 (d), 128.9 (d), 141.4 (s); mlz (Cl) 310 (M++1, 52%), 294 (18), 252 (19), 148 
(28), 134 (53), 120 (33), 105 (100); (found [M+H]+ 310.2202. C nH 32N 02S i 
requires mlz, 310.2202).
Mono Protected Amino Diol (128).
This was prepared according to the above method using (S)-3-[(rcrr- 
Butyldimethylsilyl)oxy]-l, 2-epoxypropane (prepared as described above) (3.45 g, 
18 mmol), lithium perchlorate (1.92 g, 18 mmol) and S-(-)-a methylbenzylamine 
(2.31 cm3, 18 mmol) in dry acetonitrile (10 cm^). The S, S-mono protected amino 
diol (128) (5.34 g, 96%) was isolated as a single regioisomer which was further 
purified by distillation under reduced pressure, b. p. 150-157 °C  (0.4 mmHg), 
[a] f=  -30.3 (c 0.94, chloroform); Umax (film)/ c n r1 3460, 3064,2928,1604,1462, 
1389, 1361, 1256,1108, 837, 777, 701 and 671; 5 h  (400 MHz, CDCI3) 0.01 (6 H, 
s, O / 3), 0.82 (9 H, s, CMe3), 1.47 (3 H, d, J 6.7, CHCf/3), 2.51 (1 H, dd, J 12.1 and 
8.3, C tf2), 2.75 (1 H, dd, J 12.2 and 3.4, 0 /2 ) ,  3.53 (2  H, br d, J 4.6, 0 / 2 ) ,  3.81-
3.84 (1 H, m, O /) , 3.82-3.97 (3 H, br m, O /C H 3 , OH and NH), 7.26-7.35 (5 H, m, 
aryl H); 8c  (100 MHz, CDCI3) -5.5 (q), -5.4 (q), 18.1 (s), 22.7 (q), 25.7 (q), 49.5 
(t), 58.5 (d), 65.4 (t), 69.1 (d), 126.7 (d), 127.8 (d), 128.8 (d), 143.7 (s); mlz (Cl) 310 
(M ++1,100%), 294 (14), 252 (20), 206 (19), 148 (21), 134 (42), 120 (29), 105 (78),
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91 (16); (found [M+H]+, 310.2202. C17H32NO3P requires m/z, 310.2202).
Preparation o f Epimeric Oxazaphospholidines (124) and (125).
To a stirred solution of R, S-mono protected amino diol (118) (5.27 g, 17.06 
mmol) and triethylamine (5.22 cm^, 37.53 mmol) in DCM (150 cm^) at 0 °C  was 
added phenylphosphonic dichloride (2.41 cm^, 17.1 mmol) dropwise over 10 
minutes. The resulting solution was stirred for 3 hours then warmed to room 
temperature and stirred for a further 18 hours. Saturated aqueous ammonium 
chloride solution (50 cm^) was then added and the mixture extracted with DCM (3 
x 30 cm3). The combined extracts were washed with water (20 cm^) then saturated 
aqueous brine (20 cm^) and dried (magnesium sulfate). The solution was then 
concentrated in vacuo to give a colourless oil consisting of a 1.4:1 mixture of 
epimeric oxazaphospholidines (124) and (125) which were readily separated by 
chromatography on silica, eluting with 0—>30% v/v ethyl acetate- petrol. The 
absolute configuration at phosphorus for the pure epimers was not determined.
Major diastereoisomer: obtained as a colourless oil(1.85 g, 25%), Rf 0.78 (50% 
ethyl acetate- petrol); [a] J3 = +34.1 (c 0.41, chloroform); Umax (film)/ cm fl 3060, 
2953, 1251, 1132, 837 and 696; 5 h  (270 MHz, CDCI3) -0.05 (3 H, s, C //3), -0.03 
(3 H, s, C //3 ), 0.78 (9 H, s, CMe3), 1.37 (3 H, d, J 6 .8 , CHC//3), 2.97-3.06 (1 H, m, 
C H i\  3.23 (1 H, ddd, J 12.3, 8.1 and 7, C //2 ), 3.62 (1 H, dd, J 13 and 7.1, 0 /2 ) ,
3.77 (1 H, dd, J 10.5 and 4.95, C //2), 4.12-4.47 (2 H, m, CH and C//CH3 ), 7.21- 
7.52 (8 H, m, aryl H), 7.8-7.88 (2 H, m, aryl H); 5 c  (100 MHz, CDCI3) -5.8 (q),
18.2 (s), 19.0 (q), 25.8 (q), 46.4 (dt, Jp c  12.8), 53.6 (dd, Jp c  5.5), 64.2 (dt, Jp c  
3.7), 76.7 (d), 127.1, 127.5, 128.4, 128.5, 132.1, 132.2, 132.3, 132.6 (s), 141.7 (d, 
JPC 5.5); 5p (162 MHz, CDCI3) 31.75 (1 P, s); mlz (Cl) 432 (M++1, 100%), 374 
(72), 271 (74), 133 (28), 105 (32), 91 (85); (found [M+H]+, 432.2124. 
C23H35N0 3 SiP requires m/z, 432.2123).
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Minor diastereoisomer: obtained as a colourless oil (1.28 g, 17%), Rf 0.47 (50% 
ethyl acetate- petrol); [a ]§ =  +3.3 (c0.27, chloroform); “Umax (film)/ c m 'l  3061, 
2953, 1250, 1132, 836 and 696; S r  (270 MHz, CDCI3) 0.01 (6 H, s, C //3 ), 0.84 (9 
H, s, CMe3), 1.49 (3 H, d, J 7, CHCH3), 3.14-3.32 (2 H, m, GFfe), 3.67 (1 H, ddd, J
11.1, 3.3 and 1.7, C # 2), 3.87 (1 H, dd, J 11 and 3.6, 0 72 ), 4.18 (1 H, p, J 7.1, 0 7 ), 
4.62-4.65 (1 H, m, C//CH3), 7.2-7.49 (8 H, m, aryl H), 7.82-7.89 (2 H, m, aryl H); 
8C (100 MHz, CDCI3 ) -5.9 (q), -5.8 (q), 18.7 (s), 21.2 (q), 26.1 (q), 47.4 (dt, Jpc  
10.9), 55.2 (dd, Jpc  5.5), 63.5 (dt, Jp c  7.3), 76.25 (d), 127.0, 127.3, 127.7, 128.5,
128.7, 128.8, 132.3, 132.35, 132.4 (s), 133.1, 133.15, 142.7 (d Jpc 3.7); 8p (162 
MHz, CDCI3 ) 29.5 (1 P, s); m/z (Cl) 432 (M++1, 100%), 374 (32), 270 (52), 133 
(19), 105 (30); (found [M+H]+ , 432.2124. C2 3 H 3 5 N 0 3 SiP requires m/z, 
432.2123).
Oxazaphospholidines (129).
This was prepared according to the above method using S, S-mono protected 
amino diol (128) (4.94 g, 15.9 mmol), triethylamine (4.87 cm3, 34.98 mmol) and 
phenylphosphonic dichloride (2.27 cm^, 15.9 mmol) in DCM (140 cm3). 
Oxazaphospholidines (129) were obtained as a 1:1 mixture of epimers which were 
readily separated by chromatography on silica as detailed above. Again the absolute 
stereochemistry at phosphorus was not determined. .
Less polar diastereoisomer: obtained as a white solid (1.71 g, 25%), m. p. 65-69 °C 
(d) (from ethyl acetate/ hexane); Rf 0.82 (50% ethyl acetate- petrol); [oc]^ = +14.6 
(c 1.01, chloroform); \)max (nujol)/ cm~l 2954, 2856, 1439, 1251, 1122, 998, 837, 
738 and 696; 8h  (400 MHz, CDCI3 ) 0.04 (6 H, s, 073), 0.85 (9 H, s, CMe3 ), 1.55 
(3 H, d, J 7, C H O /3), 3.35-3.42 (2 H, m, O f t) .  3.75 (1 H, dd, J 11.6 and 7.4, C/72), 
3.83 (1 H, dd, J 10.2 and 4.2, 0 7 2 ), 4.42 (1 H, dp, J 6.5 and 2.4, C H ), 4.5-4.54 (1 
H, m, C77CH3), 7.22-7.39 (4 H, m, aryl H), 7.42-7.52 (4 H, m, aryl H), 7.54-7.82 (2 
H, m, aryl H); 8c  (100 MHz, CDCI3) -4.9 (q), 18.5 (s), 20.4 (q), 26.0 (q), 47.2 (dt,
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JpC 12.8), 54.7 (dd, Jp c  7.3), 64.5 (t), 77.0 (d), 127.2, 127.7, 128.6, 128.7, 130.9 
(s), 132.3, 132.35, 132.4, 132.6, 142.2 (d, Jpc  3.7); 5p (162 MHz, CDCI3) 31.1 (1 
P, s); m/z (Cl) 432 (M++1, 22%), 374 (28), 133 (56), 115 (20), 89 (54), 75 (100); 
(found [M+H]+, 432.2124. C23H35NC>3SiP requires m/z, 432.2123).
More polar diastereoisomer: obtained as a colourless oil (1.72 g, 25%), Rf 0.55 
(50% ethyl acetate- petrol); [a ]^ =  -31.0 (c 3.01, chloroform); Umax (film)/ cm 'l 
3060, 2929, 1439, 1251, 1131, 837 and 696; 8r  (400 MHz, CDCI3 ) -0.01 (6  H, s, 
C //3), 0.84 (9 H, s, CMe3 ), 1.31 (3 H, d, J 7, CHC//3), 2.98 (1 H, ddd, J 10,11 and 
7, C H 2\ 3.32 (1 H, dt, J 8.4 and 5.5, C //2 ), 3.66 (1 H, dd, J 11.4 and 0.9, C //2), 
3.86 (1 H, dd, J 11 and 3.8, CH2 I  4.44 (1 H, p, J 6.4, Ctf), 4.56-4.61 (1 H, m, 
C//CH 3), 7.17-7.46 (8 H, m, aryl H), 7.81-7.94 (2 H, m, aryl H); 6c  (100 MHz, 
CDCI3) -5.05 (q), 14.1 (s), 18.3 (q), 25.7 (q), 45.3 (dt, Jpc 9.1), 52.9 (dd, Jp c  7.3),
63.3 (dt, J p c  5.5), 75.8 (d), 126.9, 127.3, 128.1, 128.2, 128.3, 130.3 (s), 132.0,
132.6, 132.7, 141.6 (d, J p c  3.6); 5p (162 MHz, CDCI3) 30.0 (1 P, s); m/z (Cl) 432 
(M++1, 100%), 374 (26), 328 (14), 270 (70), 133 (20), 40 (44); (found [M+H]+, 
432.2124. C23H35N0 3 SiP requires m/z, 432.2123).
Preparation ofR.  S-N-phosphinvlated Amino Alcohol (126).
Reaction of either epimeric oxazaphospholidine (124) or (125) with 
phenylmagnesium bromide gave the R, S-N-phosphinylated amino alcohol (126). 
The following procedure refers to the ring opening of the major oxazaphospholidine 
product and is typical.
To a stirred solution of the oxazaphospholidine (1.75 g, 4.06 mmol) in 
anhydrous THF (20 cm^) at -30 °C  was added phenylmagnesium bromide (1 M 
THF solution, 6.11 cm^, 6.11 mmol) dropwise over 5 minutes. The mixture was 
stirred for 1 hour then warmed to room temperature and stirred for a further 18 
hours. Water (8 cm^) was then added and the mixture extracted with DCM (4 x 10 
cm^) [CARE!: emulsification may occur on work up if the mixture is shaken
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vigorously]. The combined extracts were dried (magnesium sulfate) and 
concentrated in vacuo. The residue was purified on silica eluting with 20—>40% 
ethyl acetate- petrol to afford R, S-N-phosphinylated amino alcohol (126) as a 
colourless oil (1.34 g, 65%) [a ]# =  +4.1 (c 0.29, chloroform); \)max (film)/ cm 'l 
3314, 3060, 2927, 1471, 1439, 1253, 1119, 910, 836, 730 and 698; 8r  (270 MHz, 
CDCI3) -0.06 (6 H, s, 0 /3 ), 0.78 (9 H, s, CMe3), 1.58 (3 H, d, J 7.1, CHC//3), 2.81 
(1 H, ddd, J 16.2, 10.8 and 3.8, C //2), 3.12 (1 H, dd, J 9.7 and 9, C //2), 3.38 (1 H, 
m, C //2), 3.61 (1 H, dd, J 10 and 4.2, 0 /2 ) ,  3.89 (1 H, m, O /O H ), 4.41 (1 H, dq, J
8.1 and 7.5, C//CH3), 5.78 (1 H, br d, J 2, OH), 7.25-7.48 (11 H, m, aryl H), 7.71- 
7.88 (4 H, m, aryl H); 8 c  (100 MHz, CDCI3) -5.5 (q), 18.2 (s), 20.6 (q), 25.8 (q), 
48.7 (t), 56.0 (dd, Jp c  5.5), 65.3 (t), 71.95 (d), 127.5, 127.9, 128.4, 128.6, 128.7,
128.8, 128.85,130.1 (s), 131.4 (s), 131.9,132.2, 132.25,132.3, 132.9, 133.0, 140.7 
(d, Jp c  5.5); 8p (162 MHz, CDCI3) 36.0 (1 P, s); m/z (Cl) 510 (M++1, 52%), 452 
(78), 406 (70), 230 (100), 201 (72), 105 (75), 91 (55); (found [M+H]+, 510.2590. 
C29H4iN03SiP requires m/z, 510.2593).
Repeating the reaction using the minor oxazaphospholidine epimer (1.2 g,
2.78 mmol) and phenylmagnesium bromide (1 M THF solution, 4.17 cm^, 4.17 
mmol) in THF (15 cm^) gave R, S-N-phosphinylated amino alcohol (126) as above 
(1.06 g, 75%).
S. S-N-phosphinvlated Amino Alcohol (130).
This compound was prepared according to the above procedure using 
oxazaphospholidene (129). Both epimers gave S, S-N-phosphinylated amino 
alcohol (130) in identical yield. Treatment of the oxazaphospholidine (1.2 g, 2.78 
mmol) with phenylmagnesium bromide (1 M THF solution, 4.17 cm^, 4.17 mmol) 
in anhydrous THF (15 cm^) gave S, S-N-phosphinylated amino alcohol (130) as a 
colourless oil (840 mg, 59%), [a] d= -78.0 (c 0.83, chloroform); Umax (film)/ cm 'l 
3328, 3060, 2954, 2856, 1438, 1174, 1120, 837, 732 and 698; 8r  (270 MHz,
4 Experimental. Page 176
CDCI3) -0.01 (6 H, s, C //3), 0.91 (9 H, s, CMe3 ), 1.71 (3 H, d, J 7, CHC//3), 2.99-
3.04 (2 H, m, C //2 ), 3.16-3.18 (1 H, m, CH±), 3.41-3.58 (2 H, m, O/OHand C //2),
4.63 (1 H, dq, J 10.4 and 7, C//CH3), 5.34 (1 H, br s, OH), 7.33-7.63 (11 H, m, aryl 
H), 8.0-8.07 (4 H, m, aryl H); 5 c  (68  MHz, CDCI3) -5.7 (q), -5.5 (q), 17.6 (s), 17.7 
(q), 25.8 (q), 48.1 (dt, Jpc  4.4), 54.8 (dd, Jpc  4.4), 65.1 (t), 69.3 (d), 127.6, 128.3,
128.6, 128.65, 128.7, 128.8, 131.8, 131.8 (s), 132.0 (s), 132.15, 132.2, 132.35,
132.6, 132.8, 141.7 (d, Jpc  3.3); 5p (162 MHz, CDCI3) 34.9 (1 P, s); m/z (Cl) 510 
(M++1, 20%), 406 (22), 335 (18), 230 (100), 201 (35), 105 (52); (found [M+H]+,
510.2590. C29H4iN03SiP requires m/z, 510.2593).
Preparation ofR.  S-Phosphinamide Diol (107).
To a stirred solution of R, S-N-phosphinylated amino alcohol (126) (1.18 g, 
2.31 mmol) in THF (15 cm^) at 0 °C  was added TBAF (1.1 M THF solution, 4.22 
cm^, 4.64 mmol) dropwise. The resulting pale yellow solution was warmed slowly 
to room temperature and stirred for 45 minutes. Water (10 cm^) was then added 
and the mixture extracted with DCM ( 3 x 5  cm^). The combined extracts were 
dried (magnesium sulfate) and concentrated in vacuo. The residue was purified on 
silica eluting with 0—>5% v/v methanol- DCM to afford R, S-phosphinamide diol 
(107) as a white foam which was further purified by recrystallisation from diethyl 
ether/pentane (776 mg, 85%), m. p. 59-61 °C (from diethyl ether/ pentane); [a]$=  
+27.1 (c 0.58, chloroform); 'Umax (nujol)/ cm’ l 3345, 3059, 2930, 1439, 1381, 
1122, 1069, 998, 890, 733 and 697; 6r  (270 MHz, CDCI3 ) 1.61 (3 H, d, J 7.1, 
CHC//3), 2.64 (1 H, br t, J 6.4, OH), 2.98-3.09 (2 H, m, Cf/2), 3.25-3.42 (2 H, m, 
C //2), 3.63-3.71 (1 H, m, C//OH), 4.45 (1 H, m, C//CH3), 5.39 (1 H, d, J 3.3, OH),
7.25-7.38 (5 H, m, aryl H), 7.46-7.55 (6 H, m, aryl H), 7.78-7.91 (4 H, m, aryl H); 
8c (68 MHz, CDCI3) 19.9 (q), 47.1 (t), 55.5 (dd, Jpc  5.5), 64.0 (t), 70.9 (d), 127.6,
128.5,128.6,128.8,129.6 (d, Jp c  4.3), 131.5 (s), 132.0,132.2,132.3, 132.5,132.7,
140.5 (d, J 5.5); 5p (162 MHz, CDCI3) 36.55 (1 P, s); m/z (Cl) 396 (M++1, 66%),
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378 (40), 292 (89), 230 (90), 201 (69), 105 (95), 91 (80); (found [M+H]+, 396.1729. 
C23H27NO3P requires m/z, 396.1728).
S. S-Phosphinamide Diol (127).
This compound was prepared according to the above procedure using S, S- 
N-phosphinylated amino alcohol (130) (0.5 g, 0.98 mmol) and TBAF (1.1 M THF 
solution, 1.78 cm^, 1.96 mmol) in THF (7 cm^). S, S-phosphinamide diol (127) 
was obtained as a white foam which purified by recrystallisation from diethyl ether/ 
pentane (352 mg, 91%), [a ]g=  -113.7 (c 0.86, chloroform); a>max (nujol)/ cm- * 
3355,2933,1438,1380,1121,1072,997, 888 ,733 and 697; 5 h  (400 MHz, CDCI3)
1.65 (3 H, d, J 7, CHC//3), 2.81 (1 H, br s, OH), 3.01-3.2 (3 H, m, C //2), 3.21-3.32 
(2 H, m, CH2 and CHOH), 4.56-4.62 (1 H, m, C//CH3), 5.48 (1 H, br s, OH), 7.35- 
7.38 (5 H, m, aryl H), 7.41-7.64 (6 H, m, aryl H), 7.93-8.04 (4 H, m, aryl H); 5 c  
(100 MHz, CDCI3) 18.0 (q), 47.1 (dt, Jpc  3.6), 55.0 (dd, Jp c  3.6), 64.0 (t), 69.7
(d), 127.6, 128.4, 128.6 , 128.7, 128.75, 128.8 , 130 (d, Jpc  20 ), 131.2 (d, Jpc  20 ),
132.0,132.1, 132.2, 132.4, 132.5, 141.1 (d, Jpc  3.6); Sp (162 MHz, CDC3 ) 34.4 (1 
P, s); m/z (Cl) 396 (M++1, 7%), 292 (10), 230 (10), 186 (53), 142 (100), 100 (33); 
(found [M+H]+, 396.1729. C23H27NO3P requires m/z, 396.1728).
Reaction of Mono Protected Amino Diol (118) with P iphenviphosphinic 
chloride.
Preparation o f O-diphenvlphosphinovlated Amino Alcohol (119).
To a stirred solution of mono protected amino diol (118) (500 mg, 1.62 
mmol) and triethylamine (0.45 cm^, 3.24 mmol) in DCM (10 cm^) at 0 °C was 
added diphenylphosphinic chloride (0.31 cm^, 1.62 mmol) dropwise. The solution 
was stirred for 6  hours. Saturated aqueous ammonium chloride solution (5 cm^)
4 Experimental. £.age 173,
was then added and the mixture extracted with DCM ( 3 x 5  cm^). The combined 
extracts were washed with saturated aqueous brine (5 cm^), dried (magnesium 
sulfate) and concentrated in vacuo. The residue was purified on silica eluting with 
0-*10% v/v methanol- DCM to afford O-diphenylphosphinoylated amino alcohol 
(119) as a pale yellow oil (392 mg, 48%), Umax (film)/ cm"* 3300, 2955, 2856, 
1439, 1228, 1130, 1036, 978, 837 and 699; 8h  (270 MHz, CDCI3) 0.01 (6 H, s, 
C//3), 0.86 (9 H, s, CMe3), 1.32 (3 H, d, J 6 .6 , CHC//3), 2.25 (1 H, br m, NH), 
2.71-2.82 (2 H, m, C //2 ), 3.69-3.77 (3 H, m, CH2  and CH), 4.41-4.49 (1 H, m, 
C//CH3), 7.29-7.81 (11 H, m, aryl H), 7.82-7.92 (4 H, m, aryl H); 8c (68 MHz, 
CDCI3) -5.6 (q), 18.1 (q), 24.3 (s), 25.8 (q), 48.8 (dt, Jpc 2 .2), 57.6 (d), 64.1 (dt, 
JpC 11.1), 76.2 (d), 126.6, 126.85, 128.3, 128.4, 128.5, 131.5, 131.6, 131.7, 131.9,
132.0, 132.1; 5p (162 MHz, CDCI3) 32.2 (1 P, s); m/z (Cl) 510 (M+, 78%), 452 
(14), 333 (36), 233 (100), 201 (22), 155 (32), 105 (46), 91 (27); (found [M+H]+,
510.2590. C29H4iNC>3SiP requires m/z, 510.2593).
Reaction of M ono Protected Amino Diol (118) with /-Butvldimethvlsilvl 
chloride.
Preparation ofN-t-BDMS Protected Amino Alcohol (120).
To a stirred solution of mono protected amino diol (118) (200 mg, 0.647 
mmol) and triethylamine (0.11 cm^, 0.78 mmol) in DCM (1 cm^) was added t- 
butyldimethylsilyl chloride (107 mg, 0.71 mmol) and DMAP (5 mg, 0.03 mmol). 
The cloudy solution was stirred at room temperature for 18 hours. Saturated 
aqueous ammonium chloride solution (0.5 cm^) was then added and the mixture 
extracted with DCM ( 3 x 1  cm^). The combined extracts were then dried 
(magnesium sulfate) and concentrated in vacuo. The residue was purified on silica 
eluting with 0—>5% v/v ethyl acetate- petrol to afford N-r-BDMS protected amino 
alcohol (120) as a colourless oil (153 mg, 56%), (found C, 65.2; H, 10.9; N, 3.4.
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C23H45N02Si2 requires C, 65.19; H, 10.64; N, 3.31%); \)max (film)/ cm 'l 2955, 
2885, 1463, 1255, 1101,1005, 836, 776 and 700; 5h (270 MHz, CDCI3 ) 0.06 (6  H, 
s, C //3), 0.07 (6  H, s, 0 / 3), 0.88 (18 H, s, CMe3), 1.34 (3 H, d, J 7, CH C//3), 1.66 
(1 H, br s, OH), 2.43-2.55 (2 H, m, 0 /2 ) ,  3.46-3.58 (2 H, m, 0 /2 ) ,  3.67-3.81 (2 H, 
m, O /C H 3 and O /O H ), 7.26-7.31 (5 H, m, aryl H); 5 c  (100 MHz, CDCI3) -4.7 
(q), -4.3 (q), 18.1 (s), 18.3 (s), 24.6 (q), 25.9 (q), 51.2 (t), 58.2 (d), 66.1 (t), 72.6 (d),
126.6 (d), 126.7 (d), 128.3 (d), 145.9 (s); m/z (Cl) 424 (M++1, 24%), 408 (22), 366 
(40), 291 (26), 134 (62), 120 (36), 105 (100).
Reduction of Acetophenone with BMS Catalysed bv the Boronate Complexes 
of the Phosphinamide Diols.
The boronate complexes of the appropriate phosphinamide diol were 
generated in situ by reaction of a THF solution of the phosphinamide diol with BMS 
as described below. The presence of impurities, particularly water, appeared to 
have a detrimental effect on catalyst performance. The phosphinamide diol was 
doubly recrystallised from diethyl ether/ pentane and dried via azeotropic removal 
of water using chloroform. The ketone (initially purified and dried by distillation 
from calcium hydride) was dissolved in anhydrous THF (2 M solution) and dried for 
18 hours over activated 4A molecular sieves prior to use. The following procedure 
is typical.
Reduction Catalysed bv Boronate (1081.
To a stirred solution of phosphinamide diol (107) (50 mg, 0.127 mmol) in 
anhydrous THF (0.5 cm^) was added BMS (10 M dimethyl sulfide complex, 0.014 
cm3, 0.14 mmol) dropwise. The solution was stirred for 2 hours at room 
temperature. Acetophenone (2 M THF solution, 0.63 cm^, 1.27 mmol) was then 
added followed by BMS (10 M dimethyl sulfide complex, 0.13 cm^, 1.27 mmol).
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The mixture was stirred for 2 hours at room temperature by which time all of the 
acetophenone had been reduced (by TLC). The solution was then diluted with 
diethyl ether (5 cm^) and poured into saturated aqueous ammonium chloride 
solution (5 cm^). The mixture was then extracted with diethyl ether ( 3 x 5  cm^), 
the combined extracts dried (magnesium sulfate) and concentrated in vacuo. The 
catalyst was removed by chromatography on silica, eluting with 2 0 % v/v ethyl 
acetate- petrol, to afford 1-phenylethanol as a colourless oil (136 mg, 8 8%), 59% 
e.e. (S- major) as assessed by HPLC analysis (conditions as described in Section 
4.1); 5 h  (270 MHz, CDCI3 ) 0.95 (3 H, t, J 7.1, C //3), 1.36-1.61 (6 H, m, C //2), 
5.15 (2 H, s, CtfPh), 7.26-7.42 (10 H, m, aryl H).
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Section 4.7: Phosphinam ide N-protecting Groups for Intram olecular Directed 
Ketone Reduction.
Oxidation of N-Protected Amino Alcohols.
Preparation o f  Ketophosvhinamide (142).
To a stirred solution of pyridinium dichromate (1.07 g, 2.86 mmol) in DMF 
(10 cm^)  at 0 °C  was added N-diphenylphosphinyl protected 1R, 2S-(-)- 
norephedrine (93) (prepared as described in Section 4.6) (200 mg, 0.57 mmol) 
portionwise. The mixture was stirred at room temperature for 3 hours. Water (12 
cm^) was then added and the mixture extracted with diethyl ether ( 3 x 5  cm^). The 
combined extracts were washed with water ( 2x5  cm3) then saturated aqueous brine 
(8 cm3) and dried (magnesium sulfate). The diethyl ether solution was filtered 
through a pad of magnesium sulfate and the filtrate concentrated in vacuo to afford 
ketophosphinamide (142) as a pale yellow solid which was further purified by 
recrystallisation from diethyl ether/ pentane (180 mg, 90%), m. p. 124-127 °C (from 
diethyl ether/ pentane); [a]£4= -1.7 (c 0.88, chloroform); t>max (nujol)/ cm~l 1686, 
1178, 935 and 790; 5 r  (270 MHz, CDCI3) 1.37 (3 H, d, J 7, CHC//3), 4.24 (1 H, br 
t, J 9.5, NH), 4.88 (1 H, m, C//CH3), 7.29-7.52 (9 H, m, aryl H), 7.72-7.89 (6 H, m, 
aryl H); 5 c  (68  MHz, CDCI3 ) 22.9 (dq, Jp c  3.3), 50.9 (d), 128.3, 128.4, 128.5,
128.6, 128.7, 131.2 (s), 131.8, 131.85, 131.9, 132.0, 133.1 (s), 133.6, 133.8 (s), 
200.0 (d, Jp c  5.5); 5p (162 MHz, CDCI3) 23.0 (1 P, s); m/z (Cl) 350 (M++1, 
100%), 244 (40), 218 (19), 201 (14); (found [M+HJ+, 350.1321. C2 1 H21NO2P 
requires m/z, 350.1310).
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Preparation ofS-2-(N-(tert-butvloxvcarbonvl) amino) propiophenone (144).
This compound was prepared according to the above method using r-BOC 
protected amino alcohol (143) (prepared as described below) (140 mg, 0.56 mmol) 
and pyridinium chlorochromate (1.05 g, 2.8 mmol) in DMF (7 cm^). 
Chromatography on silica eluting with 0—>20% v/v ethyl acetate- petrol afforded 
ketone (144) as a colourless oil which solidified on standing (97 mg, 70%), [a]k8= 
-3.6 (c 2.1, DCM) (lit,105a [a ] . 3 .4  (c 2 , DCM )); 8h  (270 MHz, CDCI3) 1.41
(3 H, d, J 7.1, CHC//3), 1.45 (9 H, s, CMe3), 5.29 (1 H, p, J 7.3, CHCH3), 5.55 (1 
H, br s, NH), 7.46-7.63 (3 H, m, aryl H), 7.96-7.99 (2 H, m, aryl H); mlz (Cl) 250 
(M ++1,8%), 194 (100), 150 (58), 105 (13).
Preparation o f Ketophosphinamide (148).
To a stirred solution of N-diphenylphosphinyl protected 2-am ino-1- 
phenylethanol (147) (prepared as described in Section 4.6) (500 mg, 1.48 mmol) 
and NMO (312 mg, 2.66 mmol) in DCM (4 cm^) was added powdered 4A 
molecular sieves (20 mg) and TPAP (26 mg, 0.074 mmol). The dark green mixture 
was stirred at room temperature for 30 minutes then filtered through a pad of silica, 
eluting with ethyl acetate. The filtrate was concentrated in vacuo to afford 
ketophosphinamide (148) as a pale yellow solid which was purified by 
recrystallisation from ethyl acetate/ petrol (401 mg, 81%), \)max (nujol)/ c n r  1 1695, 
1448,1194,1118, 982,726 and 696; 5 h  (270 MHz, CDCI3) 4.21 (1 H, br m, NH), 
4.42 (2 H, dd, J 5.7 and 5.2, C //2 ), 7.35-7.51 (9 H, m, aryl H), 7.54-7.88 (6 H, m, 
aryl H); 5 c  (100 MHz, CDCI3 ) 46.4 (t), 127.7, 128.6, 128.7, 128.8, 131.3, 131.8,
131.9, 132.0, 132.2 (s), 132.6, 133.9, 142.0 (s), 194.6 (d, Jp c  9.1); 5p (162 MHz, 
CDCI3) 23.7 (1 P, s); m/z (Cl) 336 (M++1, 31%), 246 (15), 218 (33), 132 (100), 105 
(14), 86 (97); (found [M+H]+, 336.1153. C20H 19NO2P requires m/z, 336.1153).
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Preparation o f Ketophosphinamide (148) Directly from the a  -Amino Ketone.
To a stirred solution of diphenylphosphinic chloride (0.60 cm^, 3.17 mmol) 
and triethylamine (0.62 cm^, 4.43 mmol) in DCM (50 cm^) at 0 °C was added a- 
aminoacetophenone hydrochloride (362 mg, 2.11 mmol) portionwise over 2 hours 
[CARE!: rapid addition of the amino ketone results in preferential formation of the 
dimer product (see Section 2.7)]. The solution was then warmed to room 
temperature and saturated aqueous ammonium chloride solution added (15 cm^). 
The mixture was extracted with DCM (3 x 10 cm^) and the combined extracts 
washed with saturated aqueous brine (10  cm^), dried (magnesium sulfate) and 
concentrated in vacuo. The residue was purified on silica eluting with 0—>5% v/v 
methanol- DCM to afford ketophosphinamide (148) as an off-white solid (636 mg, 
90%). The data for this compound is given above.
Reduction of Ketophosphinamide (142).
11 Reduction with BMS.
To a stirred solution of ketophosphinamide (142) (prepared as described 
above) (162 mg, 0.464 mmol) in anhydrous THF (2 cm^) was added BMS (10 M 
dimethyl sulfide complex, 0.028 cm^, 0.28 mmol) dropwise. The mixture was 
stirred at room temperature for 45 minutes by which time all of the ketone had been 
reduced (by TLC). The solution was diluted with diethyl ether (5 cm^) and poured 
into saturated aqueous ammonium chloride solution (2 cm^). The mixture was then 
extracted with diethyl ether ( 3 x 1  cm^) and the combined extracts dried 
(magnesium sulfate) and concentrated in vacuo to afford the sy^-alcohol 1R, 2S- 
(93) as a single diastereoisomer (as assessed by and 31p NMR data) (148 mg, 
92%), 5 h  (270 MHz, CDCI3) 1.00 (3 H, d, J 6 .8 , CHC//3), 3.01-3.09 (1 H, m, NH), 
3.32-3.45 (1 H, m, C//CH3 ), 4.72 (1 H, br d, J 5.9, C//Ph), 5.81 (1 H, br d, J 8 ,
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OH), 7.13-7.45 (11 H, m, aryl H), 7.71-7.88 (4 H, m, aryl H); 5p (162 MHz, 
CDCI3) 25.05 (1 P, s); (full data for this compound is given in Section 4.6).
2) Reduction with Sodium Borohvdride.
To a stirred solution of ketophosphinamide (142) (prepared as described 
above) (100 mg, 0.287 mmol) in 9:1 ethanol/ water (2 cm^) was added sodium 
borohydride (5 mg, 0.08 mmol). The solution was stirred for 25 minutes at room 
temperature after which time all of the ketone had been reduced (by TLC). The 
mixture was then concentrated in vacuo and the residue dissolved in DCM (5 cm^). 
The solution was washed with water (2 cm^) followed by saturated aqueous brine (2 
cm^). It was then dried (magnesium sulfate) and concentrated in vacuo to afford 
alcohol (93) as a white solid consisting of an inseparable 2:1  mixture of 
diastereoisomers (sy/i-alcohol 1R, 2S-(93) major) (91 mg, 90%), 8h  (270 MHz, 
CDCI3) 1R. 2S-diastereoisomer: 0.97 (3 H, d, J 6.4, CHC//3 ), 3.11-3.18 (1 H, m, 
NH), 3.36-3.39 (1 H, m, C//CH3), 4.79 (1 H, m, CtfPh), 5.93 (1 H, d, J 6 .6 , OH), 
7.11-7.45 (11 H, m, aryl H), 7.71-7.81 (4 H, m, aryl H); IS. 2S-diastereoisomer:
1.05 (3 H, d, J 6 .6 , CHC//3), 3.22-3.28 (1 H, m, NH), 3.35-3.44 (1 H, m, C//CH 3), 
4.44 (1 H, br s, C//Ph), 5.61 (1 H, br s, OH), 7.07-7.45 (11 H, m, aryl H), 7.71-7.83 
(4H , m, aryl H).
Preparation oft-BOC Protected Norephedrine (143).
To a stirred solution of 1R, 2S-(-)-norephedrine (100 mg, 0.66 mmol) and 
triethylamine (0.10 cm^, 0.727 mmol) in DCM (15 cm^) was added di-f-butyl 
dicarbonate (144 mg, 0.66 mmol) portionwise. The solution was stirred at room 
temperature for 18 hours then poured into saturated aqueous ammonium chloride 
solution (8 cm3). The mixture was extracted with DCM ( 3 x 5  cm^) and the 
combined extracts dried (magnesium sulfate) and concentrated in vacuo to afford
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the protected amino alcohol (143) as a viscous oil (142 mg, 86%), [a] $=  -18.5 (c 
0.05, chloroform); 5h  (270 MHz, CDCI3) 0.91 (3 H, d, J 7, CHCZ/3), 1.39 (9 H, s, 
CMe3), 3.36 (1 H, br m, NH), 3.91-3.93 (1 H, m, CZ/CH3 ), 4.62 (1 H, br d, J 3.8, 
CZ/Ph), 4.77 (1 H, br s, OH), 7.23-7.28 (5 H, m, aryl H).
Reduction of t-BOC Protected Amino Ketone (144) with BMS.
To a stirred solution of ketone (144) (87 mg, 0.35 mmol) in anhydrous THF 
(1 cm^) was added BMS (10 M dimethyl sulfide complex, 0.02 cm^, 0.21 mmol) 
dropwise. The solution was stirred at room temperature for 18 hours. The mixture 
was then diluted with diethyl ether (5 cm^), poured into saturated aqueous 
ammonium chloride solution (2 cm^) and extracted with diethyl ether ( 3 x 2  cm^). 
The combined extracts were dried (magnesium sulfate) and concentrated in vacuo to 
afford the alcohol as an inseparable 3.75:1 mixture of diastereoisomers (syw-alcohol 
1R, 2S-(143) major) (61 mg, 70%), 8h  (400 MHz, CDCI3) 1R. 2S-diastereoisomer: 
0.96 (3 H, d, J 7, CHC//3), 145 (9 H, s, CMe3), 3.52 (1 H, br m, NH), 3.95 (1 H, br 
m, CZ/CH3), 4.62-4.67 (1 H, m, CZ/Ph), 4.83 (1 H, br s, OH), 7.25-7.33 (5 H, m, 
aryl H); IS. 2S-diastereoisomer: 1.05 (3 H, d, J 6.7, CHCZ/3), 1.43 (9 H, s, CMe3), 
3.51-3.53 (1 H, br m, NH), 3.84 (1 H, br m, CZZCH3), 4.75-4.77 (1 H, m, CZ/Ph),
4.85 (1 H, br s, OH), 7.25-7.39 (5 H, m, aryl H).
Reduction of Ketophosphinamide (148) with BMS in the Presence of Boronate 
(98).
To a stirred solution of R, R-(-)-butanediol (97, R=Me) (4.1 mg, 0.045 
mmol) in THF (1.5 cm^) was added BMS (10 M dimethyl sulfide complex, 5 pi, 
0.054 mmol). The solution was stirred at room temperature for 20 minutes then 
ketone (148) (150 mg, 0.45 mmol) was added followed by BMS (10 M dimethyl 
sulfide solution, 0.027 cm^, 0.27 mmol) dropwise. The resulting mixture was then
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stirred at room temperature for 30 minutes by which time all of the ketone had been 
reduced (by TLC). The solution was diluted with diethyl ether, poured into 
saturated aqueous ammonium chloride solution (1 cm^) and extracted with diethyl 
ether ( 3 x 1  cm^). The combined extracts were dried (magnesium sulfate) and 
concentrated in vacuo to afford alcohol (147) as a white solid (128 mg, 85%), 8h  
(270 MHz, CDCI3) 3.08-3.82 (2 H, m, C //2), 3.82 (1 H, br m, NH), 4.85-4.87 (1 H, 
m, C//Ph), 7.23-7.45 (12 H, m, aryl H and OH), 7.75-7.86 (4 H, m, aryl H); (full 
data for the racemic alcohol is given in Section 4.6).
Determination of Enanteomeric Purity hv Formation of Moshers Esters.
The method is based on a literature procedure. * *4 To a stirred solution of 
the above alcohol (50 mg, 0.15 mmol) in DCM (1 cm^) was added DMAP (2 mg, 
0.015 mmol) and R-(+)-a methoxy-a-(trifluoromethyl) phenylacetic acid (52 mg, 
0.22 mmol). The solution was cooled to 0 °C and DCC (46 mg, 0.22 mmol) added 
portionwise. The resulting mixture was then allowed to warm to room temperature 
and stirred for 18 hours by which time all of the alcohol was consumed (by TLC). 
The precipitated DCU was then filtered off and the filtrate washed rapidly with cold 
0.5 M HC1 (0.5 cm3) followed by saturated aqueous sodium bicarbonate solution 
(0.5 cm3). The solution was dried (magnesium sulfate) and concentrated in vacuo to 
afford a mixture of MTPA-esters as a colourless oil (81 mg, 97%). 31p NMR 
analysis of the crude mixture indicated a 3% diastereomeric excess, 5p (162 MHz, 
CDCI3) major diastereoisomer: 24.1 (1 P, s); minor diastereoisomer: 24.2 (1 P, s).
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6 Appendix.
Single Crystal X-Ray Study of Phosphinamide (29).
A Crystal of approximate dimensions 0.3 x 0.2 x 0.2 mm was used for data 
collection.
Crystal data: C2 0 H 2 0 NOP> M=321.3 tetragonal, a = 11.475(3), b = 
11.475(3), c = 13.328(7) A, U=1755.0 A, space group P4i, Z = 4, Dc = 1.22  gcm'3, 
ji(Mo-K<x) = 1.50 cm"l, F(000) = 680. Data were measured at room temperature on 
a Hilger and Watts Y290 four-circle diffractometer in the range 2<0<24°. 3048 
reflections were collected of which 844 were unique with I>3o(I). Data were 
collected for Lorentz and polarization effects but not for absorption. The structure 
was solved by Patterson methods and refined using the SHELX^»^ suite of 
programs. In the final least squares cycles all atoms were allowed to vibrate 
anisotropically. Hydrogen atoms were at calculated positions except in the case of 
HI which was located in the penultimate Difference Fourier and refined at a 
distance of 1.08 A from Nl. Final residuals after 10 cycles of least squares were R 
= 0.0447, Rw = 0.0455, for a weighting scheme of w = 0.8870/[a^(F) + 
0.003723(F)^]. Max. final shift/esd was 0.025. The max. and min. residual 
densities were 0.09 and -0.06 eA~3 respectively. Final fractional atomic co­
ordinates and isotropic thermal parameters, bond distances and angles are given in 
Tables A1 to A7 respectively. The asymmetric unit is shown in Figure 10, along 
with the labelling scheme used.
1 Sheldrick G. M., SHELX8 6 , a computer program for crystal structure 
determination, University of Gottingen, 1986.
2 Sheldrick G. M., SHELX76, a computer program for crystal structure 
determination, University of Cambridge, 1976.
C 1 5
Figure 10 
X-Ray structure of (29)
6 Appendix..___________________________________________Page 207.
Table A 1 Fractional Atomic co-ordinates and thermal parameters (A) for (29)
Atom X Y Z U
P I 0.22543 (15) 0.87790 (15) 0.19021 0.0429 (11)
0 1 0.2313 (4) 1.0001 (4) 0.2271 (5) 0.062 (3)
N1 0.2057 (5) 0.8587 (5) 0.0724 (5) 0.051 (4)
C l 0.3613 (6) 0.8059 (6) 0.2226 (6) 0.050 (5)
C2 0.4039(7) 0.7136 (6) 0.1656 (7) 0.060( 5)
C3 0.5048 (9) 0.6586 (9) 0.1932 (11) 0.087 (7)
C4 0.5652 (9) 0.6938(11) 0.2776 (13) 0.099(9)
C5 0.5231 (9) 0.7860 (12) 0.3336 (10) 0.098 (8)
C6 0.4205 (8) 0.8417 (8) 0.3083 (8) 0.071 (6)
C7 0.1081(6) 0.7961 (6) 0.2466 (6) 0.045 (4)
C8 -0.0065 (6) 0.8335 (7) 0.2314 (7) 0.058 (5)
C9 -0.0965 (7) 0.7767 (8) 0.2760 (7) 0.071 (6)
CIO -0.0763 (8) 0.6858 (9) 0.3408 (8) 0.081 (7)
C l l 0.0342 (8) 0.6458 (9) 0.3548 (9) 0.084 (7)
C12 0.1281 (7) 0.7046 (7) 0.3111 (8) 0.069 (6)
C13 0.2754 (6) 0.9215 (7) -0.0036 (6) 0.055 (5)
C14 0.1999 (9) 1.0114(7) -0.0593 (8) 0.078 (6)
C15 0.3328 (6) 0.8422 (7) -0.0764 (6) 0.052 (5)
C16 0.2829 (7) 0.7430 (8) -0.0045 (7) 0.063 (5)
C17 0.3364 (9) 0.6731 (8) -0.1829 (7) 0.076 ‘(7)
C18 0.4473 (11) 0.7025 (12) -0.2181 (9) 0.096 (9)
C19 0.5012 (10) 0.8001 (13) -0.1819(10) 0.099 (9)
C20 0.4454 (8) 0.8707 (9) -0.1130 (8) 0.079 (7)
H I 0.1327 (57) 0.8167 (78) 0.0378 (69) 0.107 (8)
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Table A2 Fractional Atomic Co-ordinates for the Hydrogen Atoms.
Atom X Y Z
H21 0.3571 0.6855 0.0996
H31 0.5378 0.5877 0.1481
H41 0.6439 0.6493 0.3001
H51 0.5717 0.8151 0.3983
H61 0.3869 0.9117 0.3540
H81 -0.0234 0.9081 0.1841
H91 -0.1848 0.8038 0.2605
H101 -0.1482 0.6456 0.3800
H i l l 0.0498 0.5692 0.3999
H121 0.2163 0.6786 0.3281
H131 0.3438 0.9663 0.0366
H141 0.2526 1.0568 -0.1138
H142 0.1653 1.0731 -0.0059
H143 0.1289 0.9677 -0.0970
H161 0.1965 0.7196 -0.0893
H171 0.2934 0.5952 -0.2093
H181 0.4898 0.6482 -0.2732
H191 0.5875 0.8225 -0.2081
H201 0.4883 0.9486 -0.0863
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Table A3 Anisotropic Thermal Parameters (A).
Atom U ll U22 U33 U23 U13 U12
P P I 0.040(1) 0.034 (1) 0.054 (1) - 0.001 (1) -0.003 (1) 0 .000  (1)
O l 0.071 (4) 0.037 (3) 0.077 (4) -0.005 (2) 0.006 (3) 0.004 (2)
N1 0.038 (3) 0.048 (3) 0.066 (5) 0.007 (3) 0.008 (3) -0.003 (3)
C l 0.039 (4) 0.047 (4) 0.064 (6) 0.013 (4) -0.005 (4) -0.008 (3)
C2 0.050 (4) 0.050 (5) 0.079 (7) 0.005 (4) 0.002 (4) 0.013 (4)
C3 0.062 (6) 0.077 (6) 0.123 (10) 0.024 (7) 0.018 (8) 0.014 (5)
C4 0.045 (6) 0.086 (8) 0.165 (13) 0.059 (8) 0.001  (8) 0.006 (6)
C5 0.053 (6) 0.118(9) 0.122  (10) 0.054 (8) -0.039 (6 ) -0.036 (6)
C6 0.062 (6) 0.072 (6) 0.078 (7) 0.023 (5) -0.016 (5) -0.021 (4)
C7 0.040 (4) 0.048 (4) 0.046 (5) -0.006 (4) -0.003 (4) -0.003 (3)
C8 0.036 (4) 0.066 (5) 0.073 (6) 0.001(4) 0.002 (4) 0.003 (4)
C9 0.043 (5) 0.095 (7) 0.076 (7) 0.014 (6) 0.015 (4) 0.006 (5)
CIO 0.055 (6) 0.101  (8) 0.087 (7) 0.018 (7) 0.014 (5) -0.009 (5)
C l l 0.072 (6) 0.085 (7) 0.096 (8) 0.047 (6) 0 .0 1 2  (6) -0.014 (5)
C12 0.050 (5) 0.058 (5) 0.098 (7) 0.020 (5) -0.004 (5) 0.004 (5)
C13 0.048 (4) 0.055 (5) 0.062 (5) 0.005 (4) 0.000 (4) -0.015 (4)
C14 0.084 (6 ) 0.057 (5) 0.094 (7) 0.011 (6) 0 .0 1 0  (6) 0.007 (4)
C15 0.052 (4) 0.051 (4) 0.054 (5) 0.014 (4) 0.001 (4) 0.002 (3)
C16 0.060 (5) 0.068 (6) 0.061 (6) -0.010 (5) 0.010 (4) 0.008 (4)
C17 0.080 (7) 0.088 (7) 0.060 (6) 0.001 (5) -0.001 (5) 0.012 (5)
C18 0.104(10) 0.110 (9) 0.073 (8) -0.007 (7) 0.011  (6 ) 0.043 (8)
C19 0.068 (6) 0.122  (10) 0.108 (10) 0.005 (8) 0 .021  (6) 0.027 (7)
C20 0.048 (5) 0.088 (7) 0.100  (8) 0.018 (6) 0.009 (5) 0.002 (5)
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Table A4 Bond Lengths (A).
P l - O l 1.487 (5) P l - N l 1.601 (7)
P I - C l 1.817(7) P 1 -C 7 1.805 (7)
N l - H l 1.071 (20) N1 - C13 1.479(10)
C 1 - C 2 1.392 (11) C 1 -C 6 1.391(11)
C 2 - C 3 1.369 (13) C 3 -C 4 1.382(18)
C 4 - C 5 1.381 (18) C 5 -C 6 1.382 (14)
C 7 - C 8 1.398 (10) C 7-C 12 1.377(11)
C 8 - C 9 1.359(11) C 9-C 10 1.374(12)
CIO - C l l 1.361 (13) C l l  - C12 1.398(11)
C13 - C14 1.538 (11) C13 - C15 1.484(11)
C15 - C16 1.373 (11) C15 - C20 1.420 (12)
C16 - C17 1.360(12) C17 - C18 1.398 (15)
C18 - C19 1.367 (16) C19 - C20 1.382(15)
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Table A5 Intermolecular distances (A).
0 1  - -  N1 2.87 4 - 1.0 1.0 - 1.0
0 1 - -H I 1.81 4 -1.0 1.0 - 1.0
01  — H143 2.89 4 -1.0 1.0 -1.0
01  — H161 2.49 4 -1.0 1.0 -1.0
H21 - -C18 2.96 4 0.0 1.0 - 1.0
m i ­» C19 2.81 4 0.0 1.0 - 1.0
ca  — H121 2.90 3 1.0 0.0 0 .0
H31 -  C4 2.98 3 1.0 0.0 0.0
C6 — m o i 2.98 2 1.0 2.0 - 1.0
C6 — H il l 2.99 3 1.0 0.0 0.0
H61 -  C9 2.97 4 -1.0 1.0 - 1.0
H101 -C18 2.86 3 1.0 1.0 - 1.0
C16- H191 3.00 4 0.0 1.0 - 1.0
C17- H181 3.00 4 0.0 1.0 - 1.0
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Table A6 Bond Angles (°)
N1 -  P I -  0 1 117.4 (3) C l -  P I -  0 1 108.2 (3)
C l -  P I -  N1 107.0 (4) C7 -  P I -  0 1 112.7 (3)
C7 -  P I -  N1 103.3 (3) C7 -  P I -  C l 107.7 (3)
H I -  N1 -  P I 126 (6) C13 -  N1 -  P I 121.9 (5)
C13 -  N1 -  H I 1 1 0 (6) C2 -  C l -  P I 121.2 (6)
C6 -  C l -  P I 118.7(7) C6 -  C l -  C2 120.1 (8)
C3 -  C2  - C l 120 (1) C4 -  C3 —C2 120 (1)
C5 -  C4 -  C3 119.3 (9) C6 -  C5 -  C4 121 (1)
C5 -  C6 -  C l 119(1) C8  -  C7 -  P I 118.8(6)
C12 -  C7 -  P I 122.2  (6) C12 -  C7 -  C8 118.8(7)
C9 — C8  — C7 120.3 (8) C 1 0 - C 9 - C 8 120.7 (8)
C l l  -  CIO -  C9 120.0 (9) C12 -  C l l -  CIO 119.9(9)
C l l  -  C12 —C7 120.0 (8) C14 -  C13 -  N1 110.6(7)
C15 -  C13 -  N1 112.9 (6) C15 -  C13 -C 14 110.2(7)
C16 -  C15 -  C13 124.4 (7) C20 — C 1 5 -C 1 3 119.2 (8)
C20 -  C15 -  C16 116.3 (8) C17 -  C16 -  C15 123.3 (9)
C18 -  C17 -  C16 120 (1) C 1 9 -  C18 — C17 119(1)
C20 -  C19 -  C18 120 (1) C19 -  C20 -  C15 121 (1)
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Table A7 Intramolecular Distances (A).
P I  -  H I 2.40 P I -  C2 2.80
P I -  H21 2.94 P I —C6 2.77
P I -  H61 2.89 P I  -  C8 2.77
P I -  H81 2.88 P I -  C12 2.79
P I -  H121 2.94 P I -  C13 2.69
P I  -  H131 2.66 0 1  -  N1 2.64
O l -  C l 2.68 0 1  -  H61 2.66
0 1  -  C7 2.75 O l -  H131 2.87
N1 -  C l 2.75 N1 -  H21 2.66
N1 -  C l 2.68 N1 -  H131 2.06
N1 -  C14 2.48 N1 -  H142 2.71
N1 -  H143 2.73 N1 -  C15 2.47
N1 -  C16 2.96 N1 -  H161 2.68
H I -  C7 2.81 H I -  C13 2.11
H I -  C14 2.69 H I -  H143 2.50
H I ~  C15 2.77 H I -  C16 2.79
H I -  H161 2.16 C l -  H21 2.15
C l -  C3 2.39 C l -  C4 2.77
C l -- C5 2.39 C l -  H61 2.15
C l -  C l 2.93 C l -  H 121 2.62
C2 -  H31 2.12 C2 -  C4 2.39
C2 -  C5 2.75 C2 -  C6 2.41
H21 -  C3 2.13 H21 -  C15 2.97
C3 -  H41 2.14 C3 -  C5 2.38
C3 -  C6 2.77 H31 -  C4 2.14
C4 -  H51 2.13 C 4 - C 6 2.41
H41 -  C5 2.14 C5 ~  H61 2.14
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Table A7 Cont.
H51 -  C6 2.13
C7 -  C9 2.39
C l  -  C l l 2.40
C8  -  H91 2.11
C9 -  C l l 2.75
H81 -  C9 2.12
C9 -  C l l 2.37
H91 -  CIO 2.13
CIO -  C12 2.39
C l l  -  H121 2.15
C13 -  H141 2.15
C13 -  H143 2.16
C13 -  H161 2.74
C13 -  H201 2.70
H131 -  C15 2.08
C14 -  C15 2.48
H143 -  C15 2.76
C15 -  C17 2.40
C15 -  C19 2.44
C16 -  H171 2.12
C16 -  C19 2.74
H161 -  C17 2.10
C17 -  C19 2.39
H171 -  C18 2.16
C18 -  C20 2.39
C19 — H201 2.13
C l  -  H81 2.15
C l  ~  C19 2.77
C l  -  H121 2.13
C8  -  CIO 2.37
C8 ~  C12 2.39
C9 -  H101 2.13
C9 -- C12 2.75
C I O -  H i l l 2.12
H101 -  C l l 2.12
H i l l  -  C12 2.15
C13 -  H142 2.15
C13 -  C16 2.53
C13 -  C20 2.51
H131 -  C14 2.15
H131 -  C20 2.56
H141 -  C15 2.68
C15 -  H161 2.11
C15 -  C18 2.81
C15 -  H201 2.16
C16 -  C18 2.38
C16 -  C20 2.37
C17 -  H181 2.15
C17 -  C20 2.75
C18 — H191 2.12
H181 -  C19 2.13
H191 -  C20 2.14
